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Development of a Phage-Based Biosensor to Detect 
Salmonella in Food Stuff 
 
Abstract 
Food- and waterborne illnesses are a serious public health concern worldwide and have stim-
ulated research aiming at a rapid and accurate detection of pathogens by applying biosensing 
technologies. Salmonella, Campylobacter and E. coli are some examples of pathogens that 
have an enormous impact on public health. Many publications have mentioned different type 
of biosensors for a broad range of bacteria. These methods may circumvent the limitations 
that conventional microbiological techniques have. Pathogens of interest need culture en-
richment steps to reach the detection limit, a process that requires time, as well as laboratory 
technicians with expertise skills. Detection of pathogens at a very early stage is not as easy as 
it seems, due to the necessity to unite a set of characteristics that enable the development of 
an inexpensive and robust biosensor. The ideal biosensing system should be rapid and accu-
rate and should combine specificity and sensitivity, leading to a marginal amount of false 
positive or negative results. As the biosensor is composed of two parts, a biological and a 
sensor element, the biorecognition element of choice plays a crucial role when creating the 
perfect biosensor. Bacteriophages (or simply phages) are viruses that specifically recognize 
bacteria and this characteristic can be used as a potential "key" to solve problems related with 
bacterial detection. Moreover, the easy and low cost production of these viruses combined 
with their stability in harsh environmental conditions make them excellent competitors with 
other biological elements (e.g. antibodies, enzymes). The use of phages as a therapeutic agent 
and as an interface in detection systems has gained special interest of the research communi-
ty. In many laboratories, phage-based platforms have been developed; however only a few 
have broken the barrier and went to the market as a clinical diagnostic tool. Nowadays, the 
food sector still uses conventional methods to detect Salmonella in food stuff that, as men-
tioned before, take times and requires expert skills.  Notwithstanding the great improvements 
in the detection area, biosensing systems still lack sensitivity and give erroneous results. Fur-
thermore, problems related to the detection of bacteria in a viable but nonculturable (VBNC) 
state is one of the concerns that can give false negatives. VBNC bacteria are not able to grow 
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on standard bacteriological media, but are metabolically active, albeit very low, maintaining 
the capacity to cause diseases and therefore remain a potential risk in several health facilities 
and the food industry. The use of standard microbiological methods to detect if the bacterium 
is dead or alive is no practicable, since the presence of VBNC state is not detectable. There-
fore, novel technologies that can overcome this barrier are imperative. The prevalence of this 
problem and the necessity of finding a detection technology that can fulfill the Salmonella 
detection needs, led to the proposal of the present work that explores phages as an interface in 
a magnetoresistive and magnetoelastic biosensor. The work presented herein describes the 
characterization of a broad host range lytic phage. PVP-SE1, is able to discriminate between 
cell viability states, including the VBNC condition. This phage was combined with highly 
sensitive magnetoresistive sensors originating a powerful detection system with high-
standard performance at the accuracy, specificity but also sensitivity level, detecting bacteria 
concentrations in the order of 100 cells/µL (3-4 cells/sensor). Another strategy followed, aim-
ing at circumventing the limitations of using whole phages in a biosensing interface, was the 
utilization of  recognition peptides of phage origin, responsible for the identification of the 
hosts. The proof-of-concept was demonstrated with a model phage selected from landscape 
library as a streptavidin binder. The results showed that the streptavidin binding peptides ex-
tracted from the phage bind to streptavidin with the same or better affinity than the native 
phage. The same was demonstrated with the tail fibre proteins of phage PVP-SE1, 
heterologously expressed, which showed equal binding affinities compared to their parental 
phage. This work demonstrates how phages can be explored in the development of a biosen-
sor, opening the possibility of using an accurate, sensitive, specific and cheaper device that 
can be applied to an emergent concern: foodborne pathogens.  
 
 
 
 
Keywords: Foodborne pathogens; Detection; Bacteriophages; Specificity; PVP-SE1 phage; 
Salmonella; Biosensor; Viable But Nonculturable (VBNC) state; False positives; False nega-
tives 
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Desenvolvimento de um Biossensor à Base de Fagos 
para Deteção de Salmonela nos Alimentos 
 
Resumo 
As doenças transmitidas através de alimentos e água contaminada são uma preocupação 
mundial e têm estimulado o desenvolvimento de métodos rápidos e precisos na área dos bios-
sensores para a deteção de agentes patogénicos.  Salmonela, Campylobacter e a E. coli são 
exemplos de espécies bacterianas patogénicos que tem um enorme impacto na saúde pública. 
Atualmente já existem diferentes tipos de biossensores desenvolvidos para uma ampla varie-
dade de bactérias, que contornam as limitações das técnicas convencionais, tais como tempo 
de medida, devido à amplificação do microrganismo de interesse no seu adequado meio de 
cultura, e pela necessidade de técnicos com competências específicas. No entanto, a deteção 
de agentes patogénicos não é assim tão fácil como parece devido à necessidade de combinar 
um conjunto de características que permita o desenvolvimento de um biossensor robusto e 
pouco dispendioso. Um sistema de deteção ideal deve ser rápido, preciso e combinar caracte-
rísticas como especificidade e sensibilidade, de forma a conduzir a resultados livres de falsos 
positivos/negativos. Como o biossensor é composto por duas partes, i.e. um elemento bioló-
gico e um sensor, o elemento biológico escolhido tem um papel crucial no momento da cria-
ção de um biossensor perfeito. Bacteriófagos (ou simplesmente fagos) são vírus que infetam 
especificamente bactérias podendo essa característica ser utilizada como uma “chave” para 
solucionar problemas relacionados com a deteção de bactérias. Para além disso, a produção 
simples e económica destes vírus juntamente com a sua estabilidade em condições ambientais 
adversas, torna-os excelentes ferramentas de deteção, podendo competir com outros elemen-
tos biológicos (e.g. anticorpos, enzimas). A sua utilização como agentes terapêuticos e como 
interface em sistemas de deteção tem recebido uma atenção especial por parte da comunidade 
científica. Muitos laboratórios têm desenvolvido plataformas de deteção à base de fagos, no 
entanto, somente algumas conseguiram quebrar a barreira e entrar no mercado para serem 
usadas como ferramenta deteção para uso clinico. Hoje em dia, indústrias alimentares ainda 
usam métodos convencionais para detetar Salmonela na alimentação que, tal como previa-
mente referido, são morosas e exigem mão de obra especializada. Mesmo utilizando diversas 
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estratégias de deteção com diferentes plataformas e bio recetores, problemas com resultados 
falsos positivos e negativos permanecem difíceis de resolver. Bactérias viáveis, mas não cul-
tiváveis são uma preocupação, porque estão relacionadas com resultados falsos negativos. 
Bactérias viáveis, mas não cultiváveis, não têm capacidade de crescer em meios de cultura 
convencional, mas encontram-se metabolicamente ativas, conservando a sua capacidade de 
causar doenças e de serem um potencial perigo em várias setores da saúde e na industria ali-
mentar. Assim, a utilização de métodos de cultura padronizados para detetar se a bactéria está 
viva ou morta torna-se inviável, já que a presença de bactérias num estado viável, mas não 
cultivável não é detetada.  Portanto, novas tecnologias que possam ultrapassar essa barreira 
são fundamentais. A prevalência deste problema e a necessidade de encontrar uma tecnologia 
de deteção que possa satisfazer as necessidades de deteção da Salmonela conduziu à proposta 
deste trabalho que explora os fagos como uma possível interface a usar em biossensores 
magneto-resistivos e magneto-elásticos. O trabalho presentado aqui descreve a caracterização 
de um fago lítico com um amplo espectro lítico,  PVP-SE1. Este fago provou capacidade em 
discriminar os estados de viabilidade celular incluindo o estado viável, mas não cultivável. O 
fago foi combinado com sensores magneto-resistivos, que têm mostrado uma elevada sensibi-
lidade. Esta combinação originou um poderoso sistema de deteção com um padrão de desem-
penho elevado, quer em termos de precisão e especificidade, quer em termos de sensibilidade, 
detetando concentrações de bactérias na ordem de 100 células/µL (3-4 células/sensor). Uma 
outra estratégia adotada, tendo por objetivo contornar as limitações da utilização dos fagos 
inteiros numa interface de um biossensor, passou pela utilização dos recetores dos fagos  res-
ponsáveis pela identificação dos hospedeiros. Como prova de conceito um fago com especifi-
cidade de ligação à streptavidin  foi selecionado a partir de uma biblioteca de fagos e usado 
como modelo. Os resultados demonstraram que os recetores do fago ligam-se à streptavidin 
com a mesma ou melhor afinidade do que o fago inteiro (original).  O mesmo foi demonstra-
do com os recetores do fago PVP-SE1, demonstrando igualmente afinidades de ligação, com-
parativamente, com o seu fago parental. Este trabalho demonstrou como os fagos podem ser 
explorados no desenvolvimento de um biossensor abrindo a possibilidade de desenvolver um 
dispositivo preciso, sensível, específico e económico que possa ser aplicado a uma preocupa-
ção emergente: os patogénicos de origem alimentar. 
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Scope of the thesis 
 
Problems related with Salmonella have generated a high social and economic impact world-
wide. The difficulties that come with controlling this microorganism in the food chain are 
enormous and the necessity to combine a control program with an excellent detection system 
is an ambitious goal to achieve. Several detection technologies have emerged, but none is 
able to fulfill all requirements: the perfect detection system should be rapid, sensitive, specif-
ic, accurate and inexpensive and should contain all these features in "one package". I would 
risk to say that ideally, an excellent detection system is a small device that we take from our 
pocket and tells us, in a fast and accurate manner, if what we are eating is safe or not. The 
work described in this thesis aimed at developing a detection device for Salmonella taking in 
mind the ideal characteristics of an excellent detection system. It was based on this goal that 
our interest and motivation focused on a highly specific entity that could serve as a recogni-
tion tool: Bacteriophages. Bacteriophages (phages) are viruses that specifically recognize and 
infect bacteria. Phage´s specificity and stability combined with their low production costs are 
features that can compete with many biological elements (e.g. antibodies). The idea was to 
use a lytic phage that specifically recognizes a very broad range of Salmonella strains, com-
bined with a portable magnetoresistive bio-analytical device to generate a phage-based bio-
sensor and explore its potential on the detection of Salmonella. Many challenges have to be 
faced when developing this detection tool, and many questions were formulated at the begin-
ning of the work, helping us to accomplish each step/task. Questions as: How can we benefit 
from phages as a detection agent? Will the phage preserve its excellent feature as specificity 
when immobilized on a sensor surface? When we only intend to have the recognition part 
active and available, how will we circumvent structural aspects? Can we use phage deriva-
tives as a detection tool? Can phages distinguish cell viability?   
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Structure of the thesis 
 
A scheme simplifying the main steps that built this thesis and helped to "fulfill" the proposed 
objective is shown in Figure 0:1:1. 
 
Figure 0:1:1: Informal proposed approach. 
 
This dissertation was built through a multidisciplinary approach, joining knowledge of differ-
ent fields such as physics, electronics, virology and molecular biology. The work in this the-
sis was made possible by the scientific collaboration of the Centre of Biological Engineering, 
University of Minho (Portugal) with several other Laboratories: (1) Laboratory of Gene 
Technology, Katholieke Universiteit Leuven (Belgium) where tasks such as sequencing, 
cloning and protein expression were carried out; (2) Department of Pathobiology, Auburn 
University (USA) where the "nanophages" interface was explored for detection systems; (3) 
Materials Research and Education Center, Wilmore Labs, Auburn University (USA) where 
xxix 
 
magnetoelastic biosensor was used to validate that nanophage interface and (4) The Interna-
tional Iberian Nanotechnology Laboratory (INL, Braga), where a magnetoresistive phage-
based biosensor for Salmonella viability assessment was developed. Besides these collabora-
tions other laboratories had a smaller, but important contribution, like the Pharmacy Depart-
ment (Auburn, USA), ICVS (UM, Braga), INESC-MN (Lisboa) and IST (Lisboa).   
 
This thesis describes the development of a phage-based biosensor to detect Salmonella and is 
structured in the following five chapters.  
 
Chapter I contains the background information of the thesis subject, covering the main con-
cepts, i.e. Salmonella, bacteriophages, biosensors, the current methods used for Salmonella 
detection and the advances in food testing using phage-based pathogen biosensors.  
 
Chapter II describes the characterization of three promising Salmonella phages based on 
their lytic spectrum. The results presented in this chapter led to the selection of a phage with a 
broad lytic spectrum and with the ability to infect and replicate in a nonpathogenic host. This 
phage, which was further used for the construction of the biosensor, is a safe phage product 
that can easily be approved for commercial applications. The sequences provided in this step 
opened other possibilities, regarding the use of phage derivatives products as biorecognition 
elements.  
 
Chapter III reports the development of a magnetoresistive phage-based biosensor. The de-
veloped sensor has the ability to specifically recognize Salmonella and a great potential to 
detect viable but non-culturable bacterial cells. 
 
Chapter IV focuses on the problems related with phage structure when immobilized on the 
sensor surface and how we can circumvent this limitation. Two different phages were evalu-
ated on this step, namely lytic and filamentous phages. The phage tail fiber proteins of the 
lytic phages were used for specific detection and control of Salmonella enterica. Some pre-
liminary tests of the binding affinity of the tail fiber proteins to the target (Salmonella) are 
shown. Regarding the filamentous phages, we developed a novel "nano-phages" interface for 
xxx 
 
detection systems. Our findings suggested that this new approach may be an alternative to use 
and replace the parental phage.  
 
Chapter V summarizes the general conclusions of this thesis and show how this work con-
tributed to the knowledge on phage-based biosensors. In addition, future perspectives and 
directions will be given.  
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Chapter 1 
 
General Introduction 
1 General Introduction 
Food is essential for health and well-being, although when contaminated, may cause 
serious problems with high social and economic impact worldwide. Foodborne illness 
forces a sequence of adverse events, i.e. people become ill, the food industry is dam-
aged, and the regulatory and public health sectors are affected. Despite the great effort 
to combat this problem, the World Health Organization (WHO) estimates that annually 
in industrialized countries approximately 30% of the population passes through a dis-
ease of this nature [1]. Specific control programs to prevent and control foodborne dis-
eases have been implemented as strategies to reduce the outbreak numbers (e.g. control 
program "from farm to fork") [2], but it has not been enough. Therefore it has become 
urgent to find rapid and accurate detection methods combined with high-quality control 
programs. The traditional culture  methods, immunological and polymerase chain reac-
tion based methods take hours or days to obtain results [3]. In addition, problems related 
with false results still occur. Biosensors appear as a promising detection tool in this field 
and have captured the attention of many researchers that explored this technology for 
many types of bacteria. This introduction will focus on the common foodborne patho-
gen, Salmonella, and on conventional and emergent detection methods. 
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1.1. Foodborne Illness Caused by Salmonella  
 
A foodborne illness is a disease caused by agents (e.g. bacteria, viruses) in food which, 
when ingested, originates severe human infections. Several types of food can be con-
taminated, but commonly infected are foods of animal origin, such as meat, fish and 
poultry [4]. Other food products from non-animal origin, like fruits, vegetables and wa-
ter can also be contaminated and may lead to an infectious disease. Salmonellosis (food 
poisoning caused by the Salmonella bacterium) has been an occurring problem in indus-
trialized countries. Salmonella bacterium is a gram-negative rod-shaped bacilli (typical-
ly 0.5 µm by 1-3 µm) commonly found in intestinal track of domestic and wild animals 
[5]. There are two species of Salmonella: Salmonella enterica and Salmonella bongori. 
Salmonella enterica comprises six subspecies: S. enterica (subspecies that causes more 
Salmonella infections in humans), S. salamae, S. arizonae, S. diarizonae, S. houtenae 
and S. indica. There are about 2,500 serovars and most of them are introduced into hu-
man populations by contaminated foods, soil, water or animal contact [6]. 
Immunocompromised people, pregnant women, infants, and the elderly are the groups 
more susceptible to this zoonotic bacteria [7]. The common symptoms of salmonellosis 
are fever, diarrhea, and abdominal cramps and severe infections require hospitalization. 
Salmonella can spread easily from animals to humans by the consumption of food as 
mentioned previously and by inadequately cooked or poorly handled food.  Direct con-
tact with domestic animals is another infection line that can cause salmonellosis [2]. A 
summary of the direct or indirect possible transmission vehicles of Salmonella to hu-
mans is illustrated in Figure 1:1. 
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Figure 1:1: Possible vehicles of Salmonella transmission which can cause non-typhoidal Sal-
monellosis in humans (adapted from Hilbert et. al.[2]). 
 
A complete depiction of salmonellosis occurrence is difficult to provide, since in gen-
eral only large outbreaks are studied and reported. The European Food Safety Authority 
(EFSA) considered Salmonella as the bacterium responsible for most reported cases of 
foodborne diseases in the European Union (EU) in 2010 (Figure 1:2 - A). The most 
common serovars were S. Enteritidis and S. Typhimurium (45.0 % and 22.4 %, respec-
tively) [8]. EFSA estimates that 100,000 cases of salmonellosis occur each year in Eu-
rope [9], predominantly transmitted by eggs, chicken and pork meat [10]. Eggs were in 
2010 the main vehicle of transmission (43.7%), followed by bakery products (14.4 %) 
and buffet meals (12.3%) (Figure 1:2–A). However, the problem is not centred on Eu-
rope but also extends to U.S. (1.2 million illnesses/year) and other parts of the world 
(e.g. China, India, Australia) as shown in Figure 1:2 – B [3] [4]. 
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Figure 1:2: Image A: Distribution of food-borne outbreaks with weak and strong evidence (ex-
cluding strong evidence on waterborne outbreaks) per causative agent (I); by food vehicle (II) 
and for causative agent of eggs and egg products contamination (III) in the EU, 2010 [8]. Image 
B: Some reported cases of enteric fever and salmonellosis worldwide [11]. 
 
A 
B 
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The numbers reported each year have gained special importance worldwide and 
programs to control and protect the human health have been implemented. Since 2007 
EU States Members were obliged to implement Salmonella control programs in breed-
ing flocks of Gallus gallus in accordance with Regulation (EC) No 1237/2007 [13]. 
According to EFSA, the decrease of salmonellosis from that time to 2010 was mainly 
due to the control program implemented in poultry populations [8]. Some countries 
joined their own control programs with the international safety program recognized 
worldwide, the Hazard Analysis Critical Control Points (HACCP) system. Such an inte-
gration of control programs occurred in Canada, where Canadian chicken farm-
ers combined good production practices with HACCP rules into the chicken production. 
In this particular case, farmers now follow narrow barn cleaning procedures and the 
farm water supplies are analyzed annually [14]. HACCP is a system that was imple-
mented to guarantee the safety in all stages of the commercial food process, i.e. from 
ingredients, handling procedures to all activities that involve food components. The 
critical control points (CCPs) are the stages where the hazard is high and at which ur-
gent proceedings should be developed to control the process. The CCPs are defined ac-
cording to each case. HACCP have integrated the national food safety legislation in 
many countries, although different continents have a different interpretation of this sys-
tem [15]. Even when using these plans to employ and control the production practices 
on the food chain, the verification of each HACCP stage is dependent on rapid tests that 
avoid the alarm or suspicion of a contamination. The detection of Salmonella is still a 
focal point in standard culture methods, which are time consuming (taking 3-5 days) 
and require expert skills. Therefore, the concern of finding new solutions and revolu-
tionary technologies for an early detection of Salmonella has been installed in industri-
alized countries. The idea is to combine an excellent control program with a rapid and 
accurate detection system that consequently decreases the social and economic impact 
of foodborne outbreaks worldwide. 
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1.2. Detection of Foodborne Pathogens: Emerging Technolo-
gies 
 
1.2.1. Conventional Culture Methods 
 
The method described in ISO 6579:2002 is an example of a conventional pathogens 
detection technique applied to products consumed by humans, feed for animals and en-
vironment samples collected from the areas of food production and handling. The meth-
od consists of four stages: i) pre-enrichment in non-selective liquid medium; ii) enrich-
ment in selective liquid medium; iii) plating out; iv) identification and the confirmation 
of identity [16]. Standard methods take three to five days to obtain a result, in general 3 
days to provide a negative result and 5 days to confirm a positive one [3]. The disad-
vantages of the method described in ISO 6579:2002 are the time needed to obtain re-
sults and the possibility of false negatives due the dormancy state of bacteria. Salmonel-
la and E.coli are some examples of bacteria that, under stress environment conditions, 
can enter a physiological state in which they become non-culturable even when they are 
still alive [17]. When the bacteria enter this state, they are commonly called: "Viable but 
nonculturable" (VBNC). The metabolic cell activity is lower and only under optimal 
grow conditions they can turn culturable again, renewing the ability to cause infection. 
Chemical and environmental factors are the reasons behind this cell state. Temperatures 
out of their range growth, lack of nutrients, elevated or lowered osmotic concentrations, 
effects caused by bactericidal agents (e.g. chlorination of wastewater) are some exam-
ples of stress conditions that induce the cells to enter the VBNC state. Therefore, the use 
of the standard culture can lead to an underestimation of pathogen numbers and the ac-
curacy stays far from what is expected. Other methods have arisen to complement or 
substitute the traditional culture methodologies to produce rapid and sensitive detection 
technologies. Immunological and molecular detection methods are some of the alterna-
tives which can decrease the time assay.  
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1.2.2. Immunology-based Methods 
 
Methods involving antigen–antibody interaction are widely used for pathogens detec-
tion [11, 12]. The specificity and sensitivity is dependent on the choice of antibody 
(monoclonal or polyclonal). Radioimmunoassay (RI), the enzyme-linked 
immunosorbent assay (ELISA), the enzyme-linked fluorescent assay (ELFA), 
immunomagnetic separation (IMS) assay, and lateral flow immunoassay (LFI) are some 
examples of immunoassays [20]. Nowadays a variety of commercial products exists for 
Salmonella detection based on this technique. Currently, some commercially available 
immunoassay kits exist for Salmonella detection. VIDAS
®
SLM Salmonella assay 
(BioMérieux), Salmonella ELISA (BIO ART.) [20], Tecra UniqueTM Salmonella test 
are some examples. The main disadvantage of these tests is the cross reactivity of anti-
bodies and their shelf-life. An excellent book chapter about the use of "Antibodies and 
immunoassays for detection of bacterial pathogens" can be found in reference [21], 
where the reader can find an overview of commercial immunoassay kits for pathogens.  
 
1.2.3. Polymerase Chain Reaction (PCR) 
 
PCR was developed by Mullis and colleagues in 1986 [22] and has been widely used for 
bacteria identification. This technique is based on the DNA amplification of the target 
of interest in millions of copies, using primers, an enzyme (Taq polymerase) in a pro-
cess involving a set of repeated cycles of heating and cooling. Denaturation is the first 
step of the process and occurs at 94-98
o
C allowing the DNA melting and the break of 
the hydrogen bonds between the two strands DNA. The annealing happens at lower 
temperatures (50-65
o
C), allowing the primers to hybridize to the single-stranded DNA 
template. The extension or elongation step is related to the enzymatic DNA synthesis by 
DNA polymerase, which occurs at high temperatures. A variety of thermostable DNA 
polymerases exists, but the first used in PCR was Taq polymerase, isolated from the 
bacterium Thermus aquaticus with an optimal temperature around 75-80
o
C. The PCR 
reaction is carried out in a thermocycler device. Studies including the standard PCR 
with an enrichment step are also reported. Löfström et al. [23] combined the standard 
culture method with PCR to detect Salmonella in animal feed samples. In this study, the 
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problem related with the small numbers of Salmonella and the presence of feed inhibi-
tors on samples was circumvented by using an enrichment step at 37
o
C for 18 hr in 
buffered peptone water (BPW). However, this strategy requires laboratory space, prepa-
ration of gel electrophoresis and analysis. PCR as a detection techniques was rapidly 
followed by other PCR-based applications (real-time, multiplex and reverse transcrip-
tase (RT) PCR) that have all made some improvements over the classical PCR method 
and are usually based on fluorogenic probes. These methods have the following ad-
vantages: 
 
 Real-time PCR allows to obtain rapid results without laborious manipulations, 
i.e. the equipment is composed of an optical system that follows the course of 
reaction in real time without a post-amplification process (e.g. gel electrophore-
sis) [24].  
 Multiplex PCR has the advantage to detect simultaneously diverse bacterial 
strains by introducing different primers to amplify DNA regions coding for spe-
cific genes of each strain targeted [25].  
 RT-PCR helps to overcome a limitation of both methods above: the difficulties 
to distinguish viable from non-viable cells [26].  
 
Despite the advantages mentioned above, reduction of time diagnostic and its high 
throughput character, the PCR-based detection techniques have also some limitations 
regarding the possibility of sample contamination, lack of standardization, complex in-
terpretation of results, and high cost production [27]. From an industrial point of view 
PCR can also be expensive and complicated, and requires expert workers. Therefore, 
the idea of creating a rapid, specific, sensitive, accurate and simple low cost device that 
allows in situ real-time monitoring has persisted. Recently, the research on pathogen 
detection has directed its attention to the biosensor field with some promising results.  
 
1.2.4. Biosensors and Biochips 
 
In the past two decades, we have witnessed a great evolution in the biosensor and bio-
chip field. New technologies have appeared that aim at the development of portable 
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devices to quickly analyze clinical, industrial and research samples. These systems 
should unite a set of characteristics that enable the development of an inexpensive and 
robust device. Requirements as accuracy - leading to low amount of false positive or 
negative results - , assay time, sensitivity, specificity, robustness, reproducibility and 
user-friendliness are demanded when the goal is to develop a quality device. Moreover, 
to prove those qualities the new technology needs to be validated against current stand-
ard techniques.   
 
1.2.4.1 Biosensors and biochips: a definition 
 
A biosensor, as the word itself indicates, is the combination of two components: a bio-
logical and a sensor element. Both parts play an important role in creating a sensitive 
and specific device. The biological element (e.g. antibodies, enzymes, or bacteriophag-
es) recognizes the target of interest (e.g. bacterium, cancer cell) and, as soon as the iden-
tification happens, the sensor element will convert a chemical or physical change into an 
electrical signal. The output from the transducer is then amplified, processed and dis-
played/saved as a measurable effect. (Figure 1:3). 
 
 
Figure 1:3: Schematic diagram of a biosensor, showing the possible biological elements (e.g. 
bacteriophages, DNA) and transducer platforms that can be used to develop a biosensor. 
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Biochips are the new generation of biosensors and consist of an array of single bio-
sensors that can be individually monitored. They are often used to detect multiple tar-
gets. Biosensors/biochips can be classified based on their biological or transducer ele-
ments. There are a variety of transducers, although the ones commonly used in studies 
of foodborne pathogens detection are the optical, electrochemical and mass-based trans-
ducers. A brief introduction about the transduction methods and biological elements 
will be given in this chapter. Phages as biological element and magnetoresistive and 
magnetoelastic biosensors will be explained in more detail, as they were the basis of this 
work. 
 
1.2.4.2 Transducers 
1.2.4.2.1 Optical-based Biosensors 
 
Optical biosensors are highly sought, mainly due the inherent qualities of these systems, 
including high sensitivity and possible direct, real-time and label-free detection of many 
chemical and biological components. The concept behind the label-free optical biosensors 
is based on the interaction of light with the adsorbed biological elements, i.e. the light is 
reflected on the biosensor surface and affected by the presence of the biomolecules. The 
light event is measured directly based on changes in the properties of the light used (e.g., 
intensity, wavelength, polarization, and phase). Surface plasmon resonance (SPR) and the 
fluorescence are the most commonly used techniques in optical field and used in studies 
related with pathogens detection mainly due their sensitivity. SPR determines the presence 
of the target by measuring the changes in the local refractive indices caused by the altera-
tions in the proximity of a thin film metal surface (usually gold) (Figure 1:4).  
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Figure 1:4: Illustration of the concept of SPR biosensing [28], where analyte molecules in a 
liquid sample bind to the biological element immobilized on the sensor surface. When the bind 
occurs an increase in the refractive index at the sensor surface happens and is optically meas-
ured. 
 
Gold is widely used as surface, especially due to its oxidation stability and inert-
ness, which is a wanted characteristic when working with biological samples [29]. Zor-
dan et. al. [30] reported the combination of the two optical techniques mentioned above. 
They were able to detect E. coli O157:H7 combining SPR with fluorescence and sug-
gested a "portable cytometry" and a competitive technology for the food processing 
industry. Moreover, they suggested further experiments using this system to image a 
biosensor array to perform multiplexed pathogen detection. The interest in commercial-
izing SPR products has increased and nowadays we can have access to some commer-
cial SPR-based biosensors for pathogens detection in food and water (e.g. SR 7000, 
BIAcore 3000, BIAcore J, Bios-1, SPREETA device and so on.) [31]. However, these 
biosensors also came with some limitations, such as the volume limits of the system. It 
requires small volumes and normally a pre-enrichment step to concentrate the low num-
bers of pathogens present on samples. Also, SPR-transducers are sensitive to room tem-
perature drift and they are expensive. Regarding the detection limits they also need im-
provements due to the bacterial analytes and their size. As the sensitivity of SPR sensors 
decreases with an increasing distance from the surface of metal supporting (a Surface 
Plasmon), only a small part of the bacterium captured at the surface can contribute to a 
response of the SPR sensor [28]. Examples of optical techniques used for foodborne 
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pathogens are shown in Table 1:1, which information was acquired from an excellent 
review paper of Velusamy et al. [32].  
 
Table 1:1: Examples of optical techniques applied on studies related with foodborne 
pathogens (information extracted and adapted from [32]) 
Optical techniques Detected pathogen Limit of detection Assay time 
Optic interferometer S. typhimurium 10
5 
CFU/ml 12 h 
Automated optical 
method 
Salmonella spp. and 
L.monocytogenes 
10–50 cells each in 25 g sam-
ple 
24 h 
Surface-enhanced in-
frared absorption spec-
troscopy 
 
Salmonella   
Imaging ellipsometry 
(IE) 
E. coli O157:H7, S. 
typhimurium, 
10
3
 to 10
7
 CFU/ml  
Fluorescence microsco-
py 
E. coli O157:H7, S. 
typhimurium 
10
2
 CFU/ml  
Chemiluminescent im-
munoassay 
E. coli O157:H7, Y. 
enterocolitica, 
S. typhimurium, and L. 
monocytogenes 
10
4
 to 10
5
 CFU/ml 
(for all bacterial 
Species) 
 
Bacteriophage-based 
bioluminescene 
Salmonella 10
8
 CFU/ml 1–3 h 
 
1.2.4.2.2 Electrochemical Biosensors 
 
Since the introduction of glucose enzyme electrodes by Clark and Lyons electrochemi-
cal biosensors have been extensively studied for different health purposes [33]. Their 
revolutionary discovery proved to be an excellent tool for the diabetic community and 
efforts to improve it have been made, with success. Now we have in our hands an am-
perometric needle-type glucose biosensor that has increased the patient's life quality.  
Electrochemical biosensors can be classified into four subclasses, namely as am-
perometer, potentiometer, impedimeter and conductometer and are based on the pa-
rameters current, potential, impedance and conductance, respectively [34]. Their low 
cost and the possibility to construct a portable device joined with their ability to work 
with turbid samples are their main advantages. In contrast, their selectivity and sensitiv-
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ity are their weakest points when compared with optical biosensors. In order to circum-
vent some detection difficulties, they appear combined with other types of biosensors. 
The amperometric-based biosensors are most commonly studied to detect foodborne 
pathogens. Examples of some pathogens detected by electrochemical biosensors are 
presented in Table 1:2. 
 
Table 1:2: Examples of electrochemical biosensors for foodborne pathogens [32]. 
Mode of detection Detected pathogen Limit of detection 
(CFU/ml) 
Assay time 
Amperometric S. typhimurium 1.09×10
3
 2.5 h 
Conductometric 
E. coli O157:H7 and 
Salmonella spp, 
7.9×10
1
 10 min 
Impedimetric S. typhimurium 5.4×10
5
 2.2 h 
 
1.2.4.2.3 Mass-based Biosensors 
 
Piezoelectric and magnetoelastic (another format of acoustic wave devices) biosen-
sors are examples of mass-sensitive sensors, which means that their detection principle 
is based on small mass changes. The quartz crystal microbalance (QCM) and acoustic 
wave biosensors (SAW) are piezoelectric devices with a operate principle based on an 
oscillating crystal that resonates at a fundamental frequency.  
1.2.4.2.3.1 Magnetoelastic (ME) Sensor 
 
The working principle of ME sensors is based on magnetostriction properties, in which 
material changes in dimension due the application of a magnetic field. The magnetic 
energy is converted into mechanical oscillations by applying a time-varying magnetic 
field. The resonance frequency and amplitude of such oscillations are dependent on the 
sensor material and also on the surrounding medium that acts as a damping force to the 
sensor. The characteristic fundamental resonance frequency (equation 1) of these oscil-
lations is dependent on the physical properties, such as elastic modulus (E), density (ρ), 
Poisson’s ratio (ν) and the dimensions of the material (L).  
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ρ    ν 
   (eq.1) 
 
The resonance frequency is dependent on geometry as well as mass and when an 
additional mass is loaded on the sensor surface, a shift in the resonance frequency (Δf) 
occurs (equation 2) [10]: 
    
  
 
  
 
  (eq. 2) 
 
The Δf is the change in resonance frequency, Δm is the change in the sensor's mass 
due to the mass attached over the sensor and M is the original mass of the sensor. The 
negative signal     is due to the shift of the resonance frequency to lower values as a 
consequence of the increase mass loaded over the sensor. The setup of a ME biosensor 
is presented in Figure 1:5. Further information of ME sensors is described by Grimes et 
al. and Johnson et al. [35], [36]).  
 
Figure 1:5: Setup for ME biosensors measurement (adapted from [37]), showing the elements 
involved on the process, namely the network analyzer, ME biosensor and a bar magnet that will 
creates a DC (direct current) magnetic field. 
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ME materials are iron-based that typically include iron, nickel, molybdenum and 
boron (e.g. Metglas alloy 2826 MB - Fe45Ni45Mo7B3). The sensor is coated with gold 
to prevent corrosion and to turn the surface biocompatible. After the pre-coating and 
annealing [37], the ME sensor is ready to be prepared. The biological element (e.g. anti-
body, bacteriophage) that will recognize the target of interest is immobilized on the sen-
sor surface by different strategies (e.g. physical or chemical immobilization). Then, the 
fundamental resonance frequency (f0) is measured and considered as the control value 
(i.e. value before the exposure of ME biosensor to the target). When the ME biosensor 
is "read", an AC- and DC-biasing magnetic field is applied to amplify the signal. After 
measuring the f0, the ME biosensor is exposed to the solution containing the target and 
the binding occurs (biological element + target). The mass increases over the sensor and 
consequently the resonance frequency decreases. This system can be performed in "air" 
or using a flow system. The first method uses the ME biosensor dried in air following 
the contact with the target and washing procedures. The second method is carried out 
using a flow system composed by a peristaltic pump, a target analyte container, a flush 
out container and the measurement chamber (capillary tube inside the ME sensor).   
 
ME biosensors have been studied for pathogen detection as well as for homeland 
security (e.g. B. anthracis - possible bioterrorism agent) [38–41]. Compared with piezo-
electric devices, the ME sensors are more simple and cheaper, allowing their use in a 
disposable manner. An excellent advantage is their wireless characteristic. This technol-
ogy offers real-time detection in air or in liquid without the need of direct contact be-
tween the sensor and the measurement device, a feature that can compete with many 
techniques. The limitation is their sensitivity, which can be circumvented by decreasing 
the sensor size [36].  
 
1.2.4.2.4 Magnetoresistive Sensors 
 
The massive research in spintronics has given rise to a new class of biosensors [42]. In 
such devices the transducers are magnetoresistive sensors (MR), which presently find 
their major application in the data storage market, as read heads in hard disk drives, but 
are quickly expanding to the biosensing field. Due to the advantage of being compatible 
with silicon-integrated circuit fabrication technology it originates compact chips com-
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prising single or multiple sensors along with the required electrical circuitry. Additional 
valuable assets are related to high sensitivity, low background, tunable dynamic range, 
fast performance, scalability and low production costs [43–46]. In a standard MR chip-
based bioassay, a biorecognition element immobilized over the sensor is used to inter-
rogate an unknown sample potentially containing a target molecule of interest (e.g. 
DNA strand, protein, cell antigen, toxin, etc), labeled with a magnetic particle. Whenev-
er there is recognition between the target and its probe, a biomolecular event occurs. 
After washing, the recognized targets stay over the sensor while the unbound molecules 
are washed out. Upon application of an external magnetic field, the magnetic labels at-
tached to the bound molecules will create a fringe field, which is further detected by the 
MR sensor. The discrete quantification of magnetic entities can be related to the number 
of molecular recognition events, which results in a quantitative analytical mode, over-
coming the “yes or no” basic type of answer presented by many technologies. Moreo-
ver, the magnetic particle when associated to the target molecule offers a number of 
advantages, such as: i) target concentration from the native sample into a smaller vol-
ume of a different buffer solution, ii) on-chip active transportation and iii) site-focusing 
of the magnetically-labeled molecules [47].  
Additionally, the combination of these MR biochips to electronic [48] and microflu-
idic platforms [49], may enable sample position control, temperature control, detection 
signal acquisition and processing, converting a bulky and complex analytical apparatus 
into a practical lab-on-a-chip device [50]. Since the last decade, several MR-based bio-
chips using different types of sensors, such as large giant magnetoresistance (GMR) 
sensors, spin valve (SV), anisotropic magnetoresistive ring (AMR) sensors and magnet-
ic tunnel junctions (MTJ) have been demonstrated as proof-of-concept systems. Mean-
while, most of these systems have already evolved into a prototype format and are start-
ing to be used in several biological applications [46], [50]. Presently only two main 
types of MR biochip platforms have been developed, in terms of biorecognition agent in 
use, and applied to bioanalytical assays; DNA-chips and protein-chips. Generally, the 
designation of DNA- and protein-chip stands for whether single stranded DNA se-
quences or antibodies are used as biological probes immobilized over each sensing area, 
respectively. However, some limitations of these biorecognition agents, such as pour 
stability, high production costs and cross-reactivity, have set the need for alternatives. 
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1.2.4.3 Biological Elements 
 
Since the first immunoassay used to identify bacterial pathogens [51], biomolecular 
recognition elements other than antibodies (enzymes, nucleic acids and bacteriophages) 
have been reported [52–54]. The instability of the biological element can be a disad-
vantage in a biosensor, thus their choice is an important issue to be considered. 
 
1.2.4.3.1 Enzymes 
 
The attractive use of enzymes on biosensors is emphasized by their specific binding 
capability and catalytic activity. In biosensors they are used mostly as label instead of 
recognition elements [55]. The most studied enzyme-based biosensors are commonly 
glucose biosensors, which utilize the enzyme glucose oxidase. Enzyme-based biosen-
sors are highly selective but their purification is expensive, time-consuming and their 
activity is limited [56].  
1.2.4.3.2 Antibodies 
 
Antibodies can be polyclonal, monoclonal or recombinant, depending on their selective 
properties and the way that they are synthesized [24]. Recombinant antibodies have 
been used to improve its specificity and production costs are more reasonable, com-
pared to enzymes [57]. They are used in some conventional immunoassays (as men-
tioned in point I.2.2 as well as in optic, electrochemical and mass-based biosensors [58–
61]. Apart from their advantages, these biological elements are highly fragile and sensi-
tive to harsh changes in environmental conditions [62]. Moreover, more studies using 
real samples should be done to understand their sensitivity under those conditions.  
 
1.2.4.3.3 Nucleic Acids 
 
Compared with enzymes and antibodies, biosensors that use nucleic acids as 
biorecognition elements are simple, rapid, inexpensive, stable and can be easily synthe-
sized and regenerated [32]. The use of nucleic acids as an interface in biosensors has 
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also been demonstrated by many researchers. Chen et al. [63] described a nucleic acid-
piezoelectric biosensor for detection of Escherichia coli O157:H7, a bacterium that has 
become a serious cause of foodborne illness. Their study shows that Au nanoparticles, 
when functionalized with oligonucleotides, allow for the amplification of the signals in 
frequency change in a QCM biosensor due to the large mass of the nanoparticles com-
pared to DNA targets. It is a strategy that can be used to improve the sensitivity of the 
technique and without culture enrichment. In a recent publication of Zhang et al. [64] an 
optical transducer (SPR) was created with a specific DNA probe for the invasion gene 
invA of Salmonella, allowing the detection of 10
2
 CFU of Salmonella cells in 1 ml sam-
ple in approximately in 4.5 h. Even using those platforms their advantages have been 
highlighted in microarray techniques for the simultaneous detection of foodborne path-
ogens [65]. The only concern on their use as a probe is the possibility of damages on 
DNA due external factors that can impede the detection accuracy.  
 
1.2.4.3.4 Bacteriophages 
 
Bacteriophages or simply phages are the most ubiquitous molecules on Earth. They are 
viruses that infect bacteria and possess an excellent feature: specificity. The first official 
report about the phages existence was published by Frederick Twort in 1915 [66]. Since 
their discovery by this British bacteriologist, many researchers have been exploring 
phages for different applications [67][68]. These viruses can be easily isolated from 
different sources (e.g. faecal samples, sea, soil, raw domestic wastewater, sewage and 
treated effluents) and are stable in diverse harsh environment conditions. 
 
1.2.4.3.4.1 Phage Structure 
 
Morphologically, all phages are composed by a protein coat, the capsid (usually referred 
to as ´head´) which can vary in size and shape (hexagonal and filaments form or com-
plex structures). The capsid is built by multiple copies of proteins and protects the ge-
netic material of phage (single or double stranded DNA or RNA). The majority of 
phages are Caudoviridae and their morphology is similar to the phage showed in Figure 
1:6:A. These phages have a tail attached to the capsid, which can be contractile or not. 
The tail is a hollow tube that allows the passage of the nucleic acid to the cell and con-
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tains tail fibers that are responsible for the recognition of bacteria. An example of a 
tailed phage is the T4 phage (one of the largest phages) in which 25 kbp of its genome 
is dedicated to the tail assembly. Phage T4 at the end of its tail has a base plate and fi-
bers [69]. However, it should be noted that not all phages have base plates and fibers. 
The structure of T4 and a filamentous phage is illustrated in Figure 1:6. 
 
 
Figure 1:6: A: Scheme of T4 phage [70].B: Structure of a typical filamentous phage virion [71]. 
 
The Figure 1:6:B refers to a filamentous phage (nonlytic virus) which belongs to the 
family Inoviridae. Filamentous phages are flexible rods with approximately 1 µm long 
and 6 nm in diameter. They are composed of a circular single stranded DNA genome 
that is enclosed in a tubular capsid that contains major coat protein pVIII and few copies 
of minor coat proteins at the ends of the virion (pIII, pVI, pVII and pIX) [72].   
 
1.2.4.3.4.2 Classification 
 
The International Committee on Taxonomy of Viruses (ICTV) divides phages in one 
order, 13 families and a “floating genus” Salterprovirus. Until 2006 more than 5500 
phages were analyzed using electron microscopy, with the tailed phages being the most 
predominant (96%) against 3.7% polyhedral, filamentous, or pleomorphic phages [73]. 
Their classification is based on the nature of the genomic material: single or double 
stranded DNA and RNA (Table 1:3). Caudoviridae comprise the tailed phages with a 
double stranded DNA and have 50:50 of DNA/protein. Phages from the Myoviridae 
family are morphologically complex, having contractile tails. An excellent example of 
this family is the T4 phage [69]. The well known lambda (λ) phage  is characterized by 
a long and flexible tail [74] that belongs to Siphoviridae family. P22 phage belongs is 
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an example of the Podoviridae family and their short tail structure is incorporated into a 
unique five-fold vertex of the icosahedral phage capsid [75]. The other families that are 
not assigned to an order contain circular single stranded (Microviridae and Inoviridae) 
and double stranded (Fuselloviridae, Plasmaviridae and Corticoviridae) DNA. Rudi-
viridae, Lipothrixviridae and Tectiviridae have linear double stranded DNA. The family 
Leviviridae and Cystoviridae are the ones that contain single and double stranded RNA, 
respectively.
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 Table 1:3: Classification of phages based on their family, structural morphology and genetic material enclosed (adapted from [76]).  
 
Order Family Morphology Nucleic Acid 
Caudovirales 
Myoviridae Non-enveloped, contractile tail Linear dsDNA 
Siphoviridae Non-enveloped, long non-contractile tail Linear dsDNA 
Podoviridae Non-enveloped, short non-contractile tail Linear dsDNA 
Virus families not assigned to 
an order* 
Tectiviridae Non-enveloped, isometric Linear dsDNA 
Corticoviridae Non-enveloped, isometric Circular dsDNA 
Lipothrixviridae Enveloped, rod-shaped Linear dsDNA 
Plasmaviridae Enveloped, pleomorphic Circular dsDNA 
Rudiviridae Non-enveloped, rod-shaped Linear dsDNA 
Fuselloviridae Non-enveloped, lemon-shaped Circular dsDNA 
Inoviridae Non-enveloped, filamentous Circular ssDNA 
Microviridae Non-enveloped, isometric Circular ssDNA 
Leviviridae Non-enveloped, isometric Linear ssRNA 
Cystoviridae Enveloped, spherical Segmented dsRNA 
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Table 1:4: Shape representation of the major phage groups (adapted from [78]). 
 
Nucleic acid Shape 
ssDNA 
  
 
dsDNA 
   
  
  
 
 
 
 
 
ssRNA 
 
 
 
dsRNA 
 
 
Microviridae 
Inoviridae 
Myoviridae Siphoviridae Podoviridae 
Corticoviridae Tectiviridae 
Plasmaviridae Fuselloviridae 
Lipothrixviridae 
Rudiviridae 
Leviviridae 
Cystoviridae 
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Very recently, Abedon [77] demonstrated that it is possible to ascertain phage family by the 
size of the genome as illustrated in Figure 1:7. According to this classification, Leviviridae 
and Myoviridae families are representative of the lowest and highest genome size, respec-
tively. 
 
Figure 1:7: Phage morphologies and genome sizes [62] 
 
 
Life Cycle 
 
Phages can be differentiated by their life cycle, i.e. by the interaction between phage and 
host. Phages can absorb, infect and release the bacterium (lytic cycle) or can integrate their 
DNA into the host´s genome after infection (lysogenic cycle). 
 
 Lytic Cycle 
 
Phages with this type of pathway are called lytic or virulent phages. The cycle is divided in 
different stages: attachment, penetration, biosynthesis, maturation and release. The first inter-
action between phage and bacteria happens when one or a set of adhesins present on the tail 
fibers or spikes that recognize the cell wall receptors, allowing phage adsorption. Phage then 
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penetrates and injects its nucleic acid into the cell, while the capsid and tail will remain out-
side the cell. After entering into bacterium, an eclipse period starts where no phage particles 
can be found outside and inside the cell and the viral nucleic acids assume all the activity of 
the host cell. Inside the host synthesis of the phage components occurs (viral lysozyme, inter-
nal proteins and coat proteins), followed by their assembly into mature phage particles. In 
order to release newly assembled phages, phage produce hydrolytic enzymes (endolysins) 
that digest the cell wall, resulting in cell lysis. 
 
 
Figure 1:8: Illustration of the lytic clycle [79]. 
 
 
Lysogenic Cycle 
 
Lysogenic or temperate phages can either follow the lytic pathway or enter to the cell without 
killing the host. The phage DNA is integrated into cell chromosome and replicates along with 
the host DNA, passing to the daughter cells. At this stage, the virus is called prophage and the 
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process is known as lysogeny. This process will affect the evolution of the bacterium and 
contribute to the diversification of the bacterial genome architecture (lysogenic conversion) 
[80]. The process can confer the cell immunity to the same phage and only stress conditions, 
like the ultraviolet light, can induce the lytic cycle [81]. 
 
 
Figure 1:9: The lytic and lysogenic cycles of λ (lambda) phage [82]. 
 
Phage Applications 
 
Since the first report on the existence of phages the scientific community has attempted to 
explore and benefit from this tool, provided by Mother Nature. While discovered before the 
era of antibiotics, phages were abandoned for some time after the introduction of penicillin. 
However, the emergence of antibiotic resistance in bacteria has awakened the community and 
renewed the interest in phages. Many researchers have been exploring the potential of phages 
either for therapy purposes or as biorecognition probe to use in biosensors. The power of lytic 
phages lies in their ability to lyse cells and is a characteristic appreciated in phage therapy. As 
such, they are used in studies for the treatment and prevention of bacterial infectious diseases, 
such as Listeria monocytogenes, Streptococcus pneumoniae, E.coli, Salmonella, Campylo-
bacter jejuni, among others [83–87]. Beside the applications in human diseases and the veter-
inary field, their potential has been recognized in the field of water treatment [88][89] and at 
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the level of development of phage products for food safety. The commercial LISTEX™ 
P100 [90] used for the eradication of L. monocytogenes contamination is an example of a 
phage product that was approved by FDA. The lysogenic cycle of some phages, i.e. lacking 
the ability to lyse the cell, make them poor candidates for therapy. In contrast, they are a good 
option when the objective is to use the phages as a recognition element, for instance, as an 
interface to detect pathogens. Filamentous phages have shown promising results as a 
biorecognition element on biosensors for pathogens detection and have been explored as a 
target delivery of drug-load to cancer cells. Although the life cycle of phages determines their 
use in specific applications, these limitations can be overcome by the genetic modification of 
certain genes responsible for lysis or lysogenicity [91][92].   
 
Studies related with the application of phages on the detection and control of foodborne 
pathogens have increased over the last years. However, regarding the biocontrol, the use of 
phages on foods is not considered safe by everybody. Despite some concerns and doubts 
about its use and mode of action, many organizations believe in the potential of phages and 
therefore encourage research in this field [93]. In particular, phages have proven to be an ex-
cellent tool when applied to control foodborne infections along the food chain.  Figure 1:10 
shows their applications as action points: phage therapy, biosanitation, biocontrol and as bio-
preservation elements. 
 
Figure 1:10: Phage application along the food chain on phage therapy, biosanitation, biocontrol and 
biopreservation (adapted from García et al. [68]). 
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Biocontrol is an important issue nowadays; however, an early detection technology can 
prevent rather than control mass epidemics. When applied as a prevention tool, phages do not 
need to be incorporated in the food product. Ideally, a simple product sample would be re-
quired to obtain a positive or negative result. The efforts to make this possible have been 
made and their applicability has been tested in a variety of biosensors. Therefore, biosensors 
can provide a final product that combines a biological element highly specific to the target of 
interest with portability and easy handling. 
 
Phage-based Pathogen Biosensors  
 
The urgent need for pathogen detection in agricultural, environmental and food sectors has 
generate different works that show the relevant use of phages in these fields. Table 1:5 shows 
some studies related with the use of phages attributed to the development of different types of 
biosensors.  
 
Table 1:5: The use of phage as biorecognition element in different transducers on the detec-
tion of different organisms [94].  
Transducer Organism Bioreceptor 
SPR E. coli K12 T4 Phage 
SPR E. coli O157:H7 T4 Phage 
SPR Salmonella P22 Phage TSP 
SPR C. jejuni Phage NCTC 12673 TSP 
SPR S. aureus Lytic phage (phage 12600) 
Bioluminesence E. coli E. coli phage 
Bioluminesence Salmonella newport Felix phage or Newport phage 
Bioluminesence Salmonella enteritidis phage SJ2 
Bioluminesence E. coli G2-2 AT20 
Fluorescent 
Staphylococcal 
enterotoxin B (SEB) 
phage-displayed peptides 
Fluorescent E. coli QD-labeled lambda phage 
Fluorescent E. coli T7 phage 
QCM Salmonella typhimurium Filamentous phage 
Magnetoelastic sensors Salmonella typhimurium Filamentous E2 phage 
Magnetoelastic sensors 
Bacillus anthracis 
spores 
Filamentous phage, 
clone JRB7 
Amperometric Bacillus cereus B1-7064 Phage 
Amperometric 
Mycobacterium 
smegmatis 
D29 Phage 
Amperometric 
combined with 
pre-filtration 
E. coli K12 Phage lambda 
Impedimetric E. coli T4 Phage 
Chapter 1. General Introduction 
 
28 
 
A recent review of Schofield et al. [95] lists phage-based diagnostics that were approved 
by FDA for Mycobacterium tuberculosis, Yersinia pestis, Bacillus anthracis, and Staphylo-
coccus aureus. In addition, significant progress has been made in the detection of food- and 
waterborne pathogens, such as Salmonella, E. coli and Campylobacter [31]. Recently, direct 
detection of Salmonella Typhimurium on fresh tomato surfaces was reported, using a phage-
based magnetoelastic (ME) biosensor. The results show that direct detection of foodborne 
bacteria on fresh products is possible using filamentous phages immobilized on a sensor sur-
face [96]. A study reported by Tawil et al. [97] describes a detection technique for E. coli 
O157:H7. The technology involves a surface plasmon resonance (SPR) platform with a T4 
phage as the selected biorecognition element. It was shown that efficient detection was 
achieved at concentrations of 10
3
CFU/ml in about 20 minutes. These are some examples of 
ongoing works that show how phages can be used as a recognition tool for pathogens. How-
ever, problems related to the detection of bacteria in a viable but nonculturable (VBNC) state 
is one of the big concerns in the environmental and food sector, resulting in the observation 
of false negatives. Wastewater and surfaces on which food is treated are some examples 
where they can be found. In these conditions, they are under stress environments caused by 
bactericidal agents, changes in pH or temperature, or deficiency of nutrients, all factors that 
contribute to bacteria entering this state (a survival state) [18-19]. Bacterial downsize occurs, 
revealed by a change in their membrane structure, protein composition and ribosomal content 
[99]. These cellular changes are the weakness point of various detection systems. Studies 
involving the detection of VBNC bacteria using phages are still limited and some used a 
green fluorescent protein (GFP)-labeled phage (e.g. to analyze environment samples (river, 
tap water)) [19][20][101]. However, this type of approach needs a rigorous pre-treatment of 
environment samples due the presence of any autofluorescent or light-quenching particles 
that can give false positives. The prevalence of this problem and also the necessity of finding 
a detection technology that can measure real samples without any sample treatment (e.g. a 
piece of raw meat, juice, a piece of fruit or vegetables) are still a big deal. Even when testing 
pre-treated samples the sensitivity of the measurements have a long way to go, although with 
the help of phage-based detection systems it is possible to fulfil these specificity and sensitiv-
ity requirements. 
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Abstract 
 
Salmonella is a pathogenic bacterium responsible for the majority of food-borne outbreaks 
and therefore it is urgent to develop therapeutic agents and detection systems that can elimi-
nate and/or control this pathogen. Bacteriophages (phages) have the ability to specifically 
recognize their host, a feature that is appreciated by many researchers that seek to explore 
their potential as a therapeutic and detection agent. However, as the majority of phages are 
highly specific, recognizing a limited number of strains, their application as detection tool 
might be limited.  Here we report the characterization of three lytic phages exhibiting a broad 
lytic spectrum, and thus having great potential to be used as detection tools.  Furthermore, the 
sequences of genes encoding for the tail fiber proteins (TFPs) responsible for host recognition 
and binding are presented herein to be further explored in the biosensing field. In addition, 
we propagated the phage with the broadest host range (PVP-SE1) in an alternative nonpatho-
genic host, namely E.coli BL21. The results showed that the selected phage maintained its 
ability to lyse Salmonella strains and the phage DNA restriction profile was not modified. 
This work reports on the detailed characterization of a phage that can be produced in a non-
pathogenic host, thereby contributing to an easier approval of a safer product based on this 
Salmonella biocontrol agent. 
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2  Introduction 
  
Salmonella enterica has long been recognized as an important zoonotic pathogen of econom-
ic significance in animals and humans and remains the primary cause of reported food poi-
sonings worldwide, with massive outbreaks occurring in recent years [1–3]. The serovars 
most commonly reported in human infections in the European Union (EU) and the United 
States have been Enteritidis and Typhimurium, comprising, respectively, 76% and 14% of the 
cases in the EU [4–5]. Therefore, controlling Salmonella infections has become an important 
goal for the poultry industry, the most common source of Salmonella Enteritidis infections [1, 
2, 6, 7]. The use and misuse of antimicrobials in both humans and animals has given rise to 
the emergence of infectious bacteria displaying resistance toward many, and in some cases 
all, effective antimicrobials [1, 2, 8]. Thus, the development of alternatives to chemotherapy 
is imperative and a critical priority. The use of (bacterio)phages, viruses that specifically in-
fect and lyse bacteria, as a therapeutic agent (phage therapy) is one possible option for con-
trolling pathogenic bacteria. Phages have already been tested as biocontrol agents for salmo-
nellae and other pathogens in humans and animals, and have showed advantages over antibi-
otics [9–13]. Furthermore phages are attractive tools in the biosensing field, because they 
display host recognition peptides on their capsides, spikes, tails or tail fibres (depending on 
the phage family).  However, due to the high specificity of the majority of phages, their ap-
plication as biocontrol or detection agents might be limited. Nevertheless  few studies have 
reported the isolation of multivalent phages, which are phages able to infect a broad host 
range including different bacterial species, this is the case of Felix 01 [14]. Another drawback 
of phage specificity is the fact that they often can only be produced in their natural hosts [7, 
14]. In the case of pathogens, this may turn out to be problematic, due to the release of cell 
debris and large quantities of both endotoxins and exotoxins and the presence of live cells 
that may occur in the crude phage lysate [12], [16–18]. The use of a nonpathogenic host in 
the production process would eliminate the risk of accidentally administering a pathogen [7], 
[10, 18]. Consequently, it would greatly simplify the purification process with a consequent 
reduction in cost and would furthermore increase the safety of phage preparations, leading to 
easy and faster approval of phage products. Nevertheless, this tends to be a difficult approach 
since multivalent phages are rare [7], [19–21]. Therefore, our work focused on the selection 
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and characterization of a Salmonella phage with a broad lytic spectrum and studied the possi-
bility of producing it in a nonpathogenic Escherichia coli strain. 
 
2.1 Materials and Methods 
 
2.1.1 Media and Buffer Composition 
 
The culture media LB broth and Agar were provided by Sigma-Aldrich. LB agar plates were 
prepared by adding 1.2% of agar to the LB broth, soft agar was made by adding 0.6% of agar. 
The reagents for SM buffer (100 mM NaCl, 8 mM MgSO4, 50 mM Tris-HCl, pH 7.5) were 
provided by Sigma-Aldrich. 
 
2.1.2 Bacteriophages and Bacterial Strains 
 
The three phages characterized in this work, namely PVP-SE1, PVP-SE2 and PVP-SE3, be-
long to phage collection of CEB-IBB and were isolated in the framework of the European 
Project Phagevet-P [22]. These phages were previously named as phi 2/2, 38 and 39, respec-
tively. PVP-SE1 was isolated from a Regensburg (Germany) wastewater plant, PVP-SE2 and 
PVP-SE3 were isolated from Braga (Portugal) raw sewage wastewater treatment plant [23]. 
Following the same sequence, the phage hosts are Salmonella enterica serovar Enteritidis 
strains as S1400 that belongs to the private collection of the University of Bristol, and strains 
821 and 869 from the Instituto Nacional Ricardo Jorge, Portugal [23]. The lytic spectra were 
compared to Salmonella phage Felix 01 obtained from the Profos AG collection (Regens-
burg‐Germany). The tests were carried out against thirty eight bacterial strains, thirteen of 
which were isolated from contaminated food products in Portugal and from poultry farms in 
England [23]. Two E. coli strains (N5‐bovine and N9‐porcine) were also isolated. The re-
maining strains belong to the type cultures collections NCTC (National Collection of Type 
Cultures), ATCC (American Type Culture Collection), SGSC (Salmonella Genetics Stock 
Centre), and CECT (Colección Española de Cultivos Tipo). At least two Salmonella strains 
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from each subspecies were used. Two well known E. coli strains, BL21 (BL21-Gold(DE3), 
purchased from Stratagene) and K-12, were also included in the infection studies.  
2.1.3 Phage Propagation 
 
The phages were produced using the double layer agar technique as described by Sambrook 
and Russell [24]. Briefly, from the plaque forming units (PFU) obtained, ten were selected 
and transferred several times to three new Petri dishes with the proper bacterial soft agar. 
Using sterile paper strips, the phages were spread by passing the strips several times on the 
production Petri dishes and incubated overnight at 37
o
C. Then, 3 to 10 ml of SM buffer was 
added to Petri dishes and incubated overnight at 4ºC (with agitation). The liquid was trans-
ferred to 50 ml tubes and centrifuged at 9000 x g during 10 min at 4ºC (Hettich Zentrifugen-
Universal 320) to remove the bacteria. One volume of chloroform was added to 4 volumes of 
supernatant and centrifuged at 9000 x g during 10 min at 4ºC. The top liquid phase was re-
moved carefully and filtered through a 0.2 µm filter (Minisart-Santorius stedim biotech). The 
phage titer was verified and the solution was stored at 4
o
C. 
 
2.1.4 Phage Purification 
 
Phage purification was performed by cesium chloride (CsCl) gradient ultracentrifugation 
[25]. Initially, heat-dried CsCl (MP Biomedicals, Illkirch, France) was added gradually to 15 
ml of phage in order to avoid an osmotic shock. Four CsCl solutions were prepared (densities 
of 1.33, 1.45, 1.50 and 1.70 g/ml) and 5.7 ml per gradient was added (starting from the lowest 
to the higher density) and the solution was centrifuged at 28,000 x g at 4
o
C during 3 h. The 
phage was collected from the gradient (~3 ml, white cloud) and dialyzed. To hydrate the 
membrane, the Slide-A-Lyzer dialysis cassette (Pierce, Rockford, IL) was incubated in 1 L of 
1 × phage buffer [10 mM Tris-HCl, pH 7.5, 100 mM MgSO4, 150 mM NaCl]. Three ml of 
phage suspension was added in the dialysis cassette and dialyzed 3 times for 30 min against 
300 volumes of phage buffer. The pure phage preparation was collected and stored at 4°C 
 
2.1.5 Phage Propagation in a Non-pathogenic Host 
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Phages were amplified by plate lysis as described by Sambrook and Russell [24]. Generation 
one (G1) of phage PVP-SE1 in E. coli BL21 was produced using the phage stock suspension 
obtained for PVP-SE1 in Salmonella S1400/94 (G0). This production was then used as a 
stock suspension to produce G2 of phage PVP-SE1 in E. coli BL21. G3 to G6 were obtained 
using the same procedure, i.e. each generation was obtained using phages from the previous 
generation. 
 
2.1.6 Lytic Spectrum 
 
To determine the phages lytic spectra, bacterial lawns were prepared by homogenizing the 
soft agar with fresh suspension of the test strains and applied to Petri dishes with an LB agar 
layer. After solidifying, drops (10 µl) of serial dilutions of the different phage suspensions 
were added to bacterial lawns. The plates were incubated overnight at 37
o
C. Lytic activity 
was verified by the formation of clear areas and phage plaque formation on the bacterial 
lawns. 
 
2.1.7 Single-Step Growth Curve Experiments 
 
Single-step growth curve experiments were carried out at 37°C in LB medium as described 
by Sambrook and Russell [24] using an overnight pre-inoculum of the bacteria in the same 
medium. The experiments were done in duplicate and repeated twice. The values of the pa-
rameters were determined by fitting the experimental data to a four-parameter sigmoid curve 
using least-squares fitting. 
 
2.1.8 Restriction fragment length polymorphism (RFLP) 
 
Phage DNA was extracted using the Wizard DNA Clean-Up System from Promega Corpora-
tion (Madison, WI) and digested with HindIII and EcoRV from Sigma-Aldrich Inc. (St. Lou-
is, MO) according to the manufacturer’s instructions. Fragments were separated on a 1% 
agarose (Bio-Rad Laboratories Inc., Hercules, CA) gel at 70 V for 3 h (20 V for 16 h when 
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DNA was digested with HindIII) and stained with ethidium bromide (10 g/ml; Bio-Rad La-
boratories Inc., Hercules, CA). 
 
2.1.9 Transmission Electron Microscopy (TEM) 
 
Phage particles were sedimented at 25,000 x g for 60 min using a Beckman (Palo Alto, CA) 
J2-21 centrifuge with a JA 18.1 fixed-angle rotor. Phages were washed twice in 0.1 M am-
monium acetate (pH 7.0), deposited on copper grids provided with carbon-coated Formvar 
films, stained with 2% potassium phosphotungstate (pH 7.2), and examined using a Philips 
EM 300 electron microscope (Laval University, Quebec, Canada). 
 
2.1.10 DNA Manipulations 
 
For the shotgun sequencing of phage PVP-SE2 phage DNA was prepared as follows: 
 
2.1.10.1 Phage DNA Extraction 
 
Following the phage purification, 1 ml of phage solution was incubated with 0.5% of SDS, 20 
mM of EDTA, pH 8.0, and 50 µg/ml of Proteinase K during 1 h at 56
o
C. After incubation and 
cooling down to room temperature, an equal volume (1:1) of  phenol was added and the  mix-
ture was centrifuged at 6000 x g for 2 min at room temperature. The aqueous phase was care-
fully collected to another tube. An equal volume of 0.5:0.5 of phenol-chloroform was added 
to the aqueous phage, homogenized and the mixture was centrifuged as before. The aqueous 
phase was again collected and mixed with an equal volume of chloroform (1:1), homogenized 
and centrifuged again. The aqueous phase was removed and DNA was precipitated by etha-
nol. 
 
2.1.10.2 Ethanol precipitation 
 
Ethanol precipitation was carried out by mixing 1:10 volume of 3 M sodium acetate (pH 5.2), 
1:10 volume of 125 mM EDTA and 2.5 volumes of cold 96% ethanol with the DNA obtained 
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in step II.2.10. The mixture was homogenized and incubated on ice during 15 min. Then, the 
solution was centrifuged at 18000 x g during 20 min. The supernatant was removed and the 
pellet was resuspended in 250 µl of cold 70% ethanol, homogenized and centrifuged at room 
temperature, under the same conditions as described before, during 5 min. The supernatant 
was removed and the pellet was air-dried and resuspended in EB buffer (composition EB 
buffer?). The concentration of DNA was measured on a spectrophotometer. 
 
2.1.10.3 Plasmid DNA isolation 
 
Plasmid DNA isolation was performed using the QIAprep spin Miniprep Kit as described in 
manufacturer's protocol. 
 
2.1.10.4 Restriction analyses 
 
300 ng of purified DNA of PVP-SE2 was digested with EcoRV in a total reaction volume of 
20 μl, containing 3 μl of phage DNA, 2 μl of 10 × buffer R, 14 μl of milli-Q water and 1 μl of 
enzyme. The mixture was incubated 1 h at 37
o
C and analyzed by agarose gel electrophoresis.  
 
2.1.10.5 Agarose gel electrophoresis 
 
The DNA fragments were separated using 1% of agarose gel electrophoresis. The agarose 
(Eurogenetic, Luik, Belgium) was dissolved in TAE buffer (40 mM Tris-HCl, 0.5 mM sodi-
um acetate, 50 mM EDTA, pH 7.2), after which 2 µl of ethidium bromide (1 mg/ml) was 
added (Cambrex NJ, USA). Four µl of loading buffer (0.1% bromophenol blue, 49% Su-
crose) was added to each 20 µl of sample and used 6 µl of ladder λ HindIII. The gel electro-
phoresis was run in TAE buffer at 90 V and visualized under UV radiation using a Nikon 
camera. 
 
2.1.11 Construction of a short genomic library of phage PVP-SE2~ 
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2.1.11.1  Sonication 
 
Random DNA fragments were generated by Sonication (Sonics, Vibra Cell
TM
, USA). 75 µl 
of sample containing 148 ng/µl was subjected to several pulses during 1 s to 30 % of ampli-
tude. Then, the fragments were separated on an agarose gel (1%, without ethidium bromide) 
versus λ PstI ladder during 30 min at 115 V.   
 
2.1.11.2 DNA Gel Extraction 
 
The λ PstI marker lane was carefully cut out and stained in a Tris-acetate-EDTA (TAE) buff-
er containing ethidium bromide during 30 min. Then, using the lanes of λ PstI were used as a 
control, the appropriate size (800 bp-1500 bp) was marked under UV radiation and used as a 
template to excise the non-UV-exposed phage DNA fragment. The extracted fragments were 
placed into an Eppendorf tube and purified using the GENEJET
TM
 Gel Extraction Kit accord-
ing to manufacturer's protocol. 
 
2.1.11.3 End Repair 
 
The random DNA fragments which may contain 5’ and/or 3’ protruding ends were end-
repaired (blunted). 70 µl mixture containing 50 µl of DNA previously purified, 0.6 µl of T4 
DNA Polymerase, 0.75 µl of 10 mM dNTPs, 14 µl of 5 × T4 DNA buffer and 4.65 µl of 
milli-Q water was incubated at 16
o
C during 10 min. The reaction was stopped by inactivating 
the T4 DNA polymerase at 70
o
C during 10 min. The wash step was performed with 
GeneJET
TM
 purification kit as described on manufacturer's protocol. 
 
2.1.11.4 Ligation 
 
Ligation was carried out using pUC DNA/SmaI cloning vector. A 20 µl reaction mixture con-
taining 8.8 µl of DNA (random fragments), 1µl of the vector (0.5 µg/µl), 4 µl of 25 % PEG 
4000, 2 µl of 10 × T4 DNA ligation buffer, 1 µl of T4 DNA ligase and 3.2 µl of Milli-Q wa-
ter. The reaction mixture was incubated at 16
o
C overnight and stopped at 70
o
C during 10 
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min. The ligation mixture was ethanol precipitated and used for transformation to E.coli 
XL1-Blue MRF electroporation-competent cells. 
 
2.1.11.5 Transformation 
 
42.5 µl of sample containing 2.5 µl of the ligation mixture and 40 µl of E.coli XL1-Blue 
MRF electroporation-competent cells were mixed gently and electroporated at 1.7 kV 
(BioRAD Gene Pulser
TM
 ). The cells were recovered by adding 960 μl of pre-warmed SOC 
medium (2% Trypton , 0.5% Yeast extract, 0.05% NaCl , 10 mM MgCl2 , 10 mM MgSO4, 
and 20 mM glucose) and incubated at 37 °C during 1 h under shaking conditions at 250 rpm. 
Then, the cells were plated out on LB solid medium containing ampicillin (100 μg/ml), 20 
mg/ml X-gal and 25 mg/ml of IPTG and incubated overnight at 37
o
C.  
 
2.1.11.6 DNA Sequencing 
 
Individual colonies were passed to 96-well plates containing 100 μl of selective medium 
(LB/Ap
100
) and incubated for 2 h at 37
oC. One hundred μl of the selective medium containing 
40% glycerol was added and stored at -20
o
C. A standard PCR was run to verify the presence 
of the insert using the corresponding primers. 
 The sequences of inserts in the purified plasmids were determined from one side 3 µl 
of sequencing reaction containing 0.75 µl of BigDye buffer, 0.5 µl of primer (MV-M13f), 
0.25 µl of BigDye terminator mix and 1.5 µl of Milli-Q water was performed in a Tpersonal 
thermocylcer (Biometra, Germany) with an initial denaturation at 96
o
C for 1 min, followed 
by 30 cycles of 96
o
C (30 sec), 50
o
C (15 sec), and 60oC (4 min) and storage at 4
o
C thereafter.  
Then, ethanol precipitation was performed as described in II.2.10.2., with the exception of the 
elution step in which pellet was resuspended with  20 µl of elution buffer. The samples were 
analyzed using ABI 3130 genetic analyzer (Applied Biosystems) and the sequences were 
assembled with the Sequencer 4.1 software (Genecodes). 
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2.2 Results 
2.2.1 Phage Selection 
2.2.1.1 Phage Lytic Spectrum 
 
The lytic spectra of three lytic phages were tested against thirteen poultry Salmonella isolates 
and compared with the lytic spectrum of Salmonella phage Felix-O1. Comparing the four 
phages, phage PVP-SE1 showed the broadest lytic spectrum as shown in Table 2:1. 
 
Table 2:1: Lytic spectra of isolated Salmonella phages against poultry Salmonella isolates 
and comparison with Felix 01 phage 
Phage PVP-SE1 PVP-SE2 PVP-SE3 Felix 01 
S
a
lm
o
n
el
la
 E
n
te
ri
ti
d
is
 
AL855 + + + NT 
EX2 + L + - 
S1400/94 + + + + 
269 + + + + 
546 + + + + 
629B + + + + 
657 + L L + 
821 + + + + 
855 + L + + 
869 + + + + 
905 + + + + 
932 + + + - 
9510.85 + L L - 
(-) Absence of phage halo and phage plaques; (+) Presence of phage halo and phage plaques; (L) Lysis from without: Presence of phage halo 
and absence of phage plaques; (NT) Not Tested; 
 
 
In addition, the lytic spectra were also tested for different Salmonella subtypes and other 
bacteria than Salmonella (Table 2:2). Besides being able to lyse almost all Salmonella strains 
(of all Salmonella subtypes except IIa), PVP-SE1 was also able to infect E. coli BL21 and 
K12 and was therefore considered a multivalent phage. In contrast, phages PVP-SE2 and 
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PVP-SE3 were unable to infect any E.coli and Salmonella subtypes, except the Salmonella 
NCTC 13349 (subsp. I) and the thirteen poultry Salmonella isolates (Table 2:2).  
 The results obtained for the lytic spectrum of PVP-SE1, show that this phage is able 
to infect more strains than Felix-O1 (Table 2:1). 
 
Table 2:2: Lytic spectra of isolated Salmonella phages against different Salmonella subtypes 
and other bacteria than Salmonella. 
Strains Phage 
 
PVP-SE1 PVP-SE2 PVP-SE3 
Salmonella Typhimurium NCTC 12416 - subsp. I + - - 
Salmonella NCTC 13349 - subsp. I + + + 
Salmonella spp. SGSC 3047 - subsp. II + - - 
Salmonella spp. SGSC 3039 - subsp. II + - - 
Salmonella Arizonae SGSC 3063 – Iia L - - 
Salmonella Arizonae 83 (isolate) – Iia - - - 
Salmonella spp. SGSC 3069 - subsp. IIb + - - 
Salmonella spp. SGSC 3068 - subsp. IIb + - - 
Salmonella spp. SGSC 3086 - subsp. IV L - - 
Salmonella spp. SGSC 3074 - subsp. IV + - - 
Salmonella Bongori SGSC 3103 - subsp. V + - - 
Salmonella Bongori SGSC 3100 - subsp. V + - - 
Salmonella spp. SGSC 3118 - subsp. VI + - - 
Salmonella spp. SGSC 3116 - subsp. VI + - - 
Salmonella spp. SGSC 3121 - subsp. VII + - - 
Salmonella spp. SGSC 3120 - subsp. VII + - - 
Escherichia coli N9 L - - 
Escherichia coli N5 L - - 
Escherichia coli CECT 434 (ATCC 25922) L - - 
Escherichia coli BL21 + - - 
Escherichia coli K12 + - - 
 Enterobacter amnigenes CECT 4078 (ATCC 33072) L - - 
Enterobacter aerogenus CECT 684 (ATCC 13048) - - - 
Klebsiella pseudomonas 11296 - - - 
Shigella ATCC 12022 - - - 
(-) Absence of phage halo and phage plaques; (+) Presence of phage halo and phage plaques; L-Lysis from without: Presence of phage halo 
and absence of phage plaques. 
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2.2.1.2 Phage Production in a Nonpathogenic Host 
 
To assess whether the phage maintains its lytic profile when grown in an alternative nonpath-
ogenic host, the phage was produced for six generations in E. coli BL21. It was observed that 
the lytic spectrum of the phage was maintained from G0 until G6. This indicates that replica-
tion of the phage in this alternative host does not narrow its lytic spectrum. Taking into ac-
count these characteristics - a broad lytic spectrum and the ability to be amplified in a non-
pathogenic strain without modification of its lytic spectrum - phage PVP-SE1 was further 
characterized and G6 was compared with G0. Following the production step, the lytic per-
formance, burst size, latent period and restriction profile of phage PVP-SE1 amplified in E. 
coli BL21 and in its pathogenic host strain were determined and compared. 
 
Table 2:3: Lytic spectrum of PVP-SE1 over generation 0 to 6 against poultry Salmonella 
isolates 
 Salmonella strains 
Genera-
tions 
9510/
85 
269 821 546 EX2 932 AL855 657 
S140
0/94 
629B 869 855 905 
0 + + + + + + + + + + + + + 
1 + + + + + + + + + + + + + 
2 - + + + + + + - + + + + + 
3 + + + + + + + + + + + + + 
4 + + + + + + + + + + + + + 
5 + + + + + + + + + + + + + 
6 + + + + + + + + + + + + + 
(+) Lytic halo; (-) No halo 
 
Table 2:3 shows that phage PVP-SE1 maintained its lytic spectrum even after being pro-
duced in E. coli for six generations. 
 
 
2.2.1.3 Phage Infection Parameters 
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The phage infection parameters of G0 and G6 were determined by a single-step growth 
curve. Figure 2:1 shows the increase in phage concentration over time of G0 in S1400/94 and 
G6 in BL21.  
 
Figure 2:1: One-step growth curve of phage PVP-SE1 G0 in Salmonella S1400/94 and PVP-SE1 G6 
in E. coli BL21. Fitted values are presented for both conditions. 
 
Three phage infection parameters were determined, namely burst size, rise and latent pe-
riod. Generation zero (G0), i.e. the phage produced on their pathogenic host (S1400/94) 
showed a burst size of 102 phages per infected host cell, while the generation six, i.e. phage 
produced in an alternative host (E.coli BL21), obtained a burst of 28 phages. The rise periods 
were 11 and 21 min, respectively, and the same latent period was verified for both phages. 
The production of the phage in an alternative host lead to a smaller burst size and a longer 
rise period compared with the original phage. 
 
 
2.2.1.4 Phage restriction fragment length polymorphism (RFLP) 
 
Phage PVP-SE1 was further genomically characterized by determining the restriction profile 
of phage DNA (Figure 2:2).  
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Figure 2:2 Restriction profile of phage PVP-SE1 DNA. (A) PVP-SE1 G0 DNA digested with 
HindIII. (B) PVP-SE1 DNA (G0 and G6) digested with EcoRV. Lane M (marker) is a HindIII digest 
of lambda DNA. 
 
To assess if replication of the phage in E. coli BL21 could cause significant mutations or 
modifications in the phage DNA, the DNA from G6 was extracted and digested with EcoRV, 
which produces a great number of bands with different sizes, showing a genome of 93-94 kb. 
Comparison of its restriction profile with that of G0 (phage grown in its natural host, Salmo-
nella S1400/94) showed no difference. 
 
 
2.2.2 Phages Characterization 
2.2.2.1 Phage Morphology 
The morphology of phage PVP-SE1, PVP-SE2 and PVP-SE3 was analyzed using transmis-
sion electron microscopy (TEM) (Figure 2:3). 
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Figure 2:3: Transmission Electron Microscopy analysis of phage PVP-SE1 (A), PVP-SE2 (B) and 
PVP-SE3 (C). 
 
Morphologically, phage PVP-SE1 belongs to the Myoviridae family, which is character-
ized by its contractile tail, and resembles typical O1-like phages. However, this phage has a 
head size of 84 nm and a tail of 120 by 18 nm, which is considerably larger than those of typ-
ical O1-like phages (72 nm, 113 by 17 nm) [23], [62], [63]. Phage PVP-SE2 and PVP-SE3 
are Jersey-like Siphoviridae with a head size of 57 nm, tail 125 x 8 nm and base plate with 
three or more spikes (Figure 2:3) (Data provided by H.-W. Ackermann, Université Laval, 
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Quebec, Canada). The two phage families displayed plaques with different aspects, as 
showed in Figure 2:4 below. 
 
 
Figure 2:4: Images of the plaque characteristics of: PVP-SE1 produced in S1400/94 Salmonella host 
(A) and in a nonpathogenic host (B); PVP-SE2 produced in 821 Salmonella host (C); PVP-SE3 pro-
duced in 869 Salmonella host (D) 
 
The characteristics of the plaques formed by PVP-SE1 produced in S1400/94 Salmonella 
host are matted and small (Figure 2:4–A), while PVP-SE1 produced in E.coli BL21 displays 
small but clear plaques (Figure 2:4–B). Both Siphoviridae phages show large and clear 
plaques (Figure 2:4:C-D). 
 
 
2.2.2.2 Phages Sequencing 
 
The results obtained under the selection procedures provided us the information about the 
lytic spectrum of phages and their subsequent potential as a tool in a detection system. Phage 
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PVP-SE1 showed the ability to lyse a very broad range of Salmonella strains, broader than 
the well-described phage Felix O1 [14]. PVP-SE1 was able to infect several Salmonella mu-
tants, defective in core the polysaccharide assembly, suggesting that the receptor for this 
phage is the conserved LPS inner core region, which explains its broad lytic spectrum [28]. 
Therefore it is expected that the phage recognition elements located at the tail, the tail fiber 
proteins (TFPs), may also exhibit binding abilities to a broad range of hosts. As a result, TFPs 
alone may prove to be useful entities for the construction of a diagnostic tool for the fast de-
tection of Salmonella spp. and its control. Apart from PVP-SE1, the TFPs of phages PVP-
SE2 and PVP-SE3, which only infect a few Salmonella serovars, may help us to understand 
whether the width of the lytic spectrum is determined by their TFPs. We therefore decided to 
sequence phage PVP-SE2, to identify its TFPs and compare them to their counterparts of 
PVP-SE1 [28]. 
 
Salmonella Phage PVP-SE1 
 
The isolated polypeptides sequenced in scope of this work are described below and the whole 
patent document can be consulted on Appendix A (inside the CD). The nucleotide sequences 
are identified by SEQ ID No 1-6 and protein sequences from SEQ ID No 8-12. Sequence 
identification corresponds to the numbers identified on patent and the information per protein 
sequence acquired from databases as PFAM and BlastP is presented in Table 2:4. 
 
SEQ ID No. 1: Nucleotide sequence of wt PVPSE1gp40 (1815bp) 
atgtatcctattccatgtctcttcttgacattatctggaggaggaacagaaccactaccaccaggtagtgttaagaaggtggcctttaccc
gtggtctggttggtggtgctaccaaaaggtcaatggcgatcctcctgattgatgggagactctatacccaaggggataatgcgtggtct
gaatgcgcaaacgggaacataagcccgtttaaggatcattggcacttggcggctaatggtgtagctgatgtttttggtggtggtagagc
ctttgttgtcaaatacaacaatggtggctggcagtattgtggggacaccagtcaattcactggtagtgggtctatctattcttcttggacaa
gcttcccttcatcaatcacaggcacagtatccctcgcaaatttacaaagtgtttcttgtgctctcggtaacacactctggcagatggtagat
ggaagactttatggaagcgggtcaaacacaaatggatgccttggctctggtaatactaccgtaatatcgatcccaagaagtattagtgca
tcctctgtgagagcttacagcttaaatgcttgcgtgacatacctgaacaatattggacttccccgtgtttgtggggccacccatcagatag
atggtacttcaacaacacaaacacaaaactttatcgatgttagttttgcctctgtgactgaaaccgtctatgttaaagagtggttagcgaac
gaaacaaactcaatggctatcgcctctacaggtgttgatgatacagagcattatttatatacgaggggtatcgggacagcccaatactct
aagaaagagggtattggtcctttcgagacattcagggttatcgacggtggtcagtctcatttcctgattgctgataacaagctttacggtct
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tggtgacctaagtgctcaacttggccttggcacaccatcaacaatggtgttagaaccgacccttgttccagttcctacaggaagggattg
ggatctttcgaagctgacatacattgtagacatgaagacagatgtccttaaccaggggaactctatcagccattggatggtgtatgacgg
gaacctttactacgctggtaacctttatggtttctttgggtcaaccgatagcactggtgagttcacaaacatcccagaagcatcctttgggg
ggacaactgcggatgctatcaccacagggtctatcccatacgctatcaaagggtcgagaagtcaacttacgtggactgttgagccagc
agatgctgagatttatgatatttcgttcacatcgagtgctcctaatatcgcaactgtagactcaaatggtatcatgaccttccttgaagaggg
tggttttgacatcacaatgactgctaaaacagggtctggcgcggatgctaaaacactcacagatacttctggcggttatgtttccatcttct
ctgtgactaccgattccatcccacaaaaggaagttggtgatgtgttcgtgttcatggataaaaacagtcctgactatacaccaggtccga
acgttgtcggaatggaaatttctccagccaatgttgatactaacttcatagacggagaattaacaactacaaatccggatgtggtgatgat
tgatgagggtggattcctttcctgtattgcagttggtgatgcccgttgtggtgttcgtcttatttacagggagggtcaggttgaggcatttga
tgattcgtatgtcagtgtttcagacttcacagccccaccagatcctgtggaccccggcgaaccagttgtaccttctcaaccgcaataa 
 
SEQ ID No. 8: Protein sequence of wt PVP-SE1gp40 (605 amino acids) 
MYPIPCLFLTLSGGGTEPLPPGSVKKVAFTRGLVGGATKRSMAILLIDGRLYTQGDN
AWSECANGNISPFKDHWHLAANGVADVFGGGRAFVVKYNNGGWQYCGDTSQFTG
SGSIYSSWTSFPSSITGTVSLANLQSVSCALGNTLWQMVDGRLYGSGSNTNGCLGSG
NTTVISIPRSISASSVRAYSLNACVTYLNNIGLPRVCGATHQIDGTSTTQTQNFIDVSFA
SVTETVYVKEWLANETNSMAIASTGVDDTEHYLYTRGIGTAQYSKKEGIGPFETFRV
IDGGQSHFLIADNKLYGLGDLSAQLGLGTPSTMVLEPTLVPVPTGRDWDLSKLTYIV
DMKTDVLNQGNSISHWMVYDGNLYYAGNLYGFFGSTDSTGEFTNIPEASFGGTTAD
AITTGSIPYAIKGSRSQLTWTVEPADAEIYDISFTSSAPNIATVDSNGIMTFLEEGGFDIT
MTAKTGSGADAKTLTDTSGGYVSIFSVTTDSIPQKEVGDVFVFMDKNSPDYTPGPNV
VGMEISPANVDTNFIDGELTTTNP 
DVVMIDEGGFLSCIAVGDARCGVRLIYREGQVEAFDDSYVSVSDFTAPPDPVDPGEP
VVPSQPQ 
 
SEQ ID No. 2: Nucleotide sequence of wt PVPSE1gp41 (1809bp) 
gtggcagacatgactcaatttgaacaggctgtcgatcaggttgttgaagactctgaacgcctccacaaggttgtcaacggaacggcatc
cgaaactgttgttactgaagatggtagcaccattccaacggttcgtaaagctcttcttgacaacctgttctttaaaacaccgcctatgccgt
ggatcgcgggtactcagaccacagtattcaaccagctttatgcttttaatggcacaaatggggttcaatggtggtatgcaccaaccgcaa
cagcaagcgcccctgtcgttttaccacaaaacccagctaacagtgttaactggagattgtacaacgacgcagcggcgatggcatctat
ctatgcaccaatcaacagcccgatcctgacaggaaacccacaggctccaacccctgcggctaacagcaacagtacaacaattgccac
aactgcctttgttacaaccgctattgcaagcgccttgtcaagcatctcaggtggtagtgttacctttgcaaacctgtctgtaacaggtgcta
caacactcaatagtttggtggttggtgggacaatcgaccttaatggccctgtaaacgcagataactcaacaggtcgtttccagaacctga
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tcctgacaaaagagttgtcaagtcttaccttcgtatttacagacgcagataatccgacattctttaagacgcgccttgacccatatgcgatc
caaacccacagcatccagacggacattattgtcaacggaacagtggctgaagatgatacaaccatgtctctgacaggtgtgggtaata
acgtcttcgattatgtgtatatccgtggtaacgcaagtaaagatcctacagcaccgagattaaaggtctcaggtacaactgaggtagaaa
acctgaatattacaggtaacgtaacaggtatcaccttcagtgtcaacggacttgatatttcaccaaactctgttacaaccgcagacggtgt
aactgtaggtggtgacttacaggtcagtggtgttaccaaccttggaaacgcaacaatcggtggccttgatattacaagtgatctgaccgt
aaacggtaatacaacactcgaagatttctctgcgggtaacggaaacatcactggtccattcacagtgggtgggttaaccagtctcaatg
gtggatttacaaccggaacagcagatggtacaattggcggaaaactctctgttacaggaacgtctgagtttattgaggatcttagcgtact
tgccgatgttacagtccaggataacctgaccgtaaacggtgatgtcaaccttaacaacgcaacaggaacaacgacagttaacaacctt
gttattcagggtacggttacaggtctttctgttgacttgacaggtcagaacatcaacgtaggatctctttcctctactggtgcagtaactgcc
aatagccttacggtacaggattcggcaatcttaaccaaggcaagtgttgaattcctgacacttattgctgaggatattgatagctctacag
cggcatggtccccaagtggagattccaacatctacaacgtaacagtggatgcggatttaacaattggtgcttggcctgaaccgacagat
gctttttctgctgtgatttacctgactcaagatggtactggcggtcacactgtgactttagatcctaactacttggttttaaacagcgaaaca
attaacgagacggctggttcggtgactattcttcaattaacctataatggtgttgaaggcggtgttatcgacactgtaattgttcgtcgtccg
taa 
 
SEQ ID No. 9: Protein sequence of wt PVPSE1gp41 (602 amino acids)  
MADMTQFEQAVDQVVEDSERLHKVVNGTASETVVTEDGSTIPTVRKALLDNLFFKT
PPMPWIAGTQTTVFNQLYAFNGTNGVQWWYAPTATASAPVVLPQNPANSVNWRLY
NDAAAMASIYAPINSPILTGNPQAPTPAANSNSTTIATTAFVTTAIASALSSISGGSVTF
ANLSVTGATTLNSLVVGGTIDLNGPVNADNSTGRFQNLILTKELSSLTFVFTDADNPT
FFKTRLDPYAIQTHSIQTDIIVNGTVAEDDTTMSLTGVGNNVFDYVYIRGNASKDPTA
PRLKVSGTTEVENLNITGNVTGITFSVNGLDISPNSVTTADGVTVGGDLQVSGVTNLG
NATIGGLDITSDLTVNGNTTLEDFSAGNGNITGPFTVGGLTSLNGGFTTGTADGTIGG
KLSVTGTSEFIEDLSVLADVTVQDNLTVNGDVNLNNATGTTTVNNLVIQGTVTGLSV
DLTGQNINVGSLSSTGAVTANSLTVQDSAILTKASVEFLTLIAEDIDSSTAAWSPSGDS
NIYNVTVDADLTIGAWPEPTDAFSAVIYLTQDGTGGHTVTLDPNYLVLNSETINETA
GSVTILQLTYNGVEGGVIDTVIVRRP 
 
SEQ ID No. 3: Nucleotide sequence of wt PVPSE1gp46 (1122bp)  
atggcagcgccaacagtacctattgagatttgggcttatggagatattgttcttcctaacacccatgaattaaacaaagcacgtcctatcg
atgacctgtggaacaaaggttgggaccttggtgaaaagccaacagtcgaagaatttaactacgttttaaatatgctgactgcatgggcca
agtatatcactggtgagcagatccctggtctcgacagtcgtttcttacgtgtgaatcagaaccttgcagaccttgcagacaaggccgcag
caagaacaaacctcgatgtttggagtaaaacagagtctgataccagatatgtgaacatttcaggcgacaccatgactggtgcattatctg
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ttccacgcctgaacctccaaccatccgaatcagattacgcatacatcacgaccaccaacccagcagcagacaccacattctttgattttg
tagttggtgataatatcggtaatgccccaggtacgtcgagcatcgatagtatgcgtttccgcttcgtcccttctggtggctcaatcttcaca
atgatggagttgaatgcgatcagtggcactgctgcactgtgtagggtaactggtaacattatcgcaagcggaagtataagcggtgcaa
gcgtcactgcaaccactgcaaacttcacaaacactaccgtaagcggtacgctgaatgctccaactattcagtccacaacaatcaggac
agggaccttaacggcaacaggaaacgttcaagggttcaacgttgtcgcaacaagctctttaacaaccccatatgccagtgtaaacgga
cagtgtaacgttaactcccttgttgtcaacaacaactccgctacagttggtggacgaaacgttgtgagagcaatcaatggtgcaacggc
agatggtaacggtaacgtcacactaaacctgtctggatttgttcagcagatccgtttaggtaataggtttgccacaggtgtaagtgaatcc
agattttatgcaggtcacgtcatgaccgggtgggctttcggtaacaagaaagaattgaggggcgcaacttactacactgcaccactaca
gtatctcattaacggacaatgggtaactgtttccaacctggactaa 
 
SEQ ID No. 10: Protein sequence of wt PVPSE1gp46 (373 amino acids)  
MAAPTVPIEIWAYGDIVLPNTHELNKARPIDDLWNKGWDLGEKPTVEEFNYVLNML
TAWAKYITGEQIPGLDSRFLRVNQNLADLADKAAARTNLDVWSKTESDTRYVNISG
DTMTGALSVPRLNLQPSESDYAYITTTNPAADTTFFDFVVGDNIGNAPGTSSIDSMRF
RFVPSGGSIFTMMELNAISGTAALCRVTGNIIASGSISGASVTATTANFTNTTVSGTLN
APTIQSTTIRTGTLTATGNVQGFNVVATSSLTTPYASVNGQCNVNSLVVNNNSATVG
GRNVVRAINGATADGNGNVTLNLSGFVQQIRLGNRFATGVSESRFYAGHVMTGWA
FGNKKELRGATYYTAPLQYLINGQWVTVSNLD 
 
SEQ ID No. 4: Nucleotide sequence of wt PVPSE1gp48 (1494bp)  
gtggctgctcaatatggattaaatgactacggctttgcgatcccatccctcgatgatttaatcgcagataccaagcagtcgctgatccgaa
cttttggtgaaaacttcaacactcaggctaacactgttgttgacaaacttaccacaattttgaatgaaagagaatatcagttgatccttctgg
ctgcggctgtgtattctgcacagacacttgcaggggcagaaggtatttatcttgatgaactgcttggtcgtcgtggtatttatcgtcgtggt
aaaaccagaggatcaggtactatccagatggttgttaacaacaccgtcccgtacaacatgatttacagttcttcaacatatagcattgaca
gtggtaacttcgtactcacgcaggacactcctgtcgcagggaatatcctggcgcaacaaatccttaaccaagattgggttcttggtaact
atacgttccagatgattaatcagaacgatggttcaacaaaatcaatgaacttgacgctaagtaataaggtgcctaacagccctcagttaa
atgcgttcatgtcatcgattaaggatttcattgttgacaactccacacagttaaacgaagacaggatcttcattgactctgcgggtggagc
gatgtatatcgggtatgatgctaacaagaaaatgatcggacttaacagtcgtgttgatttccgttcatcacccgtagtgggccagagaac
aattaccattgaagtaattgctgctgaagcaggggctatttctcgtgaagcaaatactgtaacgaatatcacaccgacaccaagcggtttt
atcagcatgaccaacatgaccgcctttaatgacggttccgatgttgagacagacactgattacaaggttcgtgcttcacaaagcaccgc
agcaggtgctgctgccactagacctgccgttatttctgccgttttaaacgtcgagggcgtcagcaaggttcgtgtattctcaaacaacac
aggggaaacagaccagtttggtgttccggcatataagtttgagactgtagtttatggtggttccacagaagaaatcagtgaagcactttat
aacacaatcgcattgtccaacgcaacctatggtaatgttttttatgatgttaccacagaggatgatcagacggaacgtatctatcacagca
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aagcacaggctcgtgagcttgcagtccgtgttcgttataaaggaaagctcctgtccgtgacagagcaaaacactatcaaagatgcattg
aaagccgttgttgatcctctcaacattgcagatacactttacaacatccagttggtatccgcagttggttcctctatttcaccagggcgcttc
acgcaattgttggtggatgttaagaacactgaccaacctgacagtgcttatactaacagcgatgttgttgcaggtatgacagaagtctttg
ctttagatacagacgacattacattccagcaaatcatctaa 
 
SEQ ID No. 11: Protein sequence of wt PVPSE1gp48 (497 amino acids)  
MAAQYGLNDYGFAIPSLDDLIADTKQSLIRTFGENFNTQANTVVDKLTTILNEREYQ
LILLAAAVYSAQTLAGAEGIYLDELLGRRGIYRRGKTRGSGTIQMVVNNTVPYNMIY
SSSTYSIDSGNFVLTQDTPVAGNILAQQILNQDWVLGNYTFQMINQNDGSTKSMNLT
LSNKVPNSPQLNAFMSSIKDFIVDNSTQLNEDRIFIDSAGGAMYIGYDANKKMIGLNS
RVDFRSSPVVGQRTITIEVIAAEAGAISREANTVTNITPTPSGFISMTNMTAFNDGSDV
ETDTDYKVRASQSTAAGAAATRPAVISAVLNVEGVSKVRVFSNNTGETDQFGVPAY
KFETVVYGGSTEEISEALYNTIALSNATYGNVFYDVTTEDDQTERIYHSKAQARELA
VRVRYKGKLLSVTEQNTIKDALKAVVDPLNIADTLYNIQLVSAVGSSISPGRFTQLLV
DVKNTDQPDSAYTNSDVVAGMTEVFALDTDDITFQQII 
 
SEQ ID No. 6: Nucleotide sequence of wt PVPSE1gp51 (675bp)  
atggcagatgtttcttttccaacggtgaaggtctctgaccttccttccgccgtcaccgtatctggtggtgactatgtagttatggatcaggc
agacacaaccaggaaggcttctcttgacaccatcatgactcgtatgggtattatgaaggttgtcttcttttctgagggtgggttccttgaatc
caagaaagaccttgcattctttgatacgaatggtaagtattacacatggaatggtgtttacccgaaaacaattccaatgtcatcttccccgt
caaccacaggcggcatcagtgagaacgcctggcaagagttcggtgccagtggtggcggcggttcaacaggtaaggttgtcaatcttg
gcaatgtccaagggacagcaacatgtaaccttaacaggggtgattcttttgttgccaacttgacaggtggtcagtgcgttgtcataattac
caatccatcaacggctcaggatgtatctcagtcgtttaccttatccttaacacagggtacaggggcgaatttggtttcatggcccagtaat
attaagtggaattatgggcgtgttccagttctttcttataaaaccggggtccgagacatctttcagttcgtcacttatgatggtgggaatagtt
ggttcggctcccttattatggcaggagttgagtaa 
 
SEQ ID No. 13: Protein sequence of wt PVPSE1gp51 (224 amino acids)  
MADVSFPTVKVSDLPSAVTVSGGDYVVMDQADTTRKASLDTIMTRMGIMKVVFFSE
GGFLESKKDLAFFDTNGKYYTWNGVYPKTIPMSSSPSTTGGISENAWQEFGASGGGG
STGKVVNLGNVQGTATCNLNRGDSFVANLTGGQCVVIITNPSTAQDVSQSFTLSLTQ
GTGANLVSWPSNIKWNYGRVPVLSYKTGVRDIFQFVTYDGGNSWFGSLIMAGVE 
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The information per protein sequence, as acquired from the databases Pfam and BlastP, is 
presented in Table 2:4. 
 
Table 2:4: Description of each PVP-SE1 gp and corresponding function. 
PVP-SE1 gp SEQ ID No Length (a.a) Search tool Putative Function 
40 8 605 Pfam Structural protein 
41 9 602 BlastP Tail Fiber protein 
46 10 373 BlastP Tail Fiber protein 
48 11 497  Structural protein 
51 12 224 BlastP Structural protein 
 
 
Salmonella Phage PVP-SE2: Short Genomic Library 
 
Phage PVP-SE2 was produced and purified and a shotgun library was created for se-
quencing. We found that the phage has an approximate size of 40.6 kb, which is in accord-
ance with the usual size of phages that belong to the Siphoviridae family. The sequence was 
analyzed by BLAST (Basic Local Alignment Search Tool). Figure 2:5 shows the overlapping 
sequence of groups of contigs in blocks or scaffolds, filling gaps of the sequence. The align-
ment and their assembly to the two homologous phages, namely phage SE2 and SETP3, are 
also shown. Figure 2:5 presents the similarity (in terms of percentage) of our phage to the two 
homologous phages mentioned previously.  The results show a genome with approximately 
85 % of similarity with the sequenced phage SETP3 (NCBI Reference Sequence: 
NC_009232.[29]). Another interesting phage included in this comparison was the recently 
sequenced phage SE2 [30], that even belongs to the same family and, despite bearing a simi-
lar name is not 100% identical to our phage. Both are Salmonella enterica serovar Enteritidis 
phages. Moreover, two putative TFPs were identified as gp4 and A01 and their position in the 
genome sequence is shown in Figure 2:6. Observing the sequence, the two TFPs share ho-
mology between each other, which may indicate functional similarity.  
 
Protein sequence of gp4 (684 amino acids): 
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MSSGCGDVLSLNDLQVAKKHQIFEAEVITGKQGGVAGGADIDYATNQVTGQTQKTL
PAVLRDAGFSPASFNFTTGGTLGADDADKAVLWPKEDGGDGNYYAWRGSLPKVIP
AASTPLTAGGISDSAWVAFGDITFRAEADKKFKYSVKLSDFTTLQQLADAAVDSILID
RDYNFNNNETVNFGGKTLTIDCKAKFIGDGNLVFTQLGKGSIVVAPFMESATTPWVI
KPWTDNNEWITDPAAIVATLKQSKTDGYQPTVNDYAKFPGIESLLPPEAKDQNISSV
LEIRECTGVEIHRASGLMACFLFRGCHFCRMVDADNPSGGKDGVITFENLSGDWGK
GNYVIGGRTSYGSVSSAQFLRNNGGFARDGGVIGFTSYRAGESGVKTWQGTVGSTT
SRNYNLQFRDSAVLYPVWDGFDLGADTDINPEDGRPGDFPYSQYPVHMLPLNHLID
NLLVRGSLGVGLGMDGQGLYVSNITVEDCAGSGAYLLTHETVFTNIAIIDTNTKDFP
ANQIYISGACRVNGLRLVGIRSTSGQGMTIDAPNSTVSGITGLVDPSRINVANLAEEG
LGNSRINSFNSDSAALRLRIHKLSKTLDSGSVYSRINGGPGSGSAWTEITAIAGSLPDA
VSLKINRGDYRAVEIPVAMTVLPDNAVRDNGSISLYLEGDSLKALVKRADGSYTRLT
LA 
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Figure 2:5: Genome assembly of PVP-SE2. Overlapping sequences of groups of contigs in blocks or scaffolds, filling gaps of the sequence. Each scaf-
fold of contigs corresponds to a "supercontig" called Contig assembly 1-4. The sequences are assembled to two homologous phages,  Phage SE2 and 
SETP3. 
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Table 2:5: Percentage of similarity between the short sequence of PVP-SE2 and phage SE2 and SETP3 
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0 
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Figure 2:6: Putative TFPs identified as gp4 and A01 and their position on the sequence genome. 
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2.3 Discussion 
 
The aim of this work was to select and characterize phages with a broad host range of Salmo-
nella strains and to investigate the possibility of using them as a potential tool to use in the 
biosensing field. The highly specialized nature of phages and the uncommon existence in 
nature of broad host range phages (with a host range over species borders) makes the isola-
tion of such phages a rare situation. In particular, the narrow host specificity of Salmonella 
phages and the relatively large number of pathogenic Salmonella strains exacerbate this diffi-
culty [12], [31]. Due to their broad host range among Salmonella strains the phages presented 
in this study may have added value in phage therapy or detection field. Especially phage 
PVP-SE1 had our particular interest, since it was able to lyse almost all of the Salmonella 
strains used in this work and also bacteria other than salmonellae, e.g. the non-pathogenic 
strain E. coli BL21. Its ability to recognize E. coli BL21 created the hypothesis of producing 
this phage in an alternative, nonpathogenic strain, since it is believed that the broader the host 
range of a phage, the higher the probability of success in phage therapy and of finding alter-
native hosts in which to reproduce the phage [32]. When comparing the lytic spectrum of this 
phage to that of the well known phage Felix-O1 (a virulent phage originally isolated by Felix 
and Callow in 1943 [33]), we observed that PVP-SE1 presents a broader host range. Felix-O1 
is used routinely as a diagnostic tool in the identification of salmonellae due to its ability to 
lyse up to 99.5% of Salmonella strains [34]. Therefore, like Felix-O1, the newly isolated 
phage PVP-SE1 is considered to have equal or better properties as a diagnostic tool. 
On the other hand, the ability of PVP-SE1 to recognize E. coli can be a problem when 
developing a phage-based biosensor to detect Salmonella, due to the possibility of false posi-
tives. However, this limitation may be overcome if we manage to understand which TFPs are 
responsible for the recognition of E.coli. With the help of this knowledge we may then block 
or eliminate this specific binding characteristic. Based on sequencing information we could 
have an idea of some putative tail fiber proteins and which to use in binding affinity tests. 
Moreover, the partial sequencing of phage PVP-SE2 provided us with the information wheth-
er we are dealing with a new phage or not. The sequence showed a high percentage of simi-
larity with SETP 3 and SE2 phage, however our phage is not 100% identical. Two genes en-
coding putative TFPs were identified as gp number 4 and A01. Currently, their gene products 
are being produced and examined for their binding capacities. After comparing them to the 
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binding characteristics of the TFPs of phage PVP-SE1 we expect to have more insight in to 
what extend the width of the lytic spectrum of both phages is determined by their TFPs. 
Then, using recombinant technologies that allow us to remove or add TFPs to each phage, we 
hope to obtain more data on their binding properties, which will ultimately be used to create a 
phage with a tailor-made lytic spectrum.  
 The genotype of the host in which a virus reproduces affects the phenotype of the 
newly formed virus progeny [35]. In contrast to mutation, antagonist pleiotropy may be ap-
plied simultaneously to almost all the members of a developing phage population and gener-
ally is determined only by the nature of the last host in which the phage was replicated, being 
independent of the previous phage history [36]. As a consequence of this ubiquitous phenom-
enon, the growth and adaptation of the virus to the new host will lead to the achievement of a 
new stock that may be divergent from the original [37], [38]. Taking this into account, it 
would be expected that the replication of a phage in a different host would lead to progeny 
with different characteristics. In fact, the phenomenon of host-controlled variation has al-
ready been reported for phages and is usually implemented in a few growth cycles; in some 
cases, the phenotypic change is evident right after a single growth step where phages lose 
their ability to infect and lyse their original host [36], [38–40]. Therefore, the use of a non-
pathogenic host to produce phages for therapeutic purposes could be compromised by in-
duced changes in the phage lytic spectrum. In this study, the lytic activity of the phage after 
its replication in the nonpathogenic strain E. coli BL21 (G1 to G6) showed an efficiency 
equal to that of PVP-SE1 produced in Salmonella (G0), and thus no host-induced modifica-
tion of the phage or restriction by the pathogenic target bacteria occurred, i.e. there was no 
increase in the specificity of the phage to that strain with consequent narrowing of the host 
range. Therefore, in this case, it is expected that there will be no risk of treatment failure, in 
contrast to what happened in the past when phages were produced in laboratory strains and 
then used in therapy [41].  
 Comparing the one step growth curve parameters of phage PVP‐SE1 grown in Salmo-
nella S1400/94 (G0) and in E. coli BL21 (G6), it was observed that differences between the 
burst sizes and rise periods occurred that can be attributed to the use of a different host to 
replicate the phage: the phage had not suffered any genetic modification, and the only varia-
ble in the experiments (besides the phage generation) was the host used. When repeating the 
experiment using phage from G0 and E. coli BL21 as the host the same results were obtained. 
The increased safety and consequently the lower costs when producing phage PVP-SE1 in a 
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nonpathogenic host (E.coli BL21) can overcome the disadvantages of a smaller burst size and 
a longer rise period when compared to the phage production in the S1400/94 Salmonella host. 
 
2.4 Conclusions 
 
This work reports the selection and characterization of Salmonella phages, allowing us to find 
a phage with a broad host range among salmonellae. Phage PVP-SE1 presents a broad lytic 
spectrum, one even broader than that of Salmonella-specific phage Felix-O1. That character-
istic was found to be an excellent opportunity when exploring the development of a phage-
based biosensor. PVP-SE1 was able to lyse and could be produced in a nonpathogenic E. coli 
strain, without modification of its lytic spectrum, in this way ensuring its stability when used 
in phage therapy. Furthermore, the use of this nonpathogenic E. coli strain for PVP-SE1 pro-
duction facilitates the production and purification processes by eliminating the risk of intro-
ducing a phage-resistant pathogenic bacterium. The resulting cost reduction and increased 
safety of the phage preparations will lead to easier and faster approval for commercial appli-
cations. Furthermore, this phage can be used in the creation of a small cocktail of phages able 
to act as biocontrol agents in salmonellosis. Moreover, their tail fibers, responsible for detect-
ing different strains, can be explored as detection tools. 
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3 Magnetoresistive phage-based biosensor 
Abstract 
Salmonellosis still has a huge global health and economic impact as food- and water-borne 
disease. Low infection doses, high survival rates, persistence over inauspicious conditions 
and the potential to enter a viable but non-culturable (VBNC) state, but maintaining their 
virulence, are challenging features for any detection method. In fact, culture methods lack the 
capacity to detect VBNC cells, while biomolecular methods hardly distinguish between dead 
innocuous cells and their viable lethal counterparts. In this context we present and validate a 
novel bacteriophage-based microbial detection tool able to assess for Salmonella cells viabil-
ity. The phage PVP-SE1 tested as a biological element in a previously validated bioanalytical 
platform was proven to discriminate viable and VBNC cells from dead cells, thus surpassing 
one of the epic challenges in dealing with false-negative and false-positive results. Besides, 
the combination of this “smart” biological element with highly sensitive magnetoresistive 
sensors provides a powerful detection system with high-level performance at the accuracy, 
specificity but also sensitivity level, detecting bacteria concentrations in the order of 100 
cells/µL (3-4 cells/sensor). 
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3. Introduction 
 
Food- and waterborne microbial contaminations are a serious worldwide threat to public 
health. The ingestion of foodstuffs and water contaminated with microbial pathogens (e.g. 
Escherichia coli, Campylobacter or Salmonella) is responsible for about 2.2 million deaths 
annually. To reduce the incidence and economic consequences of foodborne diseases, the 
World Health Organization (WHO) has been enforcing the establishment of a surveillance 
program to assure the safety of food along the food chain, from “farm to fork” [1]. Such ac-
tions have greatly stimulated R&D activities around new microbial tests, in particular on the 
level of biosensing technologies [2,3]. Biosensors are sought to provide outstanding perfor-
mance, ideally working at the point-of-use, outside the central laboratory units. In contrast to 
the current time-consuming culture-based methods these devices are promising to deliver 
faster and more accurate results. Even so, there still exist some concerns that must be taken 
into consideration when adopting or developing a microbial analytical method. One of these 
involves the failure to detect an active pathogen when present, the so called false-negative.  
 The occurrence of false-negatives is often attributed to technological limitations, 
namely low sensitivity or matrix interferences and inhibitions. Not less important, however, 
are biological limitations such as the viable but non-culturable (VBNC) cells, which are bac-
terial cells that, despite being viable, do not grow on standard solid culture media and thus 
fail to be detected. As a result, the absence of colony forming units (CFU) in a culture plate is 
not a reliable or safe indication that bacteria are absent, dead, unable to grow or even unable 
to cause infection. In fact, under certain conditions, VBNC cells have been shown to resusci-
tate from this “dormant” state and return to an active metabolizing and culturable form, while 
retaining virulence [4,5]. 
 The VBNC physiological state is reported for several pathogenic bacteria and occurs 
under the influence of different stress conditions, such as nutrient or oxygen limitation, os-
motic stress, temperature and humidity changes and the presence of disinfectant agents [6]. 
Given that microorganisms in most food facilities and food-contacting surfaces are submitted 
to numerous sources of stress, including disinfection treatments, different physiological states 
namely viable, dead and VBNC bacteria in variable proportions are expected to be found 
within a bacterial population [7].  
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In this context, accurate microbial detection methods, able to identify the cell’s physio-
logical state, gain particular importance. Most of the established detection methods are based 
either on the classical culture plate assays, immunoassays (e.g. ELISA – Enzyme Linked 
Immunosorbant Assay) or DNA-based technologies (e.g. PCR – Polymerase Chain Reac-
tion); all of these methods, for different reasons, lack this accuracy and therefore cannot pre-
vent outbreaks from occurring. On the one hand, culture plate methods known as laborious 
and time-consuming suffer from false-negatives originating from the impossibility to detect 
the VBNC population. On the other hand, antibody and DNA-based assays, despite being 
very promising due to the rapid, sensitive and/or specific detection, are more prone to false-
positive results but also, in particular cases, can give rise to false-negatives.  
In the immunoassays case, false-negatives may occur upon antibody denaturation or inac-
tivation. Antibodies are sensitive to environmental conditions such as temperature, pH or 
solvent nature and easily undergo irreversible denaturation, resulting in a limited shelf-life 
[8]. False-positives result from the general incapacity of the antibody to distinguish viable 
from dead cells, specifically recognizing both populations, but also from cross-reactivity 
among related species of bacteria.  
Conversely, in PCR analysis, false-negatives can be related to interference with target-
cell lysis reagents necessary for nucleic acid extraction, DNA degradation and/or direct inhi-
bition [9]; false-positives come either from the detection of dead cells or from other unknown 
DNA sources. To overcome the tendency of PCR methods to overestimate the number of 
viable cells (false-positives) reverse transcriptase (RT)-PCR, an increasingly popular strate-
gy, is used [¦10,11]. RT-PCR detects mRNA, a biomolecule that has a half-life of 3 to 5 min 
after cell death [12]. More common is the use of new DNA-intercalating dyes such as 
ethidium monoazide and propidium monoazide to block the amplification of DNA from dead 
cells [13]. Still it has been reported that the length of the PCR amplicon may influence the 
efficiency of removal of the dead cell signal [14]. Furthermore, these dyes are said to only 
penetrate the damaged membranes of the dead cells, not the viable ones, and bind to the re-
spective DNA, preventing amplification. However, a compromised membrane may not al-
ways be associated to irreversibly inactive cells. 
The same principle of actuation is the basis of other viability indicator dyes, mostly fluo-
rescent molecules widely used in epifluorescence microscopy and flow cytometry. For in-
stance, the commercially available kit format LIVE/DEAD® BacLight™ from Invitrogen 
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offers a combination of two dyes. In this case a green fluorochrome (SYTO9) able to enter all 
cells is used to assess total cell counts, whereas the red fluorochrome (propidium iodide - PI) 
only enters compromised cells. In a simplistic approach the viability dyes only discriminate a 
viable population (green stained cells) from a dead population (red stained cell). However, 
many reports in flow cytometry have shown that the staining of bacterial cells does not al-
ways produce distinct “live” and “dead” populations [15,16]; intermediate states with differ-
ent amounts of both dyes, presenting a yellowish to orange coloration when observed under 
fluorescence microscopy and identified as compromised or “unknown” population by the 
cytometry kit, have also been observed. As discussed in more detail by Berney et. al. [17], 
this unknown population can be related to the presence of intermediate cellular states. There-
fore, there is a clear need for “smarter” as well as more practical detection tools able to dis-
criminate between the different cell states, while avoiding misclassification of VBNC or de-
tection of dead cells. In this context, to address this challenge we here present and study a 
highly specific biomolecular detection tool – the bacteriophage. 
 Bacteriophages (or simply phages) are viruses that only infect bacteria while being 
innocuous to humans. Mainly due to their ability to specifically attach and capture bacteria, 
combined with robustness, great stability even under adverse environmental conditions and 
extended shelf-life, phages are considered very interesting biological elements or 
biodetection tools [18,19]. Accordingly, significant progress in the detection of foodborne 
and waterborne pathogens, making use of phages, has been reported [20-22]. A recent work 
describes the direct detection of Salmonella Typhimurium on tomatoes using a phage-based 
magnetoelastic sensor, proving the ability of detecting foodborne bacteria on fresh products 
by immobilized phages on a sensor surface [23]. Also, a recent publication reviews the 
phage-based diagnostics, approved by Food and Drug Administration (FDA), for a list of 
pathogens, including Mycobacterium tuberculosis, Yersinia pestis, Bacillus anthracis, and 
Staphylococcus aureus [24]. However, studies on the detection of VBNC bacteria using 
phages are still limited [25,26]. A phage labeled with green fluorescent protein (GFP), was 
used to analyze VBNC cells of E. coli O157:H7 in fresh water samples by epifluorescent mi-
croscopy [23]. Nevertheless, using fluorescence as the detection principle demands a rigorous 
sample pre-treatment mainly due to the presence of autofluorescent or light quenching enti-
ties that may interfere in the measurement.  
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Bearing this in mind, as well as the need to find a superior analytical technology to fulfill 
the foodborne pathogen detection needs, a well-characterized broad-spectrum virulent phage 
(i.e. PVP-SE1) that infects Salmonella was studied. Its potential as a superior microbial 
biodetection tool and biological element on a biosensor interface was evaluated. In this work, 
Salmonella Enteritidis samples at different states of viability were analyzed by the phage 
using different techniques. The VBNC cell state was induced by the disinfectant agent sodi-
um hyphochlorine (commercial bleach) and evaluated using the SYTO9/PI fluorochrome 
uptake kit (LIVE/DEAD® BacLight™) in combination with epifluorescent microscopy and 
flow cytometry techniques. Various tests on the phage ability to discriminate Salmonella cells 
in different physiological states (viable, VBNC and heat-killed cells) were successfully ac-
complished resulting in phage validation as a selective biorecognition tool. In fact, the com-
bination of the PVP-SE1 bacteriophage with a previously developed and validated 
magnetoresistive bioanalytical platform [27-29] is a completely novel approach that allowed 
us to detect, identify and quantify different microbial samples. 
 
3.1. Materials and Methods 
 
3.1.1 Media and Buffers Composition 
 
The culture media components LB broth and agar were used for phage production. LB agar 
plates were prepared by adding 1.2% of agar (standard) to the LB broth. The soft agar used 
for the bacterial lawn was made by adding 0.6% of agar (soft agar) to the LB broth. The 
washing step on gold substrates was carried out combining phosphate buffer (PB) 0.1 M, pH 
7.5, with 0.02% (v/v) of Tween 20. Phages were suspended in SM buffer (100 mM NaCl, 8 
mM MgSO4, 50 mM Tris-HCl, pH 7.5. TE was prepared by mixing 10 mM Tris‐HCl with 1 
mM EDTA at pH 7.4. The buffer used to substitute the SM buffer on the experiments was 
0.1M MOPS buffer (3-(N-morpholino) propanesulfonic acid) at pH 5.7. The blocking buffer 
used was bovine serum albumin (BSA). All reagents were provided by Sigma-Aldrich. 
 
 
Chapter 3. Magnetoresistive Phage-based Biosensor 
 
77 
 
3.1.2 Bacteriophages and Bacterial Strains 
 
PVP-SE1,  a phage with a broad lytic spectrum against different Salmonella strains, was 
used as a biological element, and was isolated from a Regensburg (Germany) wastewater 
plant in a European Project Phagevet-P [30] Salmonella enterica serovar Enteritidis strain 
S1400 was used as a host [31]. Campylobacter coli phage vB_CcoM-IBB_35, isolated from 
poultry intestines, was used as a control [32].  
3.1.3 Phage Propagation 
 
The phages were produced using the double layer agar technique as described by Sambrook 
and Russell [33]. Briefly, from the obtained plaque forming units (PFU) ten were selected 
and transferred several times to three new Petri dishes with the proper bacterial soft agar. 
Using sterile paper strips, the phages were spread by passing the strips several times on the 
production Petri dishes and incubated overnight at 37
o
C. Then, 3 to 10 ml of SM buffer was 
added to Petri dishes and incubated overnight at 4ºC (with agitation). The liquid was trans-
ferred to 50 ml tubes and centrifuged at 9000 x g during 10 min at 4ºC (Hettich Zentrifugen-
Universal 320) to remove the bacteria. One volume of chloroform was added to 4 volumes of 
supernatant and centrifuged at 9000 x g during 10 min at 4ºC. The top liquid phase was re-
moved carefully and filtered through a 0.2 µm filter (Minisart-Santorius stedim biotech). The 
phage titer was verified and the solution was stored at 4
o
C. 
 
3.1.4 Phage Buffer Exchange 
 
Phage immobilization occurred on gold surfaces chemically functionalized by Sulfo-LC-
SPDP, an amino- and thiol (sulfhydryl) reactive heterobifunctional protein crosslinker and 
therefore phage buffer exchange was needed to remove the amine groups present in the SM-
Buffer.  
 Buffer exchange was made using Vivaspin 500 Centrifugal concentrator (MWCO 
100,000 Da), starting with a pre-rinsing step as described in the manufacturer's protocol. 
Then, the concentrator was filled with 500 μl of PVP-SE1 at a concentration of 1.0x1010 
PFUs/ml and centrifuged at 9500 x g during 15 min. After the first centrifugation, the con-
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centrator was filled twice with 400 μl of 0.1 M MOPS, pH 5.7, and centrifuged as before. At 
the end, the filter walls were rinsed with 200 μl of 0.1M MOPS and the final volume was 
approximately 300 μl. Following the buffer exchange the concentration of phage was verified 
using the double layer agar technique [33]. 
 
3.1.5 Induction of Salmonella into Viable but Non-culturable (VBNC) 
State 
 
3.1.5.1 Induction of VBNC State 
 
Bacteria were induced to enter the VBNC state using sodium hypochlorite (commercial 
bleach - stock concentration: 5%) at different concentrations. A single colony of Salmonella 
(S1400) was inoculated in 20 ml of LB broth and incubated overnight at 37
o
C/200 rpm. Fol-
lowing the pre-inoculation, 1 ml was transferred to 15 ml of fresh LB broth and incubated 
approximately 2-3 h at 37
o
C/200 rpm until the OD600 reaches 0.5-0.7 (concentration at ~ 
1.0x10
7
 CFUs/ml). The cells were washed and resuspended in 0.1 M PB, pH 7.5. From the 
stock solution, aliquots of 500 μL of bacteria were transferred to 1.5 ml eppendorf tubes. The 
eppendorfs were centrifuged at 4
o
C and 2370 x g during 15 min. The supernatant was re-
moved and 1 ml of the following concentrations of sodium hypochlorite was added: 5%, 4%, 
3%, 2%, 1%, 0.5%, 0.25%, 0.125%, 0.05%, 0.03%, 0.01%, 0.00875%, 0.0075%, 0.00625%, 
0.005%, 0.0025%, and 0.00125% (v/v) to the bacterial pellet. The serial dilutions of bleach 
were done with milli-Q water. As a negative control milli-Q water was used. The samples 
were mixed during 1 min at room temperature and 200 rpm (Thermomixer Comfort 
eppendorf 1.5 ml). Following chlorination, the suspensions were centrifuged at 3420 x g dur-
ing 10 min at 4
o
C and resuspended twice at 4
o
C in 0.1M PB, pH 7.5. The number of 
culturable cells (after bleach treatment) was determined based on colony counting and ex-
pressed in colony forming units (CFUs). The experiments were conducted in triplicate. Since 
the data were collected over several trials and over multiple days, all cell counts were normal-
ized to a control value. 
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3.1.5.2 Determination of Viability by Fluorescence Microscopy 
 
The OLYMPUS BX51 EXTREMO microscope was used to observe cells viability. The fluo-
rescent dyes SYTO9 and PI (propidium iodide) were components of the LIVE/DEAD® 
BacLight kit (Invitrogen detection technologies). SYTO9 labels bacteria with intact and dam-
aged membranes when in contrast PI only permeates bacteria with compromised membranes. 
Consequently, PI will compete for the same binding sites as SYTO9, reducing the green fluo-
rescence when both dyes are present. The concentration of each dye was chosen according to 
the protocol provided by the manufacturer. 
 
3.1.5.3 Determination of Viability by Flow Cytometry 
 
The bacterial samples were stained with LIVE/DEAD
®
 BacLight™ Bacterial Viability and 
Counting Kit (Molecular Probes
®) following the manufacturer’s specifications, and incubated 
for 15 min under dark conditions. Finally, flow cytometry measurements were done using a 
FACSCalibur flow cytometer using Cell Quest software (BD Biosciences). Data were ana-
lyzed using FlowJo software (Tree Star, Ashland, OR). 
 
3.1.5.4 Resuscitation Tests 
 
The resuscitation studies were carried out by adding 1 ml of VBNC cells to 15 ml of fresh LB 
broth. During seven hours 1 ml samples of cells were taken from the medium, centrifuged at 
3420 x g during 10 min and resuspended in 0.1 M PB, pH 7.5. A hundred µl were then plated 
out on agar plates for overnight growth at 37°C. The number of reculturable cells was ex-
pressed in CFUs. 
 
3.1.5.5 Phage Infection Parameters 
 
Adsorption assays were performed to access the percentage of phages that adsorb to their host 
Salmonella cells at different states of viability (Viable, VBNC, dead) and under conditions 
that mimics the ones used in the platform. Briefly, host cells were grown to reach the expo-
nential phase (OD600 nm = 0.6), centrifuged at 6000 x g for 10 min and resuspended in 0.1 M 
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PB, pH 7.5. Different treatments of cells were made, as described previously at III. 2.5.1. One 
ml of cells was then infected with the Salmonella PVP-SE1 phage at a multiplicity of infec-
tion (MOI) of 0.001. Samples were taken every 10 min for 40 min, diluted in 1:10 of 0.1 M 
MOPS, pH, 5.7, and centrifuged at 10000 x g for 10 min. The supernatant was diluted using 
10-fold serial dilutions in MOPS. Three independent replicates of each adsorption experiment 
were performed.  
Single-step growth experiments were performed in order to assess the latent period and 
burst size of a single round of phage replication in viable exponential phase grown Salmonel-
la cells. The procedure used was identical to the adsorption assays except that the samples, 
taken from the cell cultures infected with phages at 0, 20 and 40 min, were immediately plat-
ed (without being centrifuged) and their titre determined by the double-layer agar plate meth-
od in LB medium. 
 
3.1.6 Preparation of Gold (Au) Substrates 
 
A 15 cm (diameter) silicon wafer was provided with a thin film of chromium (Cr) (5 nm), 
followed by an Au layer (40 nm) by sputtering (Kenosistec11 Targets). Then, the substrates 
were diced in an automatic dicing-saw, resulting in 7×7 mm
2
 square pieces. Before the dicing 
process, the wafer was covered with a photoresistive polymer to protect the substrates from 
impurities due to the dicing process. 
 
3.1.7 Optimization of Phage Immobilization on Au Substrates 
 
Two phage immobilization methods, physical adsorption and covalent cross-linking, were 
tested. For both methods, Au substrates of 7×7 mm
2
 were incubated for 2 h in Microstrip® 
3001 (Fujifilm Electronic Materials, Belgium) at 65ºC to remove the protective coating of the 
photoresistive polymer. The substrates were then washed three times with isopropanol and 
sterile, distilled water and dried under a N2 stream. 
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3.1.7.1 Physical Adsorption 
 
Phage PVP-SE1 (prepared in 0.1 M MOPS buffer) was immobilized by physical adsorption 
over the Au substrates. The phage spots (1 μl) at a concentration of 1.0x1010 PFUs/ml were 
incubated 2 h at room temperature in a humidified atmosphere to prevent evaporation. The 
unbound phages were removed by washing three times with the corresponding buffer. 
 
3.1.7.2 Covalent Cross-linking Immobilization 
 
Approximately 50 μL of sulfosuccinimidyl 6‐[3’(2‐pyridyldithio)‐propionamido] hexanoate 
(Sulfo‐LC‐SPDP, Thermo Scientific) was placed over the Au surface and incubated at room 
temperature for 1 h in a humidified atmosphere. The excess of cross‐linker was removed by 
rinsing with 0.1 M phosphate buffer (PB), pH 7.5. After the chemical functionalization, 
phage immobilization was continued as described for the physical adsorption method. 
 
3.1.7.2 Blocking of Au Substrates 
 
Both immobilization methodologies used 1% BSA in TE as a blocking buffer. The incubation 
was carried out during 45 min at room temperature. The excess of blocking solution was re-
moved by washing the substrate with PB 0.1 M, pH 7.5. All substrates were exposed to 
2.8x10
9
 cells/ml during 45 min and washed with ~ 3 ml of serial solutions as follows: PB 0.1 
M, pH 7.4; PB/0.02% Tween 20 and distilled water.  In addition, the blocking performance 
was carried out using the following combinations: 1%BSA in milliQ-water; 1%BSA in TE 
and SH-PEG. This procedure was applied to the experiment using a covalent cross-linking 
immobilization. Two additional combinations were used: 1% BSA in milli-Q water and TE 
were incubated separately during 30 min. Next, the sequence was inverted, incubating first 
with TE and BSA 1% in milli-Q water at the end (30 min/component). 
 
3.1.8 X-ray photoelectron spectroscopy (XPS) 
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The composition and chemistry of model biofunctionalized surfaces was characterized by X-
ray photoelectron spectroscopy (XPS) using an ESCALAB 250 Xi system (Thermo Scien-
tific). 
 
3.1.8.1 Sample Preparation 
 
The samples for XPS analysis were prepared on gold substrates freshly cleaned for 15 min in 
UV-ozone cleaner followed by soaking in ethanol for 30 min. The molecular depositions for 
characterization of the individual preparation steps were carried out by either soaking the 
substrates in the appropriate incubation solutions, or by manually spotting the solutions onto 
samples. After the deposition samples were rinsed with 0.1M PB, pH 7.5, and dried under a 
clean dry N2 stream. 
 
3.1.8.2 Analyses on ESCALAB 250 Xi System 
 
ESCALAB 250 Xi is equipped with a monochoromated Al Kα X-ray source, a hemispherical 
electron energy analyzer, an automated sample stage, and a video camera for viewing the 
analysis position. The measurements were performed at room temperature in an ultra-high 
vacuum chamber with the base pressure <5×10
-10
 mbar. Gold substrates ensured sufficiently 
high conductivity for the molecular film samples in this study, so additional charge neutrali-
zation was not necessary. The standard analysis spot of ca. 900×600 μm2 was defined by the 
microfocused X-ray source; smaller source-defined ca. 500×300 μm2 X-ray spots were used 
to analyze the samples prepared by spotting the incubation solutions. Line scans and control 
measurements at different spot sizes were performed to locate and confirm the positions of 
the spotted sample areas. 
To produce accurate binding energy (BE) measurements, the energy of the 
monochromated Al Kα X-ray source was measured to be within <0.2 eV from 1486.6 eV. 
The BE scale of the analyzer was calibrated to produce <50 meV deviations of the three 
standard peaks from their standard values: 83.98 eV for Au 4f7/2, 368.26 eV for Ag 3d5/2, and 
932.67 eV for Cu 2p3/2. In agreement with the BE calibration, the Au 4f7/2 peak was observed 
at 84.0±0.1 eV for all the samples. The aliphatic C 1s peak was typically observed at 
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284.6±0.2 eV, i.e., at the value that is commonly measured for organic monolayers on metal 
substrates. 
Regarding the instrument settings, a high-resolution elemental XPS data in Au 4f, C 1s, 
O 1s, S 2p, and N 1s regions were acquired with the analyzer pass energy set to 20 eV (corre-
sponding to energy resolution of ca. 0.36 eV) and the step size set to 0.1 eV. Additional high-
resolution scans were performed in regions corresponding to elements (including Na, P, and 
F) expected to be present in samples or detected in wide survey scans. All the spectra were 
acquired in normal emission with an effective analyzer collection angle of ca. 30°. 
 
3.1.9 Salmonella Detection in the  Magnetoresistive (MR) Biochip 
 
3.1.9.1 Biochip Design 
 
The chips used were provided by INESC- Microsystems and Nanotechnologies and the bio-
chip design comprises of an array of 32 U-shaped spin-valve (SV) sensors fully passivated 
with an oxide layer. The sensors are arranged in two sensing regions (Figure 3:1), each one 
including 14 active sensors plus two reference sensors. The active sensors correspond to the 
biological sensors and are covered with two thin gold pads (composition equal to 3. 2.6.) RF-
sputtered and patterned by lift-off on top of the sensor. The reference sensor corresponds to 
the sensor without a gold pad, thus making it biologically inert [34]. The microfabrication 
process is performed in a clean room environment. The detailed process has been described 
previously [34-36]. 
 
Chapter 3. Magnetoresistive Phage-based Biosensor 
 
84 
 
 
Figure 3:1: Magnetoresistive biochip. Left: Magnetoresistive biochip mounted on a printed circuit 
board (PCB) chip carrier; Middle: Biochip with two columns, each containing 14 active sensors (with 
Au pads) and two reference sensors (without Au pads); Right: Active sensor including two Au pads 
on top of the sensor area for immobilization of the phage probes. 
 
3.1.9.2 Phage Immobilization on Au Pads 
 
Following the microfabrication process, chip wirebonding on a chip‐carrier and wires protec-
tion with silicone gel, the chip was ready to be functionalized. First, the chip was rinsed with 
isopropanol and milli-Q water and then dried under a N2 stream. In order to remove the re-
mains of the photoresistive polymer and other organic contaminants, the chip was exposed to 
ultraviolet light/ozone plasma (Novascan Tecnologies, PSDP-UVT series, IA, USA) during 
15 min at 50
o
C. Next, covalent cross-linking was carried out as described in 3. 2.7.2. A drop-
let of approximately 1 µl of Salmonella phage was placed over the left column of sensors and 
1 µl of unspecific phage (Campylobacter phage) on right column of sensors. The phage incu-
bation occurred during 2 h at room temperature after which the unbound phages were re-
moved by washing three times with 0.1 M MOPS buffer. The unspecific binding sites were 
blocked with BSA 1% in TE during 45 min as described in 3.2.7.3. 
It should be noted that, to ensure that Au functionalization and phage immobilization was 
done properly, the experiments were conducted in parallel on Au substrates under the same 
conditions as the MR biochip and analyzed by Nikon SMZ 1500 Stereomicroscope. 
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3.1.9.3 Magnetic Nanoparticles (MNPs) Labeling 
 
Protein A coated magnetic nanoparticles (Nanomag, Micromod) were labeled with anti-
Salmonella polyclonal antibody. Protein A is a surface protein originally found in the cell 
wall of the bacterium Staphylococcus aureus and their ability to bind immunoglobulins had 
special interest on our antibody immobilization strategy [37,38]. Protein A specifically tar-
gets the Fc region on the antibody without requiring a chemical immobilization and thus the 
loss of activity of antibody can be avoided. In the magnetic concentrator (Invitrogen bead 
separation) a 1.5 ml Eppendorf tube, containing 1 µl of MNPs (4.9x10
11
 particles/ml) was 
allowed to stabilize during 3 min, until the MNPs pellet was clearly visible on the wall of the 
tube. The original buffer was gently removed and the particles were resuspended in 100 μL of 
0.1 M PB, pH 7.5. This procedure was repeated at least twice to completely remove the origi-
nal preservative buffer. Then, MNPs were labeled with 1 µl of anti-Salmonella polyclonal 
antibody (stock concentration at 1 mg/ml) in a total volume of 5 µl of 0.1 M PB/0.02% 
Tween 20. The unbound antibody was removed by washing twice. Finally, the functionalized 
MNPs were resuspended in 5 µl of 0.1 M PB/0.02% Tween 20. 
 
3.1.9.4 Microfluidic System 
 
Bacteria and MNPs suspensions are loaded in a microfluidic system that consists of a 
U‐shaped channel printed in a polydimethylsiloxane (PDMS) block, as is shown in Figure 
3:2. The channel is connected with metallic adapters to tubing for the inlet and outlet. The 
sealing of the U-shaped channel to the chip is achieved by applying pressure over the PDMS, 
guaranteeing at the same time a correct alignment between the channel and the sensors [29]. 
The samples are injected inside the fluidic system by an automated syringe pump (New Era 
Pump Systems, INC). 
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Figure 3:2: Microfluidic system using a pressure platform including the PCB aligned with the 
Poly(methyl methacrylate) (PMMA) plates and the PDMS channel. The picture on the right shows the 
U‐shaped channel in a PDMS block filled with a color fluid [36]. 
 
 
3.1.9.5 Signal Measurement 
 
After immobilization of the phage, the magnetoresistive biochip is introduced on the portable 
reading platform [27] and the microfluidic system adjusted over the sensor [29]. The sensors 
are biased by a 1 mA current while an external DC+AC magnetic field of 3mT + 1.35mTrms 
is applied to magnetize the MNP. The baseline signal is first acquired during 10 min with 
only 0.1 M PB, pH 7.5, inside the channel. Salmonella Enteritidis at 1.0x10
8
 cells/ml is intro-
duced inside the channel and allowed to settle down for 40 min. Finally, the unspecifically 
bound bacteria are washed by introducing a solution containing 0.1 M PB with 0.02% of 
Tween 20 at a flow rate of 5-10 µl/min. Then, the antibodies previously labeled with MNP 
(as described in 3.1.9.3) are introduced inside the channel, interacting 30 min with bacteria, 
previously specifically captured by phage. Then, unbound MNPs are removed by washing at 
5 µl/min and 50 µl/min during 5 min. The difference between the signal acquired after wash-
ing and the baseline signal (ΔVbinding) is proportional to the number of cells bound to the sen-
sor surface. To be able to compare the different sensors, the ΔVbinding signal is divided by the 
baseline signal, as explained in [25]. 
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3.1.9.6 Analysis by Scanning Electron Microscopy (SEM) 
 
SEM analyses were performed by Quanta 650FEG, Environmental Scanning Electron Micro-
scope (ESEM). Gold substrates containing only phages immobilized on their surface were not 
subjected to any treatment. The substrates with bacteria attached on the surface were treated 
using a fixation technique to preserve the bacterial structure. The process involves three 
steps: fixation, washing and dehydration. Initially, the samples were immersed in 3% of 
glutaraldehyde (prepared with PB 0.1 M, pH 7.5) during 30 min at room temperature and 
washed with 0.1 M PB. Sample dehydration was carried out using a graded ethanol series in 
milli-Q (30%, 50%, 70%, 80%, 90% and 96%) during 5 min/solution. 
 
3.2. Results 
 
3.2.1 Optimization of Phage Immobilization on Gold Substrates 
 
When developing a detection method for a specific microorganism it is important to collect a 
number of elements that guarantee the quality and efficiency of the device. From the selec-
tion of both platform and biological element until the selection of the detection strategy, nu-
merous optimizations steps should be considered to improve the sensor's performance. The 
techniques used for phage immobilization as well as the morphology of the immobilized 
phage are two important factors that can affect the binding affinity of the bioelement to the 
target pathogen. Researchers like Singh et al. [39], Tolba et al. [40] and Gervais et al. [41] 
have been studying immobilization techniques for lytic phages with morphological features 
similar to those of our phage. In this work, the PVP-SE1 Salmonella phage, belonging to the 
family Myoviridae, was used. It has an icosahedral head of 84 nm and a contractile tail of 120 
× 18 nm with short tail fibers. As the phage receptors that allow target recognition are located 
at the tail fibers, phage immobilization on the biosensor’s surface should preferentially occur 
through the capsid head. Our immobilization method was based on random covalent binding 
using the bifunctional crosslinker Sulfo‐LC‐SPDP on the sensor surface. Sulfo-LC-SPDP is 
an amino- and thiol (sulfhydryl) reactive heterobifunctional protein crosslinker and therefore 
phage buffer exchange was needed to remove the amine groups present in the SM-Buffer. 
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The chemical immobilization was compared to physical adsorption immobilization and the 
surfaces were analyzed by a 650 Quantum ESEM scanning electron microscope (SEM). The 
phage density was calculated based on the phages counted in SEM images resulting in an 
average surface density. The results showed a phage density of around 3.07 phages/µm
2
 when 
the gold surface is modified using the bifunctional crosslinker Sulfo-LC-SPDP. The bacterial 
captured density was visualized by Nikon SMZ 1500 Stereomicroscope and analyzed by Im-
age J software as demonstrated in Figure 3:3. 
 
 
Figure 3:3: Comparison of the bacteria surface coverage when the phage was immobilized by cova-
lent cross-linking and physical adsorption. The error bars are standard deviations coming from at least 
five surface coverage evaluations. The bottom images correspond to the chemical (I) and physical 
immobilization (II). 
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When using covalent cross-linking (Figure 3:3:I) we obtained a percentage of surface 
capture density of 33.90 ± 8.68 against 6.05 ± 3.53 by physical adsorption (Figure 3:3:II)). 
Covalent cross-linking proved to be about 5.6-fold more efficient than physical adsorption. 
Non-specific binding was not observed because 1% BSA as a blocking agent was used. The 
positive results were also compared to those obtained on surfaces coated with only BSA. 
3.2.3 X-ray Photoelectron Spectroscopy Analysis 
 
Besides the density studies the efficiency of Sulfo-LC-SPDP compared to a similar linker 
3,3´-Dithiobis(sulfosuccinimidylpropionate) (DTSSP) was also investigated (data of DTSSP 
linker not shown). The efficiency and presence of the Sulfo-LC-SPDP bifunctional linker 
used in this experiment was analyzed and confirmed by XPS. Moreover, using the same 
quantitative spectroscopic technique, the covalent coupling of phage PVP-SE1 (in MOPS 
buffer) to the chemically modified surface was simulated using the 2-fluoro ethylamine hy-
drochloride compound under the same conditions as those used for phage immobilization. 
This technique allowed us to confirm the effectiveness of the chemical immobilization, 
providing the information about the attachment, composition, and chemistry of the molecular 
layer. Sufur (S2p), Carbon (C1s) and Nitrogen (N1s) elemental regions provided the most im-
portant information. Figure 3:4 shows the Sulfo-LC-SPDP molecule, to help in the following 
XPS analysis discussion. 
 
 
Figure 3:4: Sulfo-LC-SPDP molecule structure [42]. 
 
The graph presented in Figure 3:5 shows S2p spectra for the following conditions: depos-
ited SPDP layer, phage attachment, simulated coupling of fluoroethylamine in DMSO and 
MOPS. 
 
Chapter 3. Magnetoresistive Phage-based Biosensor 
 
90 
 
 
Figure 3:5: XPS S2p spectra (top to bottom) for SPDP, fluoroethylamine with DMSO, 
fluoroethylamine with MOPS and phage. 
 
Figure 3:5 provides information about the attachment of the SPDP molecule to gold and 
the availability of sulfo-NHS groups after the attachment. The first spectrum is for SPDP 
layer after deposition; referring to Figure 3:4, we can interpret this spectrum to understand 
how SPDP molecules are bound to gold. SPDP is a biofunction linker comprising an amine-
reactive N-hydroxysuccinimide (NHS) ester group on one side of the molecule and a disul-
fide linkage in the molecular chain. Upon adsorption on gold, the disulfide bond (S-S) breaks 
and both sulfur atoms form thiolate bonds with gold, as indicated by the spectral component 
at 162 eV (highlighted in red). Note that the second S2p component at 163 eV, which corre-
sponds to unbound thiols or intact disulfides, [43], is not observed for SPDP and at most rep-
resents an insignificant small fraction for other samples (green lines). The large component at 
168 eV marked in blue in the SPDP spectrum is related to the sulfur atom in the Sulfo-NHS 
reactive group of SPDP; the three oxygen atoms of the sulfonate group significantly increase 
the BE of this component. In contrast, this sulfo-NHS component is absent in the S2p spectra 
obtained after fluoroethylamine coupling either in DMSO (ideal reaction conditions) or in 
MOPS, clearly indicating that the sulfo-NHS functional group of SPDP was available for 
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coupling and has reacted similarly under both conditions. This result shows that our reaction 
conditions (working with lower pH) do not interfere with the coupling of amines to the SPDP 
layer. In the spectrum of the phage sample, the weak intensity around 169 eV was likely pro-
duced because traces of sulfate were present in the phage incubation solution. 
The carbon (C1s) and the nitrogen (N1s) regions in Figure 3:6 and Figure 3:7, respectively, 
provide complementary information about the NHS group. 
 
 
 
Figure 3:6: XPS C1s spectra (top to bottom) for SPDP, fluoroethylamine with DMSO and MOPS, 
phage. 
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In the C1s spectrum, the red line corresponds to the aliphatic carbon component, the grey lines 
indicate different contributions from organic molecules and the blue curve (the most im-
portant) corresponds to the carbon in the NHS group. That component disappears after the 
reaction with fluoroethylamine, indicating the successful coupling under both DMSO and 
MOPS conditions, in agreement with the S2p data. In the phage spectrum, the aliphatic com-
ponent (red line) is minimal, as expected, while the three components highlighted in green 
indicate the presence of protein and DNA of the phage. 
 
 
Figure 3:7: XPS N1s spectra (top to bottom) for SPDP, fluoroethylamine with DMSO and MOPS, 
phage. 
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The N1s component marked in red for SPDP corresponds to the nitrogen in the NHS group. In 
agreement with evidence from both S2p and C1s regions, this component also disappears after 
the fluoroethylamine coupling. The N1s component marked in purple corresponds to amide 
bonds: it is present in the SPDP, increases after fluoroethylamine (amide) coupling, and dom-
inates the spectrum for the protein (and thus amide) rich phage. 
 
In addition to the increase of the amide signal in N1s region, we verified the 
fluoroethylamine coupling by observing the fluorine signal (F1s) in Figure 3:8. The similar 
intensity of the F1s peak after coupling under the DMSO and MOPS conditions directly con-
firms that the coupling was similarly efficient in both cases. 
 
 
Figure 3:8: XPS F1s spectra (top to bottom) for SPDP, fluoroethylamine with DMSO and MOPS. 
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3.2.4 Blocking Performance Analysis 
 
Besides phage immobilization on a functionalized surface, the blocking performance analysis 
was performed to verify which blocking agent can provide or exclude non-specific binding. 
SH-PEG and the combination of 1% BSA with different buffers (TE, 0.1 M PB, pH 7.5, and 
milli-Q) were tested. The bacterial density was observed by Nikon SMZ 1500 Stereomicro-
scope and the images were analyzed by Image J software (Figure 3:9). Blocking buffer BSA 
in TE gave the best results when including surface coverage outside versus inside the spot. 
Similar results were obtained with BSA in water. The binding of bacteria was two times 
higher when TE instead of water was used. In both cases, the percentage of background re-
mained the same. Thus, BSA in TE was shown to be the most efficient blocking buffer of 
nonspecific sites without inhibiting the phage receptor to bind to the bacterium. 
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Figure 3:9: A: Percentage of the bacteria surface coverage in the area in which phage was immobi-
lized (identified as "in spot") and on the nonspecific binding area in which phage was not immobi-
lized (identified as "out spot"). B: Image obtained by Nikon SMZ 1500 Stereomicroscope showing the 
"in spot" and "out spot". 
 
Moreover, after bacteria attachment a cleaning step was carried out immersing the gold 
substrates in different wash solutions in the following order: 0.1 M PB, pH 7.5; PB/0.02% 
Tween 20 and milli-Q-. This methodology allowed the removal of the unbound bacteria over 
the surface. 
 
3.2.5 Salmonella Cell Induction to the VBNC State 
 
To study the ability to detect the VBNC state of bacterial cells, a process capable to affect 
cell viability in a certain extent but not harsh enough to kill or lyse the cells was required. 
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Therefore, to induce the VBNC state in our work, bacteria were placed in contact with differ-
ent concentrations of sodium hypochlorite (commercial bleach). The concentration at which 
the cells were nonculturable was found and identified as the break-point. Fourteen different 
concentrations, ranging from 0% to 5% (v/v), were tested (0% was used as a control).  
Salmonella cells were placed in contact with different concentrations of sodium hypo-
chlorite in water and after bleach removal the cell culturability was assessed in solid medium 
plates by colony counting, while enrichment in nonselective liquid media was used for resus-
citation studies. Additionally, flow cytometry analysis and epifluorescence microscopy ob-
servation in combination with viability staining kit were used for cell state assessment. The 
break-point, the concentration at which 100% of the cells lose their culturable state and are 
unable to form colonies (CFU) in non-selective medium, was found to be around 0.006% 
(Figure 3:6-A, linear curve); below the break-point, at least a fraction of the population is still 
viable and able to grow in agar plates, while above that concentration no CFUs were ob-
served. However, when exposed to fresh liquid medium at adequate growth conditions all 
tested concentrations of bleach, even above the break-point and up to 5%, have shown cell 
growth again (resuscitation times within 16 h). 
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Figure 3:10: Assessment of physiological state of Salmonella Enteritidis (S1400) cells after treatment 
with bleach at different concentrations by different evaluation methods: (A) cfu counts on standard 
culture solid media compared to flow cytometry results for relative percentage of cells in the viable, 
compromised and dead state; (B) epifluorescence microscopy images of Salmonella Enteritidis cells; 
and (C) flow cytometry analysis showing the percentage of live, dead and compromised cells present 
after each treatment. For both assays, (B) and (C) cells were stained using a Live/Dead BacLight bac-
terial-viability kit (Invitrogen). The culturability test in (A) was collected from several trials over time 
and performed in triplicate, thus all cfu counts were normalized to the same initial cell concentration. 
Results presented for the flow cytometry analysis are the mean of independent triplicates from one 
representative experiment out of three. 
 
After evaluating cell culturability by colony counts the Live/Dead BacLight bacterial vi-
ability kit containing two fluorescent stains, SYTO9 (green-fluorescent) and propidium io-
dide (PI) (red fluorescent), was used for epifluorescence microscopy observation and flow 
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cytometry measurements. These stains differ in their ability to penetrate healthy bacterial 
cells. When used alone, SYTO9 stains both live and dead bacteria. In contrast, PI penetrates 
only bacteria with damaged membranes, reducing SYTO9 fluorescence when both dyes are 
present. Thus, live bacteria with intact membranes appear green, while dead bacteria with 
damaged membranes emit red (Figure 3:10–B). Under the fluorescence microscope, interme-
diate cell colors ranging from orange to yellowish were also observed for bleach-treated cells, 
indicating the existence of other cell states than only live or dead. Additionally, bleach-
treated cells exhibit morphological alterations by a decrease in cell size (Figure 3:10–B). 
Next, to measure the relative proportion of the different cell populations (classified as live, 
dead or compromised), flow cytometry analyses were conducted for the different cell samples 
(Figure 3:10–C). Untreated bacteria appeared mostly in the right lower corner of the plot 
(SYTO positive, PI negative), while with increasing concentrations of bleach the amount of 
green fluorescence in the cells decreases; cells move up in the plot (SYTO positive, PI posi-
tive) and the amount of viable cells loses population to the compromised and dead states. The 
gating strategy in flow cytometry is important to define and discriminates between the differ-
ent cell populations. In this case the gating strategy adopted was from the Live/Dead Back-
light kit [17], this way defining what they call an “unknown” population. This population was 
identified as “compromised” (Figure 3:10–C) and associated to the VBNC physiological state 
supported by culture medium and resuscitation results.  
Furthermore, analysis of colony forming units on agar plates showed that the cells exhibit 
irregular colony shape and size as a result of sodium hypochlorite stress (Figure 3:11–B). The 
bacteria that were not exposed to bleach showed a more regular shape. 
 
 
Figure 3:11: Colony forming units on agar plates: A: Salmonella cells without bleach contact; B: 
Salmonella cells stressed by bleach. 
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3.2.6 Phage Adsorption Profile to Cells at Different Physiological States 
 
Lytic phages naturally infect and lyse the bacterial cell. This characteristic has kept research-
ers from including these phages, since it limits their use as recognition agents in detection 
systems for live organisms [44]. Bearing in mind this concern, the phage infection time was 
evaluated. The conditions used on MR platform were simulated in solution, i.e. the phage at a 
lower pH (0.1 M MOPS, pH 5.7) was exposed to Salmonella Enteritidis in 0.1 M PB, pH 7.5, 
without agitation, during 80 min. The phage at optimal conditions for biosensing purposes 
was exposed to Salmonella Enteritidis in solution to assess its infection time and cell lysis 
period. The phage infection profile was recorded by the determination of phage’s concentra-
tion every 10 min and the number of total phages was plotted versus time after inoculation 
(Figure 3:12–A). The phage quantification was performed by double layer agar technique as 
described by Sambrook and Russell [33] (Figure 3:8–B and Figure 3:8–C). During the 80 min 
defined for the experiment, under the applied conditions, no increase in phage count was de-
tected. Moreover, no cell lysis was observed (data not shown) indicating that the phages were 
not able to propagate and burst, thereby killing the host cells, at least during the 80 min of the 
experiment. 
 
 
Figure 3:12: (A) Bacteriophage PVP-SE1 growth curve in Salmonella Enteritidis (S1400) in phos-
phate buffer at room temperature. The number of PFUs at each time point after inoculation was nor-
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malized to the initial number of PFUs (0 min) ( ). The black, red and blue lines correspond to bacte-
riophage PVP-SE1 adsorption studies to Salmonella Enteritidis (S1400) in phosphate buffer at room 
temperature.  (B) Picture of plaque forming units (PFU) on a culture plate for phage adsorption 
counts. (C) Zooming in on a couple of typical PVP-SE1 plaques. 
 
Taking into account that, under the conditions specified, the phage was not able to induce 
lysis of the target cells, we next evaluated the phage adsorption capacity to Salmonella 
Enteritidis at different cell states (viable, VBNC and dead). For that purpose VBNC cells 
were prepared by treatment with bleach at 0.01%, whereas dead cells were prepared by heat-
ing at 70ºC for 10 minutes. The phage presented an adsorption profile to VBNC cells similar 
to that of viable cells, but much different to that of dead cells. The fraction of adsorbed phage 
to the viable and VBNC cells after 20 min of incubation was about 60 and 40%, respectively. 
After the same period of time in the presence of dead cells, the phage remained free in solu-
tion, only reaching about 20% of adsorption after 40 min of incubation, about a fourth of the 
total amount of phage adsorbed to VBNC and viable cells for the same period of 40 min. 
 
3.2.7 Phage Performance as Biological Element on a Biosensor 
 
The validation of phage as a biorecognition tool consists of its immobilization on a solid 
sensing surface. After optimization of the surface chemistry (as explained in 3.2.1.), the 
phage was immobilized on a gold surface by manual spotting (Figure 3:13–B). To evaluate 
the immobilized phage in terms of Salmonella cells recognition efficiency bacteria were 
submitted to different bleach treatments and incubated with immobilized phage to evaluate 
the degree of recognition through cell surface density over the phage spot area. The acquired 
results for phage detection were compared to results obtained with an anti-Salmonella poly-
clonal antibody spotted in parallel. The phage was able to discriminate between viable and 
dead cells resulting in reduced cell densities for samples with increasing number of dead 
cells, but directly proportional to the relative concentration of viable plus VBNC cells (com-
promised population) (Figure 3:13–A). On the contrary, the antibody indiscriminately recog-
nizes and captures all cells, independent of their physiological state, attaining almost constant 
cell densities even for samples with different proportions of viable to dead cells. Even more 
interesting is the fact that heat-killed cells were completely unnoticed by the phage but 
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strongly detected by the antibody. This result reveals the superior capacity of the phage to 
discriminate viable from dead cells and simultaneously circumvent the false-negatives and 
false-positives. 
 
 
Figure 3:13: Density of cells specifically captured by phage and antibody spots, covalently immobi-
lized on gold solid surface. (A) The surface coverage was analyzed by ImageJ free software and com-
pared with the relative amount of viable + compromised cells ( curve) and dead cells ( curve) 
measured by flow cytometry. (B) Stereoscope pictures for representative spots of Salmonella cells 
specifically recognized by phage PVP-SE1 (top) and anti-Salmonella antibody (bottom). 
 
3.2.8 Phage-based Magnetoresistive Biochip for Cell Viability Assessment 
 
The feasibility of developing a phage-based biosensing system and its potential as a cell via-
bility determination tool was assessed by making use of an existent magnetoresistive (MR) 
biochip and respective electronic reader. The phage immobilization procedure previously 
Chapter 3. Magnetoresistive Phage-based Biosensor 
 
102 
 
optimized for bulk gold surfaces was transferred to the MR biochip. The functionalized bio-
chip was then used for quantitative analysis of Salmonella samples in different physiological 
states.  
 The flow cytometry analysis performed previously allowed us to identify the viability 
state of the bacterial cells detected by the MR biochip. The strategy used on the platform in-
volves a heterogeneous model that is based on magnetic labels (commercial magnetic nano-
particles (MNPs) of 250 nm in diameter) coated with Protein A for site-directed immobiliza-
tion of the anti-Salmonella antibody on their surface, combined with a specific Salmonella 
phage (PVP-SE1) immobilized on the sensor surface (Figure 3:14–A). This straightforward 
assay format allows a specific initial detection of bacteria by the phage, followed by the at-
tachment of MNPs to Salmonella. The stray field created by the labels is detected as a varia-
tion of the sensor resistance proportional to the number of captured cells. A typical experi-
ment of the response of three single sensors and the detection strategy applied in each sensor 
is demonstrated in Figure 3:14–B. 
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Figure 3:14: The detection strategy using phage PVP-SE1 (A) and a typical response of phage-
modified magnetoresistive spin-valve sensor (B) while measuring Salmonella Enteritidis contaminat-
ed samples. The positive sensor (blue curve) is modified with a specific phage PVP-SE1, while the 
negative sensor (red curve) is modified with an unspecific phage (Campylobacter coli phage). The 
reference sensor (black curve) is not bioactived. 
 
The blue curve is the response of a positive sensor to the presence of Salmonella 
Enteritidis cells. In the positive sensor, phages specific to Salmonella were immobilized over 
the MR-sensor on the chip and an anti-Salmonella specific polyclonal antibody was the se-
cond recognition element immobilized on the magnetic particles. The red curve is the re-
sponse of a reference sensor, where no biological element was immobilized over the MR-
sensor. The analysis of the signals obtained from a set of sensors is presented in Figure 3:15–
A. 
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Figure 3:15: Comparison of two groups of experimental data for Salmonella Enteritidis detection (A). 
The positive sensors were coated with specific Salmonella phage and negative sensors with unspecific 
phage. The error bars are standard deviations of the signal coming from at least 12 sensors acquired 
sequentially at the same chip. The lower images correspond to microscopic visualization of a U-
shaped spin valve sensor (2.5 x 80 μm2) I: Positive sensor (with Salmonella phage immobilized over 
the Au pad); II: Negative sensor (with unspecific phage immobilized over the Au pad); III: Reference 
sensor (sensor biologically inert). 
 
From Figure 3:15 we can conclude that the measured signals correspond to an average of 
20 cells over each sensor. Compared to the negative control (unspecific phage), the binding 
affinity of the specific phage was around 20 times higher (average absolute value of 100 µV 
against 5 µV), proving that the bio-assay is generating reliable results for this particular ex-
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ample. The results support the evidence demonstrated on gold substrates that this technique 
can specifically detect Salmonella strains and can be used in further viability assays. To gain 
further insight into the capture response of phage to the target (Salmonella), the phage immo-
bilized on the sensor surface was also exposed to bacteria in the stationary phase to examine 
whether the bacterial growth stage has an influence on the binding efficiency. 
 
 
Figure 3:16: Signal comparison of Salmonella Enteritidis in two growth states. As a negative control, 
sensors coated with unspecific phage were used. The error bars are standard deviations of the signal 
coming from at least 5 sensors acquired sequentially at the same chip. 
 
The exponential phase shows a four times higher binding signal than when cells from the 
stationary phase are used (Figure 3:16). This observation supported the hypothesis that our 
phage could be an excellent bioelement to decrease false positives or negatives when using 
the phage-based magnetoresistive biosensor.  
Following the simulation of the VBNC state in Salmonella Enteritidis (as explained in 
3.2.5), the phage-based MR biochip was exposed to different suspensions of bacteria exposed 
to different percentages of bleach. Subsequently, the voltage signal was obtained. Each solu-
tion loaded in a microfluidic system was analyzed by flow cytometry using the 
LIVE/DEAD
®
 BacLight™ Bacterial Viability and Counting Kit that, combined with beads 
(for system calibration), and allowed for the quantification and the differentiation of the bac-
terial population based on their viability state. Figure 3:17 shows the normalized binding sig-
nals (Vbindingac /Vsensorac) versus viability state, where the binding signals are differential volt-
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age values identified as Vbinding ac, calculated from the difference between the sensor baseline 
(Vsensor ac) and the signal originated from the specifically bound MPs over the sensor (Vparticles 
ac). As the binding signals are obtained from different sensors, their sensitivities must be 
normalized to a reference value and the sensor response (Vsensor ac) to the external AC excita-
tion field (Hac) was used as reference. 
 
 
Figure 3:17: Phage-based magnetoresistive biochip measurements performed on an electronic reader. 
(A) Normalized differential voltage signal for Salmonella samples subjected to different treatments 
(square points curve). The shaded area in blue on the bottom refers to the obtained signal using an 
unspecific phage on the sensor. Each point and shaded area represents the average value of at least 10 
independent sensors. Bars represent the concentration of cells and respective cell state for each cell 
sample measured on the MR-chip. Cell concentrations were obtained by flow cytometry using the 
Live/Dead counting Backlight kit from Invitrogen, in which each data point results from the analysis 
of triplicates. (B) Schematic representation of the “sandwich” type biomolecular recognition strategy 
adopted in the MR-biochip measurements. (C) Picture of the MR-biochip used for the detection of 
Salmonella cells shown on a standard cell culture plate. 
 
The highest signal was obtained for bacteria in the exponential phase. The phage-based 
MR biosensor showed to be sensitive in the presence of bacteria on VBNC state and when the 
percentage of that population reduced to half (Figure 3:17–A), the detection signal decreased 
proportionally. Moreover, based on these results we can conclude that our phage does not 
recognize the dead cells, since the signal for the condition VBNC would increase with an 
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increase in percentage of dead cells in solution. The heat-treated cells were not detected by 
the biosensor, which obtained signal occurred on the negative sensors region. 
 
3.3 Discussion 
 
Most water treatment systems in the US and Europe have been using chlorine-based 
products, usually at 0.5 to 1.0% concentration, for disinfecting drinking water for nearly 100 
years. In particular sodium hypochlorite (NaOCl), commonly known as bleach, is trusted as a 
powerful disinfectant. It is considered a bactericidal agent, except when it is used at lower 
concentrations, where it works as a bacteriostatic agent. Many scientific studies report on the 
inefficacy of bleach to completely kill bacteria, but rather induces latent forms [6,45,46], as-
sisting bacteria in entering the VBNC state. This has been related to bacterial survival mech-
anisms, which upon the exposure to harsh but sub-lethal conditions can lead cells to enter a 
VBNC state that cannot be detected by traditional bacteriological culture methods [47]. The 
reason to choose this disinfectant agent resides in the fact that it is widely used and applied in 
various food processing facilities, household cleaning and even health care facilities [48]. 
Therefore, to induce cells into the physiological state of VBNC, Salmonella Enteritidis sus-
pensions were treated with commercial bleach at a range of concentration from 0 to 5%. In 
fact, it was observed that Salmonella treated with bleach at concentrations above 0.006% 
were not able to grow in solid culture media. To prove the presence of viable cells under the-
se conditions several analytical techniques were used to assess the physiological state of the 
cells as well as their total count number. The applied methods, fluorescent microscopy and 
flow cytometry [49], are common techniques in microbiology that, when associated with via-
bility stains, allow the rapid characterization of cells from nonhomogeneous populations. 
Both methods, in agreement, showed that bleach induces Salmonella to enter the VBNC state. 
The different efficiencies on green and red fluorophores cell uptake rates denote the presence 
of a compromised population that was proven to be VBNC by resuscitation tests. These re-
sults prompted us to study whether the Salmonella-specific phage PVP-SEI would be able to 
detect bacteria at the VBNC state. An additional important issue is the fact that PVP-SE1 is a 
virulent phage, able to lyse the cells, which in a solid state biosensing system could be a limi-
tation. This opposed to other types of phages, such as filamentous phages, which do not lyse 
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the infected cells. This characteristic has refrained researchers from including these phages in 
detection systems, since it limits their use as a recognition agent for live organisms [15]. 
Bearing this in mind, the phage infection time was evaluated prior to the realization of phage-
cell adsorption studies. Our results show that no cell lysis occurred during the period of a 
common biosensing experiment. This allowed us to circumvent the limitation of using lytic 
phages as a detection tool mentioned by other researchers [50]. A first test involved the eval-
uation of the phage adsorption efficiencies to cells at different physiological state in solution. 
We demonstrated that the PVP-SE1 phage has a completely different adsorption profile for 
viable (including the VBNC) cells than for cells killed by temperature treatment. Viable cells 
were rapidly recognized by the phage while dead cells were completely ignored (80% of ad-
sorption against 20%, respectively). Moreover, the 20% of adsorption can be due to an un-
specific attachment from phages to the cell surface, which after washing (as verified on MR 
platform) can be removed. Considering that the cell receptors of PVP-SE1 are lipopolysac-
charides and taking into account that it has been observed that different serotypes of Salmo-
nella can display different receptors under stress conditions [51], cell recognition may be af-
fected by those changes.  
As for the biological element, the detection signal generated was proportional to the con-
centration of viable plus VBNC cells in the sample, whereas dead cells were absolutely unno-
ticed. This gave us an indication of the possibility to explore this phage as a biological ele-
ment in biosensing systems.  
Following the optimization of phage immobilization conditions over a solid sensing sur-
face, we therefore designed a set of experiments with the intention to explore the potential of 
PVP-SE1 to capture, detect and, above all, discriminate between different physiological states 
of Salmonella. Gold coated solid substrates were used as sensing surfaces for phage immobi-
lization aside with anti-Salmonella antibody. The two biorecognition agents were evaluated 
and compared in their cell binding and capture performances for different cell populations. 
The bacteriophage presented a cell surface coverage proportional to the sample concentration 
on viable cells (including VBNC), while the antibody presented an almost constant surface 
density following the total number of cells in the sample (including dead cells). From these 
results one important assumption arises: the phage and the antibody are not recognizing the 
same cell membrane receptors and may work successfully in combination. In fact, one major 
concern when developing biomolecular recognition strategies, mainly “sandwich” type assay, 
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where two biological elements may specifically bind to the target analyte, is the competition 
for target receptors. Identical biological elements may hamper each other’s proper attach-
ment. This is a common scenario in standard immunoassays where a labeling antibody may 
block the epitopes to the capture antibody or vice versa. In this case by conjugating two 
bioligands of a different nature, antibody and bacteriophage, in a so-called heterogeneous 
“sandwich” assay, we took advantage of non-competitive capture and labeling steps. After 
setting up the phage immobilization conditions as well as the recognition strategy the phage 
was evaluated in terms of cell viability discrimination and detection tool. Results clearly 
demonstrate that a device using PVP-SE1 as the biorecognition interface has the potential to 
decrease both false-negative and false-positive results. The binding signals (Vbinding ac /Vsensor 
ac) obtained from the MR biochip measurements besides confirmation of the results obtained 
by direct imaging of captured cells in optical microscopy add quantitative information at 
much higher sensitivity than optical inspection. The amplitude of the binding signal for the 
different samples is matched up to the flow cytometry analyses of the samples loaded on the 
MR platform. When the percentage of VBNC loses population to the dead state, the biochip 
detection signal also decreases proportionally. Additionally, heat-killed cells did not create 
any signal at all, remaining at the level of the negative control for unspecific phage signal and 
both at the system noise level.   
 The results showed that, when in a buffer with lower pH, the phage can be efficiently 
immobilized with approximately 80% of attachment to the surface (data not shown). 
 
3.4 Conclusions 
 
The lytic phage PVP-SE1 was explored as an alternative biological element for pathogen 
detection and viability assessment. Taking into account the problematic occurrence of false 
positives associated to DNA-chips and the high production costs, poor stability and cross-
reactivity related to immuno-chips, the development of phage-based biochips emerges as a 
valuable tool. The feasibility to conjugate this biomolecular tool with electronic analytical 
devices without losing functionality was proven. An existent magnetoresistive type of biochip 
was used as proof-of-concept system to demonstrate the potential of the phage as biological 
element. However, the potential of this biomolecule is not limited to one type of detection 
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platform or transducing principle. The countless possibilities to combine this biological ele-
ment in microbial detection and characterization approaches may also include the develop-
ment of a phage-based viability kit for flow cytometry, where a fluorescently labelled phage, 
eventually by genetic modification, is used as a viability marker. Also optical or even other 
detection principles have plenty of room to be explored.   
Still this can be the tip of the iceberg because taking into account the diversity of phages 
that are currently available for different targets, this hybrid technology presents an enormous 
potential to be explored in a multitude of applications where bioanalytical devices are re-
quired, namely in the environmental area, food and beverage industry, or even biomedical 
field.  
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4.1 Novel "Nano-Phages" Interfaces for Biosensors 
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Abstract  
 
Biosensing systems are emergent in various areas of health due to limitations of conventional 
techniques. Developing diagnostic biosensor devices of quality involves several distinct strat-
egies, including the choice of the biorecognition element. Qualities most sought for are: spec-
ificity, sensitivity, stability and low cost-production. If all combined in one system, the diag-
nostic device can lead to a rapid and real-time detection system. Bacteriophages (or phages) 
are viruses that infect bacteria and their elevated specificity is a potential advantage when 
used as a biorecognition element. In particular, filamentous phages have proven to be excel-
lent bioelements and their exploration in the biosensor field is a challenge. Their specificity 
and stability under harsh environmental conditions are advantages that can compete with ex-
isting types of bioelements (e.g. antibodies). Studies involving filamentous phages as an in-
terface describe that phages aggregate, forming bundles of fibers that cannot completely cov-
er the sensor’s interface. Subsequently, this can lead to a decrease in the sensor’s perfor-
mance. In this work, we report a new interface formed by biorecognition nanoparticles, called 
“nano-phages”. “Nano-phage” comprises nanoparticles composed of self-assembled fusion 
major coat proteins of landscape phages selected against a target analyte. The interface was 
studied using a model phage selected from landscape library as a streptavidin binder. The 
results show that the “nano-phage” binds to streptavidin with the same or better affinity than 
the native phage. This new approach can be used to develop biosensors with increased per-
formance in a wide range of applications, such as early detection of cancer diseases and other 
pathologies. 
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4.1 Introduction 
 
Bacteriophages (phages) are viruses that infect bacteria and their intrinsic nature to infect 
bacteria make them a potential tool to detect and combat diseases. Phages can be divided in 
two groups depending on their life cycle: lytic or lysogenic. Virulent phages follow a strictly 
lytic pathway and are a good option for therapeutic use due to their ability to lyse the cell 
without interacting with the bacterial genome. However, this fact limits their application as 
biorecognition elements. In contrast, temperate phages follows a lysogenic pathway, integrat-
ing their genetic material into the host genome and therefore are considered better candidates 
to explore in biosensing systems [1–6]. Alternatively, filamentous phages are also good op-
tion because they  are extruded across the bacterial outer membrane without causing cell 
lysis. Features such as specificity, sensitivity, stability and low production costs make these 
biomolecules a promising alternative to antibodies, nucleic acids and enzymes, which are 
considered expensive, fragile and sensitive to environmental conditions [7–9]. Several studies 
have demonstrated that phages are more efficient compared to antibodies. In particular, the 
environmentally robust filamentous phages have been successfully used as an alternative to 
fragile antibodies in wireless biosensor systems for real-time pathogen detection [10]. Fila-
mentous phages are natural biopolymers, which can be genetically engineered to display mul-
tiple copies of foreign peptides that bind various hazardous biological agents, including bac-
teria, spores and cancer cells [11]. Peptide-displaying phage clones are typically selected by 
affinity from a landscape phage library, followed by DNA sequencing to identify the phage-
displayed peptides [12]. Morphologically, filamentous phages are flexible thread-shaped bac-
terial viruses, with a dimension of approximately 6 nm wide and 800–900 nm long. The pro-
tein tube contains thousands of copies of pVIII (major coat protein) and pIII, pVI, pVII and 
pIX (minor coat protein), which are located at the tube ends [13,14]. The potential of land-
scape phages as a selective and robust interface in biosensors was shown in numerous publi-
cations as mentioned previously. However, due to their structure, when immobilized on sen-
sor surfaces, they aggregate easily, forming bundles of fibers [15]. In such a situation, the 
bio-element cannot completely cover the sensor’s interface leading to a decrease in the sen-
sor’s performance. Moreover, in detection systems false positive results may occur due their 
ability to detect Escherichia coli. In order to find a solution for this problem, we developed 
nanosized phage particles, called “nano-phages” (NPs). “Nano-phage” comprises nanoparti-
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cles composed of self-assembled fusion major coat proteins of landscape phages selected 
against the target analyte. The main objective of this work was to improve the detection sen-
sitivity, developing small molecules derived from filamentous phages (NPs) and construct a 
competitive interface that can be tested and used in different types of sensor's platforms. The 
proof-of-concept was established by using a phage previously selected from the landscape 
libraries as a streptavidin binder (7B1) [11]. Enzyme-linked immunosorbent assays (ELISA) 
were used to confirm and test the NPs specificity. Their binding affinity when they are im-
mobilized by physical adsorption on a solid surface (e.g. gold) was confirmed by scanning 
electron microscopy (SEM). The ELISA assay confirmed that the NPs affinity is approxi-
mately 1.6 times higher than when the entire phage is used. Moreover, when immobilized to a 
magnetoelastic (ME) sensor by physical adsorption they demonstrate specificity and selec-
tivity towards the target analyte used for selection of parental phage. Our findings suggest an 
interface that can lead to the development of efficient devices to apply in the food industry, 
environmental area and health. 
 
4.1.1 Materials and Methods 
 
4.1.1.1 Bacteriophages and Bacterial Strains 
 
Phages of the Ff class infect E. coli with the plasmid-encoded F-pilus [12] and Escherichia 
coli K91 BluKan cells used for phage amplification were obtained from the Natasha Lab. The 
phage used in this work was selected from a landscape library as a streptavidin binder. Ac-
cordingly, phage 7B1 was selected from an 8-mer library as streptavidin binder and displayed 
the peptide VPEGAFSS [11], [16]. In this study, the wild-type phage F8-5 was used as a neg-
ative control [17]. 
 
4.1.1.1 Phage Propagation 
 
The phage was propagated in E. coli K91 BluKan cells and purified by polyethylene glycol 
(PEG) precipitation as described before [18]. Briefly, 4 L of 2 XYT Medium (16 g, bacto-
yeast extract 10 g, and NaCl 5 g/1 L, pH 7.4) containing 20 μg/ml tetracycline was inoculated 
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with a single colony of cells harboring 7B1 phage. The culture was grown for approximately 
15 h until reaching the stationary phase. The culture was then centrifuged at 2,744 x g 
(Beckman Coulter Avanti J-E; Rotor JA-10) during 10 min at 4
o
C and, supernatant contain-
ing phage was collected and centrifuged at 7,025 x g (Beckman Coulter Avanti J-E; Rotor 
JA-10) for 10 min at 4
o
C. Cleared supernatant was transferred to a fresh centrifuge bottle, and 
0.15 volume of polyethylene glycol (PEG)/NaCl (16.7% PEG, 3.3 M NaCl) was added, 
mixed thoroughly by inversion, and left overnight at 4°C. Phage was pelleted by centrifuga-
tion at 7,025 x g (Beckman Coulter Avanti J-E; Rotor JA-10) for 40 min at 4
0
C, and the pellet 
was resuspended in 10 ml of Tris-buffered saline (TBS). The phage suspension was clarified 
by centrifugation at 22,554 x g (Beckman Coulter Avanti J-E; Rotor JA-17) for 10 min at 4
o
C 
and was transferred to a fresh centrifuge tube for the second phage precipitation step with 
PEG/NaCl. Phage collected by centrifugation as described above was resuspended in 5 ml of 
TBS. The phage suspension was clarified by centrifugation at 22,554 x g (Beckman Coulter 
Avanti J-E; Rotor JA-17) for 10 min at 4
o
C and its concentration was measured 
spectrophotometrically and calculated in virions per milliliter, assuming that 1 (AU)269 = 6.5 
× 10
12 
virions/ml (physical titer). The concentration of infective phage particles (biological 
titer) of the phage suspension was done by infecting the host cells, plating, and counting of 
colonies.  
 
4.1.1.2 Peptide Sequence Determination 
 
The peptide sequence was determined by PCR amplification of the pVIII gene of the phage 
and purification of PCR products, followed by sequencing. The PCR reaction was carried out 
using the forward primer f8s-20: (5'-CAAAGCCTCCGTAGCCGTTG -3') and the reverse 
primer f8as-20: (5'- CATTCCACAGACAGCCCTCA -3'). Each primer was used at a con-
centration of 10 pmol/µl. The phage 7B1 was diluted 1:100 in filter-sterilized water and add-
ed to the PCR reaction tube containing 24 µl reagents for PCR: 10×Mg-free reaction buffer 
(2.5 volumes); 25 mM MgCl2 (2 volumes); 2.5 mM dNTPs (2 volumes); Taq DNA polymer-
ase (0.04 volumes); 0.3 volumes of each primer and 16.9 volumes of filter-sterilized water. 
PCR was performed using GeneAmp PCR System 2400 (Perkin Elmer, Norwalk, CT, USA) 
using the following conditions: the first cycle corresponds to initial denaturation and occurred 
at 94
o
C during 3 min, then followed by 35 cycles at 94
o
C for 10 s, 46
o
C for 20 s, 72
o
C for 45 
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s; and finally one cycle at 72
o
C for 4 min. The PCR products obtained were analyzed using 
agarose gel electrophoresis (2% wt/vol agarose) in 1× TBE. The gel was run at 70 V during 1 
hour in 1× TBE buffer. The gel was stained with SYBR Green I nucleic acid gel stain 
(Cambrex BioScience Rockland, Rockland, ME, USA) and illuminated on the Dark Reader 
(Clare Chemical Research, Denver CO). DNA bands were visualized using a Kodak EDAS 
290 imaging system (Eastman Kodak Company, Rochester, NY, USA). To remove the pri-
mers and dNTPs, which can interfere with sequencing reactions, PCR products were purified 
using QIAquick PCR purification Kit (QIAGEN Inc., Valencia, CA) following the manufac-
turer's description and sequenced at the Auburn University Genomic and Sequencing Labora-
tory (Auburn, AL) using primer f8s-20 at 20 ng/µl (8 µl of primer solution/purified PCR 
sample). The sequences obtained were analyzed using CHROMAS software (version 1.45 
Conor McCarthy, Griffith University, Southport, Queensland, Australia). 
 
4.1.1.3 Isolation of Phage Coat Protein (PCP) 
 
Following phage propagation, isolation of the phage coat protein 7B1 was carried out using a 
Sepharose 6B-CL (column preparation procedure in Appendix B) (Amersham biosciences, 
NJ, USA) column (1 x 50 cm) according to the following procedure: a 1.5 ml eppendorf tube 
containing 350 μL of phage clone (1.5x1014 vr/ml in TBS), 700 μL of cholate stabilizing so-
lution (120 mM cholate with 10 mM Tris-HCl and 0.2 mM EDTA, pH 8.0) and 27 μL chloro-
form was incubated overnight at 37°C by rotation. Then, 1 ml of phage coat protein 7B1 was 
applied to the column at a flow rate of 0.5 ml/min. As a running buffer 100 mM cholate was 
used. Fractions were collected every 5 min, and stored at 4
o
C. The process was monitored by 
the Econo UV monitor (Bio-Rad, CA, USA). The concentration of protein per fraction was 
measured on a spectrophotometer (Nanodrop, Model ND-1000).   
 
4.1.1.4 "Nano-Phages" Purification 
 
The biorecognition nanoparticles called “nano-phages” (NPs) were obtained using two tech-
niques: chromatography by eluting the phage coat protein in 10 mM Tris-HCl, pH 8.0 and 
ultracentrifugation.  
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4.1.1.5.1 Chromatography 
 
After the isolation of PCP, 1 ml fractions containing high pure protein concentrations were 
loaded onto a sepharose column and eluted with 10 mM Tris-HCl pH 8.0 at a flow rate of 0.5 
ml/min, collecting fractions every 5 min. Protein concentration and purity of each fraction 
was determined by measuring the absorbance at 280 nm. The sample used for binding affinity 
tests was selected based on the ratio A260/280.  
 
4.1.1.5.2 Ultracentrifiugation  
 
One hundred microliters of phage protein in 100 mM cholate buffer was centrifuged and con-
centrated in 30 kDa Amicon centrifugal units at 1,362 x g (Allegra 21R Centrifuge) for 15 
min to remove the excess of detergent. The residual ∼30 µl portion was diluted to 4 ml with 
10 mM Tris-HCl, 0.2 mM EDTA pH 8.0 (first 1 ml was added and gently mixed, then 3 ml 
more was added and again mixed) followed by centrifugation for 15 min at 1,362 x g. Fifty µl 
of the concentrated protein was obtained and transferred to a 0.5-ml tube. The Amicon unit 
was washed with 50 µl of 10 mM Tris-HCl, pH 8.0. The washing fraction was added to 50 µl 
of the concentrated protein and characterized by UV spectroscopy. 
 
4.1.1.5 Size distribution by Dynamic Light Scattering (DLS) 
 
The size of the NPs was evaluated using the Nicomp Model 380/DLS particle sizer. The min-
imal volume of sample allowed by the equipment was 700 µl. Therefore, the samples were 
diluted in 10 mM Tris-HCl, pH 8.0, until reaching the required volume. The size of NPs at 20 
µg/ml was also analyzed before immobilization on the sensor surface.  
 
4.1.1.6 Enzyme-linked Immunosorbent (ELISA) Assays  
 
ELISA binding assays were performed to confirm the specificity and dose-dependent binding 
of the NPs to the target.  
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4.1.1.8 Binding Affinity of Phage 7B1 and NPs Based on Direct ELISA 
 
Entire phages and the NPs at concentrations of 7, 14 and 20 µg/ml were immobilized onto a 
96-well polystyrene microtiter plate by physical adsorption and incubated for 2 h at room 
temperature. 0.1% Bovine serum albumin (BSA-SIGMA) was used as a blocking buffer and 
as a negative control to evaluate nonspecific binding. Unbound NPs and phages were washed 
on Microplate Washer (ELX-405) using repeated washes with 100 µl of 10 mM Tris with 
0.1% Tween 20. The wells were filled with different concentrations of streptavidin conjugat-
ed alkaline phosphatase (AP-SA). After incubated during 1 h, the wells were washed and 
developed with p- nitrophenyl phosphate (NPP) at OD405. The slope of color development 
was measured as a change in optical density (mOD/min or /hr) in a Synergy™ H1 Hy-
brid Microplate Reader.  
 
4.1.1.9 Inhibition of AP-SA binding by NPs and 7B1 phage 
 
In the competition assay the wells were coated with NPs and phage 7B1 and washed as de-
scribed above. The wells were filled with constant concentrations of AP-SA (6.25 µg/ml) and 
com petitive inhibitors at different concentrations (Table 4:1). Controls consisted of wild type 
phage (F8-5) and the BSA 0.1% in the absence of AP-SA. 
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Table 4:1: Concentrations of competitive inhibitors. 
 
 
4.1.1.10 Magnetoelastic Resonator Platform 
 
The theory behind the ME resonator platform is described in detail in Chapter 1, nevertheless, 
some important technical aspects of this platform are given here.  
 
Fabrication Process and Operation Principle 
 
The ME strip-shaped resonator platforms were supplied by METGLAS
®
 2826MB alloy and 
its microfrabrication process has been described in many papers from Dr. Chin's Group [19–
22]. The ME material was provided by the company in the shape of a roll of ribbon and was 
diced in rectangular pieces of 200 µm x 1 mm using a micro-dicing saw. ME sensors were 
cleaned ultrasonically with acetone and ethanol. The small pieces were coated with two film 
layers: chromium (Cr) and gold (Au). Cr formed the first layer deposited, allowing the adhe-
sion of the Au layer. The main function of Au is to protect the ME material from corrosion 
[23], when exposed to saline solutions, and in addition it provides a bioactive surface for NPs 
immobilization. The operation principle of ME biosensors is based on the magnetostriction 
effect, where the material dimensions change in the presence of a magnetic field [24]. When 
exposed to an alternate magnetic field, the applied magnetic energy is converted into mechan-
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ical oscillations with a characteristic resonant frequency. As the resonance frequency depends 
on the physical properties and materials dimensions when a non-magnetoelastic mass is add-
ed to the sensor, their mechanical oscillations decrease, consequently decreasing the reso-
nance frequency. Resonance frequency measurements of ME biosensors were performed in 
an electrical circuit that consists of a network analyzer (HP/Agilent 8751A Agilent Technol-
ogies Inc., Santa Clara, CA, USA), operated in the S11 mode. A single-layer solenoid coil 
around a glass capillary tube (0.4 mm inner diameter) was used. The experimental setup is 
illustrated in Figure 4:1. 
 
Immobilization of the NPs and Streptavidin Detection 
 
Unpolished magnetoelastic (ME) sensors were immersed in 100 µl of NPs suspension at 25 
µg/ml and incubated during 1 h at room temperature under continuous smooth rotation. The 
rotation allows the NPs to self-assemble over the sensor surface. Then, the ME biosensors 
were washed three times to remove unbound NPs and incubated with 0.1% BSA (blocking 
buffer) during 40 min. The control sensors were treated only with 0.1% of BSA. The biosen-
sors and control sensors were exposed to 1.0x10
7 
beads/ml (Streptavidin polystyrene beads, 
0.97 µm, Bangs Labs, Inc., Fishers, IN) and subsequently washed three times with milli-Q 
water to remove unbound streptavidin beads. Binding affinity of the NPs to the target (strep-
tavidin beads) was measured as a change in resonance frequencies and visualized by scanning 
electron microscopy (JOEL 7001 SEM). Dose dependence experiments were conducted using 
the NPs-based ME biosensors exposed to different concentrations of streptavidin polystyrene 
beads and carried out "in air". In simple words, following NPs immobilization and blocking 
step each sensor was dried and the signal was measured (f0: characteristic resonance frequen-
cy considered as a start point or reference). Then, after streptavidin exposition and washing 
steps, the sensors were dried in air and the frequency was measured (fmass). Subtracting the 
fmass from f0, the resultant resonance frequency is the result of the mass changed over the sen-
sor (Δm), described by the equation 1 (Chapter 1).  
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Figure 4:1: Scheme of the experimental setup using a NPs-based ME sensor. A: Image of the meas-
urement circuit of the magnetoelastic sensor; B: Image of the wire coil around glass capillary and a 
ME sensor after exposed to the target; C: Network Analyzer. 
 
 
4.1.1.7 Western Blot 
 
The presence of NPs was also confirmed by Western blot. NPs were immobilized on the sen-
sor as explained previously, and the sensor was immersed in 20 µl of Laemmli Sample buffer 
(BioRad) and heated at 95
o
C during 10 min. The sensor was washed three times and a 10-µl 
sample of each washing step was treated with 10 µl of sample buffer and heated (95
o
C, 10 
min). Subsequently, 10 µl samples were loaded onto a 16.5 % Tris-Tricine gel. Electrophore-
sis was carried out during 40 min at 100 V. Proteins were transferred to a 0.2 µm 
polyvinylidene difluoride (PVDF) membrane. The resulting blots were probed with anti-fd 
antibody for N-terminus detection (3.3 mg/ml). Following incubation with horseradish perox-
idase (HRP) conjugated antirabbit IgG (200µg/0.5ml) and NeutraAvidin-HRP the blots were 
visualized using a chemiluminescent substrate solution (West Pico: Stable Peroxide Solution 
and Luminol/Enhancer Solution).  
A 
B 
C 
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4.1.2 Results 
 
The aim of the present study was to analyze an alternative to using entire phages as an inter-
face for detection systems. NPs were produced, purified and their efficiency was analyzed 
and confirmed using immunoassays techniques (ELISA-based formats).  
 
4.1.2.1 Phage Characterization and Phage-coat Protein Isolation 
 
Following amplification and purification, the filamentous phage 7B1 was characterized and 
the results are presented in Figure 4:2. The absorbance profile (Figure 4:2–A) was the first 
indicator that provided the elements to calculate the physical titer, as well as the information 
of protein and DNA ratio [25].  
 
 
Figure 4:2: Phage 7B1 characterization: A - Absorbance profile obtained with a NanoDrop spectro-
photometer; B - Phage characteristics C- PCR products of three 7B1 phage stocks with the following 
biological titers: 1- 7.9x10
11
vr/ml; 2- 8.5x10
11 
vr/ml; 3-  1.49x10
12
vr/ml. 
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The adsorption spectrum in Figure 4:2 shows a broad plateau in the area 260-280 nm 
with a maximum at 269 nm as expected for filamentous phages [26]. The absorbance was 
used to calculate the physical titer as follows: 6.5 × 10
12 
× 23=1.5x10
14
vr/ml. The ratio 
A260/280 was 1.12. PCR amplification of the pVIII gene of the 7B1 phage and the sequencing 
of the amplified DNA fragment allowed the confirmation that phage production was carried 
out well, as shown in Figure 4:2-C (bands of ~5.8 kDa) and has the following sequence: 
AAVPEGAFSSDPAKAAFDS LQASATEYIGYAWAMVVVIVGATIGIKLFKKFTSKAS.  
 
After the analysis of the phage propagation parameters, the coat protein was isolated 
from the phage particle by solubilization with sodium cholate solution and subsequent size 
exclusion chromatography (Figure 4:3). 
 
 
Figure 4:3: Isolation of the phage-coat protein by size-exclusion chromatography. Phage 7B1 
(VPEGAFSSD) was loaded on a Sepharose column with 100 mM sodium cholate running buffer flow 
rate of 0.5 ml/min and fractions were collected every 5 min. Phage-coat protein was collected in a 100 
mM sodium cholate buffer solution, which was subsequently exchanged for biosensor purposes 
 
 
4.1.2.2 NPs Formation 
 
The sodium cholate buffer containing the phage coat protein was exchanged for 10 mM Tris-
HCl, pH 8.0, by an additional chromotography step as presented in Figure 4:4. The surfactant 
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from the solution was removed allowing NPs formation and further improvement of the ad-
hesion quality of these biomolecules to the sensor surface during the immobilization step. 
 
 
Figure 4:4: Elution/exchange buffer of a fraction of the phage coat protein (pVIII) on a sepharose 
column with 10 mM Tris-HCl, pH 8.0, at a flow rate of 0.5 ml/min. Fractions were collected every 5 
min. Peak 1, 2 and 3 correspond to the NPs fractions obtained. Chromatography allowed the NPs for-
mation at a slow flow rate, which may assist in maintaining the correct particle configuration preserv-
ing their biological activity. 
 
4.1.2.3 Assessments of the NPs Activity 
 
Production and purification conditions like buffer composition, pH, temperature, centrifuga-
tion velocity are aspects that may compromise the biological activity of nanoparticles and 
need to be considered during the process of NPs formation [16]. Accordingly, assessments to 
verify the stabilization and binding affinity of NPs were performed. Initially, the objective 
was to obtain higher concentrations of NPs and verify their behavior or activity under those 
conditions. Therefore, during NPs formation, fractions were collected from the third peak and 
their activity was tested. From that peak two type of samples were used, i.e. a sample contain-
ing one collected fraction and a second sample joining three fractions. It should be noted that 
all fractions used belong to the third peak. The idea was to understand if it is possible to in-
crease the concentration and if the NPs activity can be compromised using these conditions; 
the NPs, when too concentrated, can aggregate. As a result, the active part may not be availa-
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ble to recognize the target of interest. The process was carried out by ultracentrifugation and 
their activity analyzed using a direct ELISA assay. PBS and Tris-HCl, pH 8.0, were also used 
to verify if the Tris-HCl buffer is a favorable option to use in NPs formation. The binding 
affinity (Figure 4:5–A) represented by mOD/hr  is the linear rate of change in absorbance 
over the time period during which the absorbance was monitored. The NPs were tested 
against 50 µg/ml of streptavidin conjugated alkaline phosphatase (AP-SA). The size distribu-
tion in each sample was evaluated, using dynamic light scattering (DLS) represented (Figure 
4:5–B and C).    
  
 
Figure 4:5: Analysis of the activity of NPs using one or three fraction mixtures prepared in two dif-
ferent buffers: Tris-HCl, pH 8.0, and 1×PBS, sample no 1 and no 2, respectively. The 0.1% BSA was 
used as a control. A: Signal obtained for both samples by direct ELISA assay against 50 µg/ml of AP-
SA. B-C: Intensity-Weighted Gaussian distribution obtained by NICOMP 380 DLS. 
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Figure 4:5–A shows that the higher sensitivity was confirmed for sample No 1, which 
contains NPs collected from one fraction (diameter of 5.8 nm ± 0.9 nm). When mixing more 
than one fraction, the DLS results showed three size NPs populations (Figure 4:5–C). The 
first population (2.1%) presented an average diameter of 20.4 nm (± 2.4 nm), the second 
(13.7%) displayed an average size of 66.6 nm (±9.1 nm) and the last presented the largest 
size ( 84.2%) with a mean diameter of 270.9 nm (±53.6 nm). Correlating these values with 
NPs sensitivity, the heterogeneous population exhibited a decreased sensitivity, suggesting 
that aggregation may interfere with their activity. Homogeneous NPs size population 
presented a higher signal for the solution prepared with Tris-HCl buffer. The results obtained 
so far enabled the establishment of the protein fraction to be recovered and the optimal buffer 
to prepare NPs. After this first optimization, three concentrations of phage particles, 7, 14 and 
20 µg/ml, were tested with the purpose of verifying which concentration improves the 
sensitivity of the signal (Figure 4:6). 
 
 
Figure 4:6: Comparison of the binding affinity of NPs against different concentrations of AP-SA. 
 
The efficiency of each NPs suspension (eluted in 10 mM Tris-HCl, pH 8.0) was tested by 
direct ELISA against different concentrations of AP-SA. The highest signal was obtained for 
NPs at 20 µg/ml. In addition, a few stability tests were conducted, taking into consideration 
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the ratio A260/280 nm and the storage time (Figure 4:7). The results showed that the binding 
affinity of fresh NPs was greater than the NPs stored during 15 days (Figure 4:7–A), suggest-
ing that improvements should be considered to increase the shelf-life of these biomolecules. 
 
Figure 4:7: Stability tests considering the storage time and the ratio A260/280 nm as parameters. A: 
Dose-dependent binding comparison of fresh samples of NPs to a sample stored during 15 days. 
Different concentrations of AP-SA were used. B: Binding affinity of NPs at two different ratios when 
exposed to 50 µg/ml of AP-SA. BSA 0.1% and phage 7B1 were used as a negative and positive 
control, respectively.  
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When using equal NPs concentration but different A260/280 ratio (Figure 4:7–B), the bind-
ing affinity increased considerably for a ratio of 0.7 < A260/280  ≥ 0.5. The binding affinity of 
stored samples decreased approximately 56.5% compared to fresh samples (when NPs are 
exposed to 25 µg/ml of AP-SA). Based on these results, freshly NPs at 20 µg/ml were con-
sidered for the following affinity tests. In order to use a phage concentration equal to that of 
the NPs (20 µg/ml), calculations - as shown in an example below - were carried out to esti-
mate the phage coat protein present in whole phage: 
 
Parameters: 
Concentration of phage solution   2.64×1014vr/ml  2.64×1017vr/L 
                   
            023                     
4000 copies of major coat protein pVIII 
                                        
 
Calculation: 
                              
  
 
 
    
       023
             
 
   
        
 
 
             
 
 
4.1.2.4 . Binding Affinity of NPs Versus Parental Phage 
 
A direct ELISA was performed, allowing the confirmation of the specificity and dose-
dependent binding of NPs to the analyte - different concentrations of AP-SA. 
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Figure 4:8: Sigmoidal fit to ELISA data points indicates dose-dependent binding ( r
2
= 0.94) between 
NPs and AP-SA. Phage 7B1 and 0.1% BSA were used as a positive and negative control, respective-
ly. 
 
The dose-dependent binding obtained in Figure 4:8 showed NPs with the same affinity to 
the analyte as a parental phage, however based on sigmoidal fit, the NPs showed a sensitivity 
slightly higher than phage. The 0.1 % BSA solution demonstrated no binding. These results 
gave also the information on which concentration of AP-SA generates a suitable signal for 
inhibition (6.25 µg/ml). The affinity of NPs was also demonstrated using other ELISA for-
mat, i.e. by measuring the ability of NPs at different concentrations in solution to competi-
tively inhibit binding of AP-SA to an immobilized phage 7B1 (Figure 4:9). The competitive 
assay involved 0.1% BSA and the wild-type phage F8-5 as controls, which displayed 129 
times less binding to streptavidin than 7B1 phage, as demonstrated by [27].   
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Figure 4:9: A: Inhibition of AP-SA binding (6.25 µg/ml) by NPs at different concentrations. B: com-
pared with parental phage (7B1) Wild-type phage F8-5 and BSA 0.1% were used as a control. 
 
In the competitive assay, the parental phage 7B1 was immobilized on well surfaces that 
were filled with competitive phages and NPs. The inhibition ELISA assay presented in Figure 
4:9 showed that the non-immobilized NPs compete with immobilized phage for binding to 
their respective target (AP-SA), producing total inhibition when their concentration is be-
tween 20-60 µg/ml. Comparing the NPs inhibition in Figure 4:9–B with the positive control 
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(parental phage 7B1) and negative control (wild-type phage F8-5 and BSA) we can observe 
that NPs was a good competitor, displaying ~78% of efficient inhibition against 70%, 45 % 
and 18% obtained by 7B1, F8-5 and BSA, respectively.  
 
4.1.2.5 NPs Immobilization on Gold Surfaces 
 
NPs were immobilized on the sensor's surface by physical adsorption and the initial confir-
mation that NPs were successfully immobilized was obtained by Western blotting. This assay 
allowed us to measure the relative amount of the protein present in the sample and to confirm 
whether, after several washes, the NPs were correctly immobilized on the sensor surface with 
the assurance that unbound protein was completely removed.  
 
 
Figure 4:10: Western blot analysis showing the NPs immobilized on the sensor surface (band of ~5.8 
kDa). Kaleidoscopic ladder (on the left side). 
 
As can be observed in Figure 4:10, the band of 5.8 kDa refers to 7B1 NPs that remained 
immobilized on the surface after several washes.  It was found that, after the third wash, all 
unbound NPs were removed (results not shown).  
Following the evidence obtained by the binding affinity tests and the information that our 
NPs were immobilized over the gold surface (Figure 4:10), unpolished ME biosensors were 
coated with 20 µg/ml of NPs and exposed to 1.0 × 10
8 
streptavidin beads/ml. The decision of 
using an unpolished or polished sensor surface was based on preliminary observations in an 
optical microscope (Figure 4:11) which showed that the polished one contained some 
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scratches that might affect the binding of the biological element and unspecific streptavidin 
binding to the sensor surface.  
 
 
Figure 4:11: Optical images obtained by Nikon Eclipse L150 of streptavidin beads of 0.99 µm (A), 
polished ME sensor (B) and streptavidin bound on sensor surface (C and D). 
 
Indeed, beads retained on the scratched area were observed (Figure 4:11–C and Figure 
4:11–D) and consequently may result in a false positive signal during the measurement pro-
cess. Therefore, following experiments were done using unpolished sensors. The binding 
affinity images acquired by SEM are shown in Figure 4:12.  
Figure 4:12:A-C shows the binding affinity of NPs to the target (streptavidin beads). 
Streptavidin beads with a diameter of approximately 1 µm were selected to simulate the di-
mension of a bacterium, making this the ideal strategy model. Based on SEM observations 
and compared to the control sensor (Figure 4:12–D: sensor surface covered with 0.1% BSA) 
we can conclude that, when used as an interface, NPs display the same affinity and specificity 
as their parental phage. 
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Figure 4:12: SEM images of the ME biosensors exposed to 1.0 x10
8 
beads/ml when: A - sensor sur-
face is covered with nano-phages (NPs); B - sensor surface covered with entire phage 7B1; C – en-
larged view of the area of the sensor surface covered with nano-phages; D - sensor surface covered 
with 0.1% BSA (negative control). 
 
The enlarged view of the sensor surface on Figure 4:12–B allows us to observe how NPs 
were dispersed along the surface. The fact that no higher target density was obtained cannot 
directly be associated with NPs surface coverage. The loss of beads may be related to other 
aspects, for instance the intensity of the washing procedure, which may remove some beads 
that were bound specifically. Moreover, the weak bond of NPs to the sensor surface caused 
by the immobilization technique could be another reason for the target absence in various 
sites on the sensor surface.  
 
4.1.2.6 Analyte Binding Measurement 
 
Figure 4:13 shows the resonance frequency shifts of ME biosensors as a function of the 
concentration of streptavidin polystyrene beads, where each data point corresponds to the 
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mean value of the frequency readings from at least three sensors. It should be noted that the 
data were typically collected from a daily experiment and for each sensor the frequency was 
measured five times, followed by the calculation of  the mean value.  
 
 
Figure 4:13: Magnetoelastic biosensor’s responses, when exposed to increasing concentrations of 
streptavidin polystyrene beads. Negative controls were coated only with BSA 0.1%. The dotted line 
represents the mean value reached for control sensor when exposed to the highest concentration of 
streptavidin beads. 
 
When exposing the biosensors to an increasing concentration of streptavidin beads we 
observed an amplified signal compared to the control sensors. However, the results show 
some signal variability which is also reflected by the standard deviation. This fluctuation can 
be attributed to the sensor position inside the coil center; for each biosensor five measure-
ments were taken, meaning that the biosensor exits the coil center. After returning it is not 
able to take its exact previous position, which may result in signal variation.  
Damages on the sensor surface can also occur during the experiment, due to successive 
washing processes which lead to the removal of small portions of gold on the surface. As a 
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result, the resonance frequency will decrease and false negatives may occur. Despite the sig-
nal variation, the difference between biosensors and control sensors is notorious. 
 
4.1.3 Discussion 
 
Particles in nano-scale are relevant in various areas, with the food industry (e.g. 
nanoencapsulated vitamins) and the health sector (e.g. drug delivery) as good examples 
where this technology is needed. Filamentous phages are viruses that specifically recognize 
bacteria and therefore are promising entities to use as nanocarriers for drug delivery and as a 
detection tool for pathogens. In the biosensing field, the idea of using nano interfaces that can 
increase the biosensor sensitivity and consequently increase its performance, has gained more 
importance when phages are concerned. The entire phage forms aggregates, blocking the 
availability of receptors recognizing the target. In this work, we found that NPs (phage-
derived products) have affinity and sensitivity equal to their parental phage. When examining 
the dose-dependent binding we found that NPs had a 1.6 times higher affinity than the paren-
tal phage. Moreover, competitive assay showed that NPs-APSA interaction occurred, which 
inhibited the ligation between Phage and AP-SA. These results suggested that NPs may be 
used as a new type of substitute for entire phages and explored as a biological element in bio-
sensors with the same elevated specificity as their parental phage. Despite the promising re-
sults obtained with NPs, our findings suggested that specificity and sensitivity features can be 
further improved, taking in account some aspects. To avoid problems related with the NPs 
stability and activity we used immobilization by physical adsorption, however the ME sur-
faces were not completely covered with the target. Two reasons may be behind that result: 
either the washing procedures were too harsh or the immobilization technique failed. Other 
studies have reported different immobilization strategies using chemical functionalization and 
physical adsorption [17,18]. Both have advantages and disadvantages: physical adsorption is 
the simplest method, but the adsorbed biological elements can easily be removed during the 
washing steps due to the weak binding. On the other hand, chemical attachments can interfere 
with their stability and activity [15]. Researchers from Austria Biophysics Institute conducted 
some immobilization techniques and nanolithography tests using NPs. Two types of func-
tionalization were tested to obtain a stable attachment of the phage-particle to the surface: the 
use of bivalent ions and a single molecule layer of aminopropyltriethoxysilane (APTES). The 
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APTES allows the binding of molecules by electrostatic interaction as well as by charge ef-
fects, showing that using APTES coated mica led to a densely covered surface of nano-
phages. These results give the impression that an efficient immobilization step combined with 
the small size of the NPs enables a uniform surface coverage density, improving the interface 
sensitivity. Even further studies of NPs stability, specificity and immobilization need to be 
done, our results clearly show that replacement of filamentous phage for NPs is possible, in-
creasing the sensors sensitivity. This new approach can be used to develop biosensors with 
increased performance for early detection of food borne pathogens, cancer diseases and other 
pathologies. 
 
4.1.4 Conclusions 
 
As a proof-of-concept the features of NPs were demonstrated. This study proved that NPs can 
bind to streptavidin-coated beads with a binding affinity equal to or better than a parental 
phage. The two binding assays tested confirmed the NP´s binding specificity and sensitivity. 
When examining the dose-dependent binding we found that NPs had a 1.6 times higher affin-
ity than the entire phage. When immobilized to the ME sensor by physical adsorption NPs 
demonstrated specificity and selectivity towards the target analyte used for selection of the 
parental phage. However, the gold surface was not completely covered with the target, which 
led us to conclude that more studies related to the type of immobilization or the optimization 
of washing steps need to be implemented, to increase the target density on the surface without 
compromising the NPs activity. Besides their advantages concerning specificity and sensitivi-
ty, NPs may lead to a decrease of false positives at the detection level, since the protein re-
sponsible for infecting Escherichia coli is not present (pIII). This new perspective of phages 
by the introduction of a phage-derived product - NPs  can be a new format of interfaces that 
can contribute to the development of a robust and inexpensive biosensors for several applica-
tions.  
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Chapter 4 
4.2 Phage tail-fibre Proteins 
 
 
 
 
 
 
 
 
Parts of the work presented in this chapter is based on: 
 
 
Patent application PPI46027-12, entitled “Phage Tail Proteins for Specific Detection and 
Control of Salmonella Enterica”.Inventor(s): Azeredo, J., Kluskens, L., Santos, S., Silva, S., 
Fernandes, E., Lavigne, R., Vandersteegen, K., Cornelissen, A., August 2012. 
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Abstract 
 
Bacterio(phages) have been studied by many researchers as a potential recognition tool for 
detection systems due their excellent features, in particular their specificity. However, phages 
also have disadvantages such as their size, which can influence the successful capture of the 
interest target. The Salmonella phage used in this study belongs to the family Myoviridae and  
is characterized by an icosahedral head of 84 nm in apical diameter and a contractile tail of 
120 x 18 nm with short tail fibers. Since the recognition elements are peptides present in the 
phage tail fibers, the possibility to obtain a phage-derived detection tool, composed only by 
the recognition peptides, with the same specificity as their parental phage and excluding the 
rest of phage structure was studied. The phage tail fiber proteins (TFPs) were expressed 
heterologously in E. coli. The binding abilities of the expressed TFPs were assessed by im-
munofluorescence assays and by stereomicroscopic observations. The results revealed that 
TFPs exhibited the same signal intensity as the parental phage, showing the high binding ef-
ficiency of TFPs. This new approach can be used as a detection tool or a kit for the identifica-
tion of Salmonella strains in foodstuff, food processing equipment, food processing plants, 
food processing surfaces and in other areas where Salmonella might be present. 
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4.2 Introduction 
 
Foodborne diseases are of major concern due to their worldwide impact. The Center for Dis-
ease Control and Prevention (CDC) estimates that 76 million cases of foodborne diseases 
occur every year in the United States, causing roughly 5000 deaths [28]. From the reported 
cases, it has been observed that Salmonella is the most common and widely distributed caus-
ing agent constituting thus a major public health burden with significant impact in the society 
costs worldwide. Besides the effort that has been done to control this pathogen, including the 
general improvement of food safety knowledge and good practices, they are still a major 
cause of the increasing occurrence of foodborne diseases [29]. Moreover, the production and 
distribution of foodstuff increased dramatically in volume and in number of consumers, in-
creasing the risk of mass epidemics. Consequently, it is critical to identify and quantify the 
presence of such pathogen to monitor the safety of foodstuff and also to define strategies to 
reduce the number of outbreaks. The golden standard for Salmonella detection is still the bac-
teriological culture (ISO 6579:2002) which is time-consuming, laborious, expensive and inef-
fective in detecting non-cultivable organisms [30]. Salmonella detection methods typically 
take 3-5 days to obtain a result and during this long period portions of the food may have 
been distributed, marketed, sold, and eaten before a problem is even detected. A number of 
methods aiming at reducing the time required for the identification of foodborne pathogens 
have been developed, which include the use of antibodies to detect microbial antigens such as 
the enzyme-linked immunosorbent assay (ELISA) and nucleic acid-based techniques such as 
the polymerase chain reaction (PCR), DNA microarrays/DNA chips, sequencing-based iden-
tification and DNA hybridization [31–34].However, the sensitivity of immunological meth-
ods has been found to be low, with a variable specificity depending on the antibody used, 
commonly with the occurrence of cross-reactivity phenomena. Often, these methods do not 
allow the discrimination between dead and living microorganisms. Also, the feasibility of the 
method depends on the origin of samples [35].Despite the high sensitivity of the nucleic acid-
based techniques and their increased value in the detection of fastidious microorganisms, they 
usually require extensive sample preparation, often including a DNA extraction step. These 
procedures are laborious, expensive and time consuming and may not be enough to remove 
all the contaminants, commonly found in the samples, that may inhibit (or influence) the re-
actions needed for the microorganisms detection. Moreover, the nucleic acid-based tech-
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niques such as the PCR and microarrays demand a high initial investment in equipment and 
expertise personnel [36]. Bacteriophages (phages) are naturally evolved entities that due to 
their intrinsic characteristics present high potential in the control and detection of bacteria, 
namely foodborne pathogens. Phages are viruses that only infect bacteria and are obligate 
intracellular parasites lacking their own metabolism. They are extremely specific, usually 
infecting a single species or even strain and consequently they have been found to present 
potential in the rapid detection of bacteria [37]. Phage PVP-SE1 belongs to the family 
Myoviridae and is characterized by an icosahedral head of 84 nm in apical diameter and a 
contractile tail of 120 x 18 nm with short tail fibers. This phage has the ability to bind to a 
very broad range of Salmonella strains which makes it an interesting phage to be used in the 
detection of Salmonella [38]. In addition the lytic spectrum of this phage is broader than that 
described by Felix O1. PVP-SE1 is able to infect Salmonella several mutants defective in 
core polysaccharide assembly suggesting that the receptor for this phage is the conserved 
LPS inner core region and explains its broad lytic spectrum [39]. Therefore it is expected that 
the phage recognition elements located at the tail fibers, the tail fiber proteins (TFPs), may 
also exhibit binding abilities to a broad range of hosts. In the work described herein, TFPs 
were expressed heterogously and their binding abilities to Salmonella strains were assessed. 
This work constituted the first step towards the development of a phage-based sensor that 
makes use of the recognition elements instead of the entire phage particle. 
 
4.2.1 Materials and Methods 
 
 
4.2.1.1. Bacteriophages and Bacterial Strains 
 
 
In this work were used two Salmonella phages: PVP-SE1 and PVP-SE2. The phage PVP-SE1 
with a broad lytic spectrum against different Salmonella strains was isolated from a Regens-
burg (Germany) wastewater plant in a European Project Phagevet-P [38] and their host is 
Salmonella enterica serovar Enteritidis strain S1400 [40]. The Phage PVP-SE2 was isolated 
from raw sewage, wastewater treatment plant (Braga; Portugal) [40]. Their host is Salmonella 
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enterica serovar Enteritidis strain 821 was provided by Instituto Nacional Ricardo Jorge, Por-
tugal [40].  
 
4.2.1.2 Phage Propagation 
 
The phages were produced using the double layer agar technique as described by Sambrook 
and Russell [41]. Briefly, from the plaque forming units (PFU) obtained ten were selected 
and transferred several times to three new Petri dishes with the proper bacterial soft agar. 
Using sterile paper strips, the phages were spread by passing the strips several times on the 
production Petri dishes and incubated overnight at 37
o
C. Then, 3 to 10 ml of SM buffer was 
added to Petri dishes and incubated overnight at 4ºC (with agitation). The liquid was trans-
ferred to 50 ml tubes and centrifuged at 9000 x g during 10 min at 4ºC (Hettich Zentrifugen-
Universal 320) to remove the bacteria. One volume of chloroform was added to 4 volumes of 
supernatant and centrifuged at 9000 x g during 10 min at 4ºC. The top liquid phase was re-
moved carefully and filtered through a 0.2 µm filter (Minisart-Santorius stedim biotech). The 
phage titer was verified and the solution was stored at 4
o
C. 
 
4.2.1.3 Phage Purification 
 
The phage purification was performed by cesium chloride (CsCl) gradient ultracentrifugation 
[42]. Initially, heat-dried CsCl (MP Biomedicals, Illkirch, France) was added gradually to 15 
ml of phage in order to avoid an osmotic shock.  Four CsCl solutions were prepared (densi-
ties of 1.33, 1.45, 1.50 and 1.70 g/ml) and 5.7 ml per gradient was added (starting from the 
lowest to the higher density) and the solution was centrifuged at 28,000 x g at 4
o
C during 3 h. 
The phage was collected from the gradient (~3 ml, white cloud) and dialyzed. To hydrate the 
membrane, the Slide-A-Lyzer dialysis cassette (Pierce, Rockford, IL) was incubated in 1 L of 
1 × phage buffer [10 mM Tris-HCl, pH 7.5, 100 mM MgSO4, 150 mM NaCl]. Three ml of 
phage suspension was added in the dialysis cassette and dialyzed 3 times for 30 min against 
300 volumes of phage buffer. The pure phage preparation was collected and stored at 4°C. 
 
4.2.1.4 Isolation of the TFPs of Phage PVP-SE1 
 
Chapter 4. Development of a Detection Tool Based on Phage Recognition Peptides 
147 
 
Followed the general procedures explained previously, the cloning, expression and purifica-
tion of the tail proteins of the Salmonella Enteritidis phage PVP-SE1 was performed as de-
tailed below.  
 
4.2.1.5 Design of Primers 
 
Primers used for the gene amplification were based on the genes encoding the tail fiber pro-
teins of PVP-SE1 and developed using programs like Expasy Translate, BLAST analysis and 
Phyre.  
 
Table 4:2: Information of primers used for the sequencing reaction. 
 
 
4.2.5.1 PCR Amplification 
 
50 µl of PCR sample was performed using: 15 µl of genomic DNA; 5 µl of 10 x Pfu buffer + 
MgSO4; 1 µl of 10 mM dNTP Mix; 0.5 µl of forward primer; 0.5 µl of reverse primer; 0.5 µl 
of Pfu DNA polymerase and 27.5 µl  of Milli-Q water. The samples were sealed with a drop 
of mineral oil. PCR amplification was carried out in a thermal cycler with an initial denatura-
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tion at 95
o
C (2 min), followed by 35 cycles at 95
o
C (30 s), incubation at the annealing tem-
perature for each primer pair during 30 s and extension at 72
o
C during 4 min for gp40, 41 and 
46; 2 min for gp51 and 53; finishing with a final extension at 72
o
C during 10 min and storage 
at 4
o
C thereafter. Amplified products were subjected to electrophoresis on 1 % agarose gels 
(the agarose (Eurogenetic, Luik, Belgium) was dissolved in TAE buffer (40 mM Tris-HCl, 
0.5mM sodium acetate, 50mM EDTA, pH 7.2) and added 2 µl of ethidium bromide at 1 
mg/ml (Cambrex NJ, USA)). PCR products were purified using QIAquick PCR purification 
kit (Qiagen). After purification, the samples were stored at -20
o
C.  
 
4.2.5.2 Vector Preparation 
 
An overnight culture was prepared with 14 ml of LB medium, 4 µl of kanamycin at 50 µg/ml 
and 25 µl of XL1-Blue / pNIC28-Bsa4 from glycerol stock.  
The plasmid DNA extraction and purification was performed using QIAprep spin 
Miniprep Kit as described in manufacture's protocol. The elution step was done with 30 µl of 
Milli-Q water and the plasmid DNA analyzed by electrophoresis.  
 
4.2.5.3 Restriction with BsaI 
 
The vector was cut with restriction enzyme BsaI. A reaction mixture containing 23.40 µl of 
pNIC28-Bsa4, 10 µl of 10 × Buffer G (Fermentas), 3 µl of BsaI restriction enzyme 
(Fermentas) and Milli-Q water was added to obtain a total volume of 100 µl and was incubat-
ed during 3 h at 37
o
C and stored a 4
o
C. However, during the time of incubation, 3 µl of extra 
restriction enzyme was added after 1 h. The restriction step was verified by agarose gel and 
the plasmid DNA was purified.  
 
4.2.5.4 Generation of Cohesive Ends 
 
The insert preparation was done in 10 µl reaction mix: 3 µl of DNA (PCR product), 2 µl of 
5x T4 DNA polymerase buffer, 0.25 µl of 100 mM dCTP, 0.5 µl of 100 mM DTT, 0.1 µl of 
100 × BSA, 0.25 µL of T4 DNA polymerase and 3.9 µl of Milli-Q water. The reaction mix 
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was incubated at 22
o
C during 30 min and inactivated at 75
o
C during 20 min and stored until 
use at 4
o
C. 
 
The vector preparation was conducted in a total volume of 100 µl with the exception of 
addition of dGTP. The reaction mixture was done using: 50 µl of BsaI-digested plasmid, 20 
µl of 5 × T4 DNA polymerase buffer, 2.5 µl of dGTP (100 mM), 1 µL of 100 × Bsa, 5 µl of 
DTT (100 mM), 19 µl of Milli-Q water and 2.5 µl of T4 DNA polymerase. The mixture was 
incubated for 3 h at 37
o
C and stored a 4
o
C. 
 
4.2.5.5 Ligation  
 
6 µl of a ligation mixture containing 2 µl of treated vector and 4 µl of treated insert was incu-
bated at 22
o
C during 20 min and then transferred to ice. 
 
4.2.5.6 Transformation 
 
Initially LB agar plates with 50 µg/ml of kanamycin and 5% (w/v) of sucrose were prepared 
and an electroporation of E.coli XL Blue was done at 1.7 kV. The cells were recovered by 
adding 960 μl of pre-warmed SOC medium (2% Trypton, 0.5% Yeast extract, 0.05% NaCl, 
10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose) and incubated at 37
o
C during 1 h at 250 
rpm. The cells were then plated on LB solid medium containing kanamycin and incubated 
overnight at 37
o
C. 
 
4.2.5. 7 Colony Analysis 
 
Individual colonies of each transformation were collected with a toothpick and placed in 
glass tube containing 4 ml of LB medium and 4 µl of kanamycin and incubated overnight at 
37
o
C. The cultures were used for colony PCR and for glycerol stock preservation at -20
o
C 
and - 80
o
C. 1.5 ml of liquid culture was used for plasmid purification. 10 µl of the overnight 
culture was used in a 50 µl PCR mix and the end products verified on a 1 % agarose gel. 
  
 
Chapter 4. Development of a Detection Tool Based on Phage Recognition Peptides 
 
150 
 
4.2.5.8 DNA Sequencing 
 
Purified plasmids containing inserts were sequenced from one direction. 10 µl of sequencing 
reaction was prepared containing 1 µl of DNA plasmid, 1 µl of primer, 2 µl of 5 × sequenc-
ing Buffer, 0.5 µl of BigDye terminator and 5.5 µl of Milli-Q water. The samples were pre-
pared in a thermal cycler using the program described previously. After standard ethanol pre-
cipitation and added formamide the samples were analyzed using ABI 3130 genetic analyzer 
(Applied Biosystems) and the sequences were assembled with the Sequencer 4.1 software 
(Genecodes). 
 
4.2.5.9 Small-scale Protein Expression 
 
Small-scale protein expression was carried out at two different temperatures: 16
o
C and 37
o
C.  
 
4.2.5.10 Cell Growth and Induction 
 
A volume of 80 µl of overnight culture was inoculated in 4 ml of LB medium with 4 µl of 
kanamycin (50 µg/ml) and incubated at 37
o
C until OD600nm=0.6. Then, two cultures were 
induced with 4 µl of IPTG (1/1000) and incubated overnight at 16
o
C and during 4 h at 37
o
C. 
As a control, two non-induced cultures were included. 
 
4.2.5.11 Induced Culture 
 
A: After 4 h of induction, the induced cultures were centrifuged at 8,500 x g during 10 min. 
The supernatant was removed and the pellet was resuspended with 1 ml of lysis buffer (10 
mM imidazole). The volume was frozen and thawed three times, followed by sonication of 15 
sec in 3 cycles (1 cycle/5 sec) at 40 % of amplitude.  
 
B: Total protein fraction (TPF): a mixture containing 150 µl of the sample prepared be-
fore, 50 µl of SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel electrophoresis) and 
4 × loading buffer was prepared. This mixture was stored at 4
o
C.  
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Soluble protein fraction (SPF): 150 µl of the sample prepared in A was centrifuged at 
8,500 x g during 10 min. Then, 120 µl of supernatant was transferred to a new tube and 40 µl 
of 4 × SDS-PAGE loading buffer was added. This mixture was stored at 4
o
C.  
 
C: Insoluble protein fraction (IPF): the remaining supernatant was removed and the pellet 
was resuspended in 200 µl of Milli-Q water. The mixture was centrifuged at 8,500 x g during 
10 min and the supernatant was removed. The pellet was resuspended in 150 µl of lysis buff-
er (10 mM imidazole) and 150 µl of 4x SDS-PAGE loading buffer was added. The mixture 
was stored at 4
o
C. 
 
The different fractions TPF, SPF and ISF were analyzed by SDS-PAGE and compared to 
a low molecular weight (LMW) ladder. A sample of 16 µl stored at 4
o
C was heated at 95
o
C 
during 2 min and then loaded on the appropriate gel. The gel was run at 200 V during approx-
imately 1 h. 
 
4.2.5.12  Binding Ability of the Tail Proteins of Phage PVP-SE1 by Immunofluorescence 
Assay 
 
The TFPs at concentrations of 100 μg/ml, 200 μg/ml, 300 μg/ml, 400 μg/ml and 500 μg/ml in 
PB (phosphate buffer 0.1 M, pH 7.5; 3.1 g NaH2PO4.H2O, 10.9 g Na2HPO4) or SM (100 mM 
NaCl, 8 mM MgSO4, 50 mM Tris-HCl, pH 7.5) and the positive/negative controls were im-
mobilized onto a polystyrene microtiter plate by passive adsorption and incubated during 2 h 
at room temperature, followed by a three times washing procedure with PB or SM. Positive 
controls consist of Salmonella spp Polyclonal Antibody (200 μg/ml) and PVP-SE1 (phage 
stock at a concentration 1.0x10
10
 pfu's/ml). Negative controls consisted of bovine serum al-
bumin (BSA) 5% in PB and PB or SM. After the immobilization of tail proteins, 1% of BSA 
in PB was added as a blocking agent to each well followed by a 40 min incubation at room 
temperature and three times washing with PB. One hundred milliliter of an exponential cul-
ture of S. Enteritidis S1400 grown in LB (37ºC, 120 rpm) until an optical density of 0.4 at 
600 nm (corresponding to 1.0x10
9
 cells/ml), was added to each well followed by a 1 h incu-
bation period at room temperature. After a washing step with PB to remove unbound bacteria, 
the wells were filled with 100 μl of Salmonella spp. Polyclonal Antibody, Biotin conjugated 
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at 200 μg/ml (Thermo Scientific, ref PA1-73022) and incubated during 1 h. After, the wells 
were washed with PB and filled with 100 μl conjugated Streptavidin Rhodamine (TRITC, 
Pierce, ref 21724) at 20 μg/ml and incubated for 40 min at room temperature. After several 
washes with PB, a volume of 100 μl of PB was added to each well and the fluorescence was 
measured by a Synergy H1 microplate reader at 520 nm of excitation and at 570 nm of emis-
sion.  
 
4.2.5.13 Binding Affinity of the Tail Proteins of Phage PVP-SE1 Immobilized on Gold 
(Au) Substrates 
 
Au substrates (7x7 mm) were incubated for 2 h in Microstrip® 3001 (Fujifilm Electronic 
Materials, Belgium) at 65ºC for removal of the protective coating of photoresistive polymer. 
The substrates were then washed three times with isopropanol and sterile, distilled water and 
dried under a N2 stream. After the cleaning step, the tail proteins (200 μg/ml, prepared in SM 
buffer) were immobilized by physical adsorption on the Au substrates in spots of 1 μl and 
incubated for 4 h at room temperature in a humidified atmosphere, in order to prevent evapo-
ration. The unbound tail proteins were removed by washing three times with SM buffer. The 
spots were then incubated with the blocking agent BSA 1% prepared in TE during 45 min 
and the excess of blocking solution was removed by washing the substrate with PB (0.1 M, 
pH 7.5). All substrates were exposed to 2.8x10
9
 cells/ml during 1 h and washed with PB 
(0.1M, pH 7.4) and distilled water. The bacterial coverage extent “in spot” and “out spot” 
was visualized by a Nikon SMZ 1500 microscope. 
 
4.2.2 Results 
 
The tail fiber proteins (TFPs) used for the preliminary binding ability tests were gp40 and 
gp51. Protein expression was tested using two different temperatures (16 and 37
o
C). After the 
establishment of the optimal temperature, both TFPs were expressed and purified according 
the protocol described in the materials and methods section. A representative image of pro-
tein expression and purification is shown in Appendix B.2.   
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4.1.4.1 Binding Ability of the Tail Fiber Proteins (TFPs) 
 
The TFPs were tested using an immunofluorescence assay and based on intensity signal it 
was possible to confirm their binding affinity as shown in Figure 4:14. 
 
 
Figure 4:14: Fluorescence intensity measured at 520 nm in the wells coated with different concentra-
tions of PVP-SE1 gp40 and PVP-SE1 gp51 in 0.1M PB buffer or SM buffer. 
 
The results of the fluorescence intensity in Figure 4:14 showed that both the buffer com-
position and the protein concentration influence the signal intensity. Gp40 presents a higher 
signal in 0.1 M PB buffer at 200 μg/ml, while gp51 gives better results in SM buffer at 200 
μg/ml. This preliminary study has shown that these two variables need to be optimized for 
each tail protein. The peptides in their optimal concentration (which gave the higher intensity 
signal) were tested and compared with positive controls such as phage PVP-SE1 and Salmo-
nella Polyclonal antibody. As a negative control BSA 5% was used (Figure 4:15). 
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Figure 4:15: Fluorescence intensity measured at 520 nm in the wells coated with 200 μg/ml PVP-
SE1gp40 and PVP-SE1gp51. Negative control was BSA (5%) and as positive controls: the phage 
PVP-SE1 (1×10
9pfu’s/ml) and Salmonella Polyclonal Antibody. 
 
When comparing the tail fiber peptides gp40 and 51 with the positive and negative con-
trols we can observe that the tail proteins showa signal intensity similar to that of the Salmo-
nella Polyclonal antibody and the entire phage particle. 
Following the confirmation by the immunofluorescence assay, the TFPs were immobi-
lized by physical adsorption on gold substrates. The bacterial attachment was optically con-
firmed (Figure 4:16). 
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Figure 4:16: Images obtained by Nikon SMZ 1500 Stereomicroscope showing the bacteria surface 
coverage in the area in which PVP-SE1gp51 was immobilized on gold substrates specifically recog-
nizing Salmonella Enteritidis cells. A: PVP-SE1gp51 at 200 μg/ml, B: PVP-SE1gp51 at approximate-
ly 10 mg/ml, C: PVP-SE1gp51 at 10 mg/ml and a Negative control of Salmonella Enteritidis cells 
detection using a spot of unspecific protein (Bovine Serum Albumin-BSA) (Image D). The Positive 
Control (E) shows spots of immobilized PVP-SE1 phage on gold substrate specifically recognizing 
Salmonella Enteritidis cells. 
 
In Figure 4:16, the surface coverage obtained was consistent with the results reported 
previously by immunofluorescence assay, meaning that the tail protein concentration influ-
ences its binding ability. Moreover, the binding ability of the tail protein seems equal to that 
of the entire phage PVP-SE1. 
 
4.2.3 Discussion 
 
The specificity and the low cost production are unquestionable qualities of phages. However, 
bearing in mind their use as a detection tool, the phage structure can be a limitation, because 
its size can compromise the number of cells attached to the surface. Moreover, the presence 
of the lytic activity can also be a problem when our purpose is to only recognize, without 
lysing the cell. Thus, TFPs can circumvent these limitations due to their small size and inabil-
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ity to lyse bacterial cells. PVP-SE1 has a broad host range among salmonellae [38] which 
represents an added value when the goal is to select a TFP specific for a Salmonella strain, 
However this phage is also able to infect some E. coli strains [38] and therefore it is neces-
sary to test the binding affinity in order to understand which tail is responsible for the recog-
nition of what strain. It is likely that more than one tail is required for the recognition of a 
broader panel of strains and we therefore need to consider the use of a mixture of tails. The 
TFPs tested in the work described herein  work showed a binding affinity similar to the pa-
rental phage and only slightly inferior to that of  a specific antibody (~10% less binding). The 
use of phage-derived molecules has been suggested by other researchers [43], with the studies 
involving P22 as a good example [44, 45]. A recent publication of Singh et al. [44] suggested 
the use of tailspike proteins (TSPs) to detect Salmonella Typhimurium. The TSPs were engi-
neered to express cysteine tags at their N- or C-termini, immobilized onto gold substrates 
using thiol-chemistry. The authors  found that the appropriate orientation of the TSPs on the 
surface is important for efficient capture of the host bacterium. When applying that infor-
mation to our study, we might be able to explain the difference of binding between the TFPs 
and the polyclonal antibody. It may be that, due to their orientation,  a small amount of the 
phage derivatives was not able to detect Salmonella. When immobilized over the gold sub-
strates the results were also promising, proving that further tests should be implemented to 
improve even more their potential as a detection tool. Immobilization techniques, stability 
and specificity are some examples of the points that need more attention . Despite their speci-
ficity, in general, the tail proteins are more stable than antibodies and their manufacturing 
costs can also be competitive. Thus, we have in our hands an excellent tool to explore in the 
biosensing area, leading to the development of a helper device that could be applied in the 
biomedical field.  
 
4.2.4 Conclusions 
 
The use of phages has been mentioned in different studies related with biosensors, but apply-
ing them as whole entity in a detection tool can be a problem, since this may limit the surface 
to capture a high target density.  The development of nanomolecules to use in biosensors has 
kept the interest of many researchers.  Accordingly, TFPs can be considered as a potential 
nanomolecule to compete with their parental phage. Considering this particular case, our 
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phage dimensions are 84 nm (head) and 120 by 18 nm (tail) and therefore too big when the 
aim is to obtain a thin and uniform active layer. The tails used in this work, namely gp40 and 
gp51, showed a binding ability similar to that of the parental phage, suggesting that their re-
placement can be possible. When immobilized over the gold substrates the results were in 
agreement with those from tests in an immunofluorescence assay. However, TFP efficiency 
can still be further improved by studying their stability and binding affinity in detail.  
TFPs are promising biological elements that may find use in various detection systems or 
even in treatment of Gram-negative contamination of foodstuff, food processing equipment, 
food processing plants, surfaces coming into contact with foodstuff, medical devices, surfaces 
in hospitals and surgeries, or environmental samples.  
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Conclusions and Future Perspectives 
5 Conclusions and Future Perspectives 
The research work described in this thesis aimed at addressing the necessities in developing a 
biosensor that can fulfil the requirements of systems that detect foodborne pathogens, using 
bacteriophages as a potential recognition tool.  
This chapter is divided into four sections, corresponding to the main conclusions and fu-
ture perspectives obtained along the different steps, which contributed to achieve the overall 
objective of the work described herein.  
 
5.1 Salmonella Phage 
 
The initial experimental work of this thesis was the selection and characterization of Salmo-
nella phages with the objective to find a good candidate to explore as a biological element for 
biosensing purposes. The phage PVP-SE1 was the one exhibiting the broadest lytic spectrum 
and thus the phage with the greatest potential as bioelement in biosensing systems. Due to its 
multivalent characteristics we proved that PVP-SE1 can be propagated in a nonpathogenic 
strain, maintaining its binding abilities. In economic and market perspectives, this property 
can be used to develop a safe product, and might even lead to lower production costs. To de-
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velop reliable bio-interfaces in a detection device, the biological element should be a small 
active molecule, allowing a homogenous and uniform surface coverage with an efficient 
binding ability to the target. Biorecognition is not necessary restricted to the phage’s whole 
structure, since the binding ability of phages is made through their host recognition peptides. 
Accordingly, genes encoding the host binding peptides of two of the selected phages were 
identified, aiming at using this information for the development of biosensing systems with 
host recognition peptides as an interface.  
 
5.2 Phage PVP-SE1 as a Biorecognition Interface 
 
The first approach used in the development of a biosensing system to detect Salmonella was 
based on the use of entire phage particles. The proof-of-concept was established with phage 
PVP-SE1 using a magnetoresistive platform. This was the first time that lytic phages were 
used as bioelements in biosensing devices, in fact, only temperate and filamentous phages 
have been previously tested due to their non-lytic behavior. Accordingly, the great challenge 
of this work was obtain an active and non-lytic interface built with entire phage particles. 
This was possible after testing and optimizing the immobilization conditions of the phage on 
the sensor’s surface.  Furthermore, the binding ability of phages immobilized over a magne-
toresistive platform (MR) to bacteria in different viability states was assessed. Surprisingly, 
the phage-based magnetoresistive biosensor showed a great ability to distinguish among vi-
able, VBNC and heat-killed cells. The phage infection parameters were also tested and con-
firmed the results given by the MR platform. Indeed, phage PVP-SE1 has a different adsorp-
tion profile for viable (including the VBNC) cells than for cells killed, namely 80% of ad-
sorption against 20%, respectively. Besides the evidence showing that phage may not recog-
nize bleach-killed cells, we suggested to include viability assessment tests, cells killed under 
different conditions, simulating real environment situations. Including this type of experi-
ments, it will be possible to determine whether the phage's behavior maintains constant for a 
diverse range of samples. Another interesting feature to develop in the future, which was not 
possible in this work due to equipment limitations, is to sort the different viability states of 
the cell populations by flow cytometry and test them in a MR platform. This technique will 
allow us to obtain separate samples from a heterogeneous population with different viability 
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states and will analyze how each bacterial population contributes to the measured signal. Be-
side the binding affinity tests, the shelf-life of the phage-based biosensor should be an impor-
tant issue to be considered and monitored in the future.  
 
5.3 A detection tool based on host recognition peptides of phage 
origin 
 
The second approach used in the development of a biosensing system to detect Salmonella 
was based on the use of host recognition peptides derived from lytic and filamentous phages. 
The proof-of-concept was established with filamentous phages, by creating peptides called 
"nano-phages" (NPs) with the ability to bind to streptavidin. The binding ability of NPs to 
streptavidin beads (mimetizing bacterial cells) was compared to that of filamentous phages by 
different ELISA assay formats. NPs bound approximately 1.6 times better than the parental 
phage, which was an excellent indicator that this different application  of phage compounds 
can be used as an alternative, increasing thus the sensor's performance. Tests were also con-
ducted in a magnetoelastic (ME) sensor. Although the results presented some variation, SEM 
observations of the gold surfaces coated with NPs or phage confirmed the different binding 
patterns to streptavidin beads. Nevertheless, the binding efficiency can be improved, testing 
other types of immobilization techniques to allow the orientation of the NPs on the surface 
leaving the active parts available to capture the target. Moreover, changes in the washing pro-
cedures should be implemented in order to understand how these implicate the binding effi-
ciency. The results obtained were the starting point of multiple assays that may lead to devel-
opment of a robust and reliable biosensor.  
This new approach was also confirmed using two heterologously expressed tail fiber pro-
teins (TFPs) of PVP-SE1. The binding affinity of these proteins tested in an ELISA format 
was found to be equal to that of the entire phage. The results showed that TFPs binding af-
finities are sensitive to buffers changes, suggesting that more conditions should be considered 
to test their stability. When immobilized on gold substrates (a metal widely used on trans-
ducer platforms) results showed that this substrate can be used without losing the TFP´s bind-
ing capability.  
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Overall the results presented in this thesis showed that with phages is possible to con-
struct smart biofunctional surfaces with high specificity, sensitivity and, contribute for the 
decreasing of false and negative results, leading to the introduction of phage-based biosensors 
as a new generation of biosensors.  
 
5.4 Answering the important issues... 
  
1) Will the phage preserve its excellent feature as specificity when immobilized on a sen-
sor surface? Yes, PVP-SE1 as entire phage was immobilized in a MR platform and 
their specificity was evident against the target. Also, they challenged their capabilities 
when showing their potential as a viability assessment tool. 
 
2) Can we use phage derivatives as a detection tool? Yes, phage derivatives from two 
different types of phages were tested and both showed to have potential as an alterna-
tive for the entire phage structure.  
 
3) Even showing promising results, what is missing? Validation. Regarding the phage-
based MR platform, the specificity should be analyzed with samples containing dif-
ferent targets and real samples also still need to be tested, in order to understand how 
they can influence the measurement. The binding affinity should be tested compared 
against other validated platforms under the same conditions. With regard to using 
phage derivatives as an interface, the same tests need to be considered. Stability tests 
are also necessary to construct a robust and reliable biosensor.  
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Appendices 
 
Appendix A:  
 
Information on the CD attached to this document. 
 
Appendix B:  
 
B.1. Preparation of Sepharose column  
  
(Sepharose CL-6B -Amersham Biosciences) 
 
Packing Buffer: Packing Buffer/Running Buffer  
a) 10mM Sodium Chloate  
b) 10mM Tris-HCl, pH 8.0  
c) 0.2mM EDTA  
 
Sepharose Chromatography Column:  
a) Mix 48mL sepharose with 192mL Packing Buffer.  
b) Degas slurry for 20min.  
c) Mix by swirling gently and pour the slurry into the column in one continuous motion along a 
glass rod held against the column.  
d) Fill the column reservoir to the top with buffer.  
e) Allow the column to pack, ensure that the buffer doesn’t drain out of the column. Leave about 
1cm of buffer above the surface of the column.  
f) Stop the flow by closing the stopcock at the bottom of the column.  
g) When the column is ready, connect all tubing and ensure there is no air bubbles in the flow 
path.  
h) Equilibate the column with packing buffer until a stable baseline is achieved.  
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B.2. Phage tail-fibre Proteins 
 
The small-scale protein expression of the tail protein gp51 tested at different temperatures: 
16
o
C and 37
o
C.  
 
Figure B.2: (representative example) SDS-PAGE analysis of the expression and purification of 
PVP-SE1gp51 and PVP-SE1gp53. The SDS-PAGE analysis shows non-induced protein (1 and 6), 
total protein fraction (2 and 7), soluble protein fraction (3 and 8), insoluble protein fraction (4 and 9) 
and the LMW ladder (5).  
 
Optimal temperature = 37
o
C.   
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